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 ABSTRACT 
 
Stress related to chronic exercise affects both the immune and endocrine systems, but there 
are still many issues that are poorly understood, particularly effects of stress on the 
functional capacity of immune cells.  This thesis probed some of these issues using 
physiological models of physical and psychological stress.  Both exercise training stress and 
chronic psychological stress in human subjects were shown to result in an up-regulation of 
spontaneous reactivity of white blood cells in vitro, using two different assays, namely a) a 
peripheral blood mononuclear cell (PBMC) culture assay measuring immune cell 
responsiveness and b) a relatively new flow cytometry technique for assessing activation 
status of cells by their expression of the surface marker CD69, in a lymphocyte 
subpopulation-specific manner.  An up-regulation of immune cell activation in the absence of 
an additional stressor was associated with a decreased capacity to mount a response to a 
subsequent mitogen stimulus in vitro after chronic psychological stress and acute, extreme 
exercise stress.  Another novel finding was that cortisol high-responders to chronic 
psychological stress exhibited a higher spontaneous reactivity of both CD4+ and CD8+ 
lymphocytes when compared to cortisol low-responders.  This result indicates that chronic 
exposure to cortisol may decrease its usual inhibitory effect on spontaneous T lymphocyte 
responsiveness.   
 
After optimisation of an animal model of mild, psychological stress, we demonstrated (using 
an IL-6 antibody) that IL-6 is necessary for a full-blown cortisol response to chronic, 
intermittent mild stress.  Results also suggest that IL-6 plays a role in regulation of its own 
secretion by PBMCs in response to a stressor, by maintaining the production of IL-1β in the 
face of stress.  Basal serum corticosterone concentration was shown to be the main 
determinant of the magnitude of mitogen-stimulated PBMC secretion of IL-6 in vitro in the 
stress-free controls.  However, after blocking of IL-6 in vivo, IL-1β was identified as a major 
regulator of IL-6 secretion by mitogen-stimulated PBMCs in vitro, independently of the 
presence or absence of stress.  The implications of these novel findings are that pro-
inflammatory cytokines are sensitively regulated during mild stress. 
 
 Mean serum cortisol concentration at rest was not a useful tool to assess chronic exercise 
stress after training intervention.  However, classification of athletes at baseline into two 
groups according to their resting serum cortisol concentration illustrated two distinct patterns 
for the responses of both cortisol and the cortisol:testosterone ratio to chronic stress.   
 
These studies on the effects of chronic stress on parameters of the endocrine stress-axis 
and the immune system led to the following main conclusions: a) chronic exposure to cortisol 
results in a decreased inhibition of spontaneous immune cell activity at rest, b) this increased 
spontaneous activation of immune cells at rest in the absence of a stressor, is associated 
with a suppression of immune capacity to respond to a subsequent challenge, c) the latter 
finding is not evident under stress-free conditions where cortisol promoted immune cell IL-6 
secretion, and d) IL- 1β and IL-6 are involved in the regulation of each others’ secretion. 
 OPSOMMING 
 
Chroniese oefening-verwante stres beïnvloed beide the immuun- en endokriene sisteme, 
maar daar is nog baie aspekte wat swak begryp word, veral m.b.t. die effekte van stres op 
die funksionele kapasiteit van immuunselle.  Hierdie tesis het sommige van dié vraagpunte 
ondersoek deur gebruik te maak van fisiologiese en psigologiese stres.  Beide oefening 
program-verwante stres en chroniese psigologiese stres in proefpersone het ‘n op-regulering 
van spontane witbloedselreaktiwiteit in vitro tot gevolg gehad, wat d.m.v twee verskillende 
metodes aangetoon is, naamlik a) ‘n perifere bloed mononukluêre selkultuur (PBMS-kultuur) 
bepaling van immuunsel reaktiwiteit en b) ‘n relatief nuwe vloeisitometriese tegniek vir die 
assessering van aktiveringsstatus van selle, deur hul uitdrukking van die oppervlakmerker 
CD69, op ‘n limfosiet subpopulasie-spesifieke wyse.  ‘n Opregulering van 
immuunselaktiwiteit in die afwesigheid van ‘n addisionele stressor is geassosieer met ‘n 
verlaagde kapsiteit om te reageer op ‘n latere mitogeniese prikkel in vitro, na chroniese 
psigologiese stres en akute, erge oefeningstres.  Nog ‘n nuwe bevinding was dat kortisol 
hoog-respondeerders, in reaksie op chroniese psigologiese stres, ‘n hoër spontane 
reaktiwiteit van beide CD4+- and CD8+-limfosiete toon in vergelyking met kortisol laag-
resopndeerders.  Hierdie bevinding toon aan dat chroniese blootstelling aan kortisol die 
inhiberende effek daarvan op spontane reaktiwiteit van T-limfosiete verminder.   
 
Na optimalisering van ‘n rotmodel van gematigde, psigologiese stres, het ons gedemonstreer 
(deur gebruik te maak van ‘n IL-6 teenliggaam) dat IL-6 nodig is vir ‘n volledige 
kortisolreaksie op chroniese, onderbroke, gematigde stres. Die resultate dui daarop dat IL-6 
‘n rol in die regulering van sy eie sekresie deur PBMSe in reaksie tot ‘n stressor speel, deur 
die handhawing van produksie van IL-1β in die teenwoordigheid van stres.  Basale serum 
kortisolkonsentrasie is as die belangrikste beslissende faktor in die omvang van mitogeen-
gestimuleerde PBMS sekresie van IL-6 in vitro in die stresvrye kontroles aangedui.  Na 
blokkering van IL-6 in vivo, is IL-1β egter as ‘n belangrike reguleerder van IL-6 sekresie deur 
mitogeen-gestimuleerde PBMSe in vitro geïdentifiseer, onafhanklik van die teenwoordigheid 
of afwesigheid van stres.  Die implikasie van hierdie nuwe bevindinge is dat pro-
inflammatoriese sitokiene tydens gematigde stres sensitief gereguleer word.  
 Die gemiddelde serum kortisolkonsentrasie in ‘n rustende toestand was nie ‘n gepaste 
instrument om chroniese oefeningstres na ‘n oefenprogram-ingreep te assesseer nie.  Na 
basislyn klassifikasie van atlete in twee groepe volgens hul rustende serum 
kortisolkonsentrasie, is twee afsonderlike patrone vir die reaksie van beide kortisol en die 
kortisol:testosteroon verhouding egter aangetoon.   
 
Hierdie studies rakende die effekte van chroniese stres op parameters van die endokriene 
stres-as en die immuunsisteem het tot die volgende vernaamste gevolgtrekkings gelei: a) 
chroniese blootstelling aan kortisol het ‘n verlaagde inhibisie van spontane 
immuunselaktiwiteit tydens rustende toestande tot gevolg,  b) hierdie verhoogde spontane 
aktivering van immuunselle tydens ‘n rustende toestand word geassosieer met ‘n 
onderdrukking van immuunkapasiteit om te reageer op ‘n daaropvolgende prikkel, c) 
laasgenoemde bevinding is nie sigbaar tydens stresvrye toestande, wanneer kortisol IL-6 
sekresie bevorder, nie en d) IL- 1β en IL-6 is betrokke by die regulering van mekaar se 
sekresie. 
 
  
 
 TABLE OF CONTENTS 
 
 
Acknowledgements……………………………………………………………………….. 
List of publications and conference contributions...…………………………………… 
List of figures………………………………………………………………………………. 
List of tables……………………………………………………………………………….. 
List of abbreviations………………………………………………………………………. 
 
Chapter 1 
 
Introduction 
 
1.1 General introduction………………………………………………………………….. 
1.2 Overview of the immune system……………………………………………………. 
1.2.1 White blood cells………………………………………………………….. 
1.2.2 Immune cell function……………………………………………………… 
1.2.3 Cytokines………………………………………………………………….. 
1.2.4 Interaction between WBCs and cytokines……………………………... 
1.2.5 Immune functional tests………………………………………………….. 
1.3 Overview of the endocrine stress-axis……………………………………………... 
1.3.1 The hypothalamo-pituitary-adrenal (HPA-) axis………………………. 
1.3.2 Cortisol receptors and binding globulins……………………………….. 
1.3.3 Endocrine anti-glucocorticoid agents…………………………………… 
1.4 Involvement of the endocrine stress-axis and immune system in the general 
stress response………………………………………………………………………. 
1.4.1 Immune response………………………………………………………… 
1.4.2 Anti-inflammatory response……………………………………………… 
1.4.3 Other stress-associated effects of glucocorticoids..…………………... 
1.5 Summary………………………………………………………………………………. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 
 
i 
ii 
iv 
vi 
vii 
 
 
 
 
 
1 
3 
3 
7 
7 
10 
12 
14 
14 
15 
17 
 
19 
19 
20 
20 
21 
 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter 2 
 
Literature review 
 
2.1 Immune and cytokine system responses to exercise stress…..………………… 
2.1.1 Responses to acute stress.……………………………………………… 
2.1.2 Responses to chronic exercise stress (training)………………………. 
2.1.3 Responses in overreaching and overtraining………………………….. 
2.2 Immune and cytokine responses to psychological stress………………………... 
2.3 Responses of the endocrine stress-axis to exercise stress……………………… 
2.3.1 Responses to acute exercise stress……………………………………. 
2.3.2 Responses to chronic exercise stress (training)………………………. 
2.3.3 Responses to overreaching and overtraining………………………….. 
2.4 Endocrine responses to psychological stress……………………………………... 
2.5 Relationships between the  immune system, endocrine stress-axis  and  anti- 
      catabolic agents in the stress response…………………………………………… 
2.5.1 Relationships measured in the response to acute stress…………….. 
2.5.2 Relationships measured in response to chronic stress………….. 
2.6 Summary………………………………………………………………………………. 
2.6.1 Immune and cytokine system responses to stress……………………. 
2.6.2 Responses of the endocrine stress-axis to stress…………………….. 
2.6.3 Relationship between the immune system, endocrine stress-axis and anti- 
         catabolic agents in the stress response………………………………………….. 
2.7 Current challenges for immune-endocrine exercise physiologists……………… 
 
 
Chapter 3 
 
Determination of the functional ability of peripheral blood mononuclear 
cells to secrete interleukin-6 using a whole blood culture technique, in 
samples from athletes participating in an ultra-distance triathlon  
 
3.1 Introduction……………………………………………………………………………. 
3.2 Methods……………………………………………………………………………….. 
3.3 Results…………………………………………………………………………………. 
3.4 Discussion…………………………………………………………………………….. 
3.5 Conclusion…………………………………………………………………………….. 
3.6 Limitations……………………………………………………………………………... 
 
 
 
Page 
 
 
 
 
24 
24 
34 
39 
41 
44 
44 
48 
51 
54 
 
58 
58 
61 
63 
64 
65 
 
66 
67 
 
 
 
 
 
 
 
 
70 
71 
73 
75 
77 
77 
 
 
 
  
Chapter 4 
 
Effect of performance enhancing high-intensity cycling training on selected 
endocrine and immune parameters 
 
4.1 Introduction…………………………………………………………………………….  
4.2 Methods……………………………………………………………………………….. 
4.3 Results…………………………………………………………………………………. 
4.4 Discussion…………………………………………………………………………….. 
4.5 Conclusion…………………………………………………………………………….. 
 
Chapter 5 
 
A profile of selected endocrine and immune parameters in individuals 
exposed to chronic (occupational) psychological stress  
 
5.1 Introduction……………………………………………………………………………. 
5.2 Methods……………………………………………………………………………….. 
5.3 Results…………………………………………………………………………………. 
5.4 Discussion…………………………………………………………………………….. 
5.5 Conclusion…………………………………………………………………………….. 
 
Chapter 6 
 
The effect of acute immobilisation stress on the concentrations of 
corticosterone, testosterone and selected inflammatory cytokines in male 
Wistar rats 
 
6.1 Introduction……………………………………………………………………………. 
6.2 Methods……………………………………………………………………………….. 
6.3 Results…………………………………………………………………………………. 
6.4 Discussion…………………………………………………………………………….. 
6.5 Conclusion…………………………………………………………………………….. 
6.6 Limitations……………………………………………………………………………... 
 
 
 
 
 
 
 
Page 
 
 
 
 
 
79 
82 
85 
91 
96 
 
 
 
 
 
 
97 
99 
100 
103 
106 
 
 
 
 
 
 
 
107 
109 
110 
112 
116 
116 
 
 
 
 
 
 
 
  
 
Chapter 7 
 
The efficacy of Sutherlandia frutescens supplementation to reduce stress 
levels in rats subjected to chronic intermittent immobilisation stress 
 
7.1 Introduction……………………………………………………………………………. 
7.2 Methods……………………………………………………………………………….. 
7.3 Results…………………………………………………………………………………. 
7.4 Discussion…………………………………………………………………………….. 
7.5 Conclusion…………………………………………………………………………….. 
7.6 Acknowledgements………………………………………………………………….. 
 
Chapter 8 
 
Effect of in vivo administration of an anti-IL-6 antibody on the response of 
selected endocrine and immune parameters to short-term intermittent 
immobilisation stress in rats 
 
8.1 Introduction……………………………………………………………………………. 
8.2 Methods……………………………………………………………………………….. 
8.3 Results…………………………………………………………………………………. 
8.4 Discussion…………………………………………………………………………….. 
8.5 Conclusion…………………………………………………………………………….. 
 
Chapter 9 
 
Synthesis 
 
9.1 Introduction……………………………………………………………………………. 
9.2 Impact of results………………………………………………………………………. 
9.3 Conclusions and recommendations for future studies……………………………. 
 
References………………………………………………………………………………... 
 
 
 
 
 
 
 
Page 
 
 
 
 
 
 
117 
118 
120 
123 
126 
126 
 
 
 
 
 
 
 
127 
129 
130 
134 
138 
 
 
 
 
 
139 
139 
144 
 
146 
 
 
 
 
 
 
 
  
 
Appendix A 
 
Determination of T lymphocyte subpopulation distribution and 
responsiveness using flow cytometry………………………………………………. 
 
Appendix B 
 
ELISA for IL-6 secretion in whole blood culture supernatant (human)………... 
 
Appendix C 
 
Determination of in vitro mitogen-induced IL-6 secretion after in vivo 
administration of anti-IL-6 antibody (rat)……………………………………………. 
Page 
 
 
 
 
190 
 
 
 
197 
 
 
 
 
199 
 
 
 ACKNOWLEDGEMENTS 
 
I would like to thank the following people for their contributions to this thesis: 
 
• First of all, I would like to acknowledge my promotor, Prof. Kathy Myburgh. Without 
her leadership, dedication and continued support, this thesis would not exist. I am 
proud to call her my mentor. 
 
• My gratitude goes to Prof. Patrick Bouic for invaluable advice and discussions. 
 
• I would like to thank Dr Paula Ansley for her role in initiating the study on endurance 
athletes (Chapter 3). 
 
• The endocrine results of the study on chronic stress (Chapter 5) also formed part of 
baseline measurements for a M.Sc. thesis (Ms Lucy Saunders, 2002).  I would like 
to express my gratitude to Ms Saunders for her role in that study. 
 
• My appreciation also goes to Dr Carl Albrecht, who provided the Sutherlandia 
frutescens leaves used in the stress-relief study in rats (Chapter 7), as well as 
helpful advice regarding this herb. 
 
• To my Heavenly Father, thank you.  I will strive to express my gratitude through 
actions. 
 
• Last but not least, I would like to thank my husband, John, for his continued support, 
motivation and patience, and for doing duty as research assistant on numerous 
weekends. 
 
I would also like to thank the following people/institutions for technical assistance: 
 
• Dr Edmund Pool, for performing the in vitro PBMC assay in the first study (Chapter 
3) and for teaching me the technique 
 
• Ms Jo-Ann du Toit, for assistance in laboratory testing of subjects in the training 
study (Chapter 4) 
 
• Ms Anel Clark, for flow cytometry procedures  
 
• Pathcare laboratories, for analysis of blood samples for full blood counts, differential 
white blood cell counts and serum testosterone and SHBG concentrations 
 
• Mr Johnifer Isaacs and Mr Rodger Lawrence, for their care of the experimental 
animals and assistance with experimental procedures 
 
Finally, I would like to thank the Stellenbosch University Sub-Committee B, the National 
Research Foundation (Indigenous Knowledge Systems) and the Medical Research Council 
for funding of projects in this thesis. 
 LIST OF PUBLICATIONS AND CONGRESS CONTRIBUTIONS 
 
NATIONAL 
Posters 
 
• Smith C, du Toit J, Myburgh KH.  The effect of a high-intensity training intervention 
on performance and selected endocrine parameters in male cyclists. 30th annual 
congress of Physiological Society of Southern Africa, Stellenbosch, South Africa. 
2002 
 
• Smith C, Myburgh KH. Selected immune and endocrine responses to increased 
training intensity. 31st annual congress of Physiological Society of Southern Africa, 
Potchefstroom, South Africa, 2003 
 
• Smith C, Myburgh KH.  IL-1β, IL-6 and peripheral blood mononuclear cells’ 
responses to intermittent immobilisation: a rat model of chronic inflammatory stress. 
32nd annual congress of Physiological Society of Southern Africa, Coffee Bay, South 
Africa, 2004  
 
Oral Presentation 
 
• Smith C, Myburgh KH. Sutherlandia frutescens supplementation influences the 
corticosterone response to chronic stress in rats. 31st annual Congress of the 
Physiological Society of SA, Potchefstroom, South Africa, 2003 
 
Peer-Reviewed Paper 
 
• Smith C, Myburgh KH.  Treatment with Sutherlandia frutescens subs. microphylla 
alters the corticosterone response to chronic intermittent immobilisation stress in 
rats. South African Journal of Science 100: 229–232, 2004 
 
Non-Peer-Reviewed Paper 
 
• Smith C, Myburgh KH. Immune system functional testing of athletes at University of 
Stellenbosch. http://www.scienceinafrica.co.za/2002/may/athlete.htm 
 
 INTERNATIONAL 
Oral Presentation 
 
• Myburgh KH, Du Toit J, Smith C. Changes in performance and resting cortisol in 
response to 8 weeks of high intensity training. American College of Sports Medicine, 
Saint Louis, Saint Louis, USA, 2002 
 
Published Conference Proceeding 
 
• Myburgh KH, du Toit J, Smith C. Changes in performance and resting cortisol in 
response to 8 weeks of high intensity training. Med Sci Sports Exerc 34(5S):S276, 
2002. Saint Louis, Saint Louis, USA, Lippinco H Williams and Wilkins. 
 LIST OF FIGURES 
 
  Page 
Figure 1.1 Lymphocyte subpopulations………………………………………………. 
 
6 
Figure 1.2 Interaction between cytokines and immune cells in the immune 
response ……………………………………………………………………. 
 
 
11 
Figure 2.1 Interaction of immune, cytokine and endocrine systems in the 
response to exercise stress……………………………………………….. 
 
 
63 
Figure 3.1 Mean in vitro spontaneous PBMC IL-6 release obtained before, 
immediately after and one week after an ultra-endurance triathlon. 
The first and final samples were taken in a properly rested condition 
at least 24 hours after the previous exercise bout, whereas the middle 
sample was within 30 minutes post-race……………………….. 
 
 
 
 
 
73 
Figure 3.2 Average LPS-induced IL-6 release by peripheral blood mononuclear 
cells (PBMC) before (rested condition), immediately after (within 30 
minutes) and one week after (rested condition) an ultra-endurance 
triathlon………………………………………………………………………. 
 
 
 
 
74 
Figure 3.3 The relationship between spontaneous IL-6 release by PBMC and 
mitogen-induced IL-6 release by PBMC, pre-race (a) and immediately 
post-race (b)………………………………………………………………… 
 
 
 
75 
Figure 4.1 Improvement in (a) PPO, (b) 5TT and (c) 40TT performance in 
response to training.  Error bars indicate standard deviation………….. 
 
 
86 
Figure 4.2 Changes in the (a) spontaneous and (b) mitogen-induced expression 
of CD69 by CD4+ and CD8+ cells as a result of changes in training 
volume and intensity……………………………………………………….. 
 
 
 
87 
Figure 4.3 Relationships between training volume and the CD4+:CD8+ ratio at 
rest in recreationally competitive cyclists at (a) B, (b) post-HI training 
and (c) post-SMI training…………………………………………………... 
 
 
 
90 
Figure 5.1 Average (a) cortisol (b) DHEAs and (c) testosterone concentrations, 
as well as the ratios between cortisol concentration and (d) DHEAs 
and (e) testsoterone concentrations for high vs. low-responder 
groups………………………………………………………………………. 
 
 
 
102 
   Page 
Figure 6.1 Comparison of mean body mass in control rats and in rats subjected 
to acute, short-term immobilisation stress with or without subsequent 
recovery……………………………………………………………………… 
 
 
 
110 
Figure 6.2 Effect of acute short-term immobilisation stress and recovery from 
stress on mean a) serum corticosterone concentration, b) serum 
testosterone concentration and c) the corticosterone:testosterone 
ratio…………………………………………………………………………... 
 
 
 
 
111 
Figure 6.3 The effect acute immobilisation stress with or without 24 hr recovery 
on a) IL-1β and b) TNF-α concentrations………………………………... 
 
 
112 
Figure 7.1 Serum concentrations of (a) corticosterone and (b) testosterone, and 
(c) the corticosterone:testosterone ratio…………………………………. 
 
 
121 
Figure 7.2 Box-plot analysis of serum IL-6 concentrations…………………………. 
 
123 
Figure 8.1 Percentage change in body mass for 4 days before the start of the 
intervention protocol vs. during the 4 days of the intervention 
protocol………………………………………………………………………. 
 
 
 
131 
Figure 8.2 Differences in corticosterone concentration between experimental 
groups………………………………………………………………………... 
 
 
132 
Figure 8.3 Differences in serum IL-1β concentrations between experimental 
groups………………………………………………………………………... 
 
 
132 
Figure 8.4 Effect of in vivo anti-IL-6 treatment on (a) spontaneous and (b) 
mitogen-induced secretion of IL-6 by PBMCs in plasma-replaced 
blood culture, after 24 hours of incubation………………………………. 
 
 
 
133 
Figure 9.1 Differences in the effect of training on the responses of a) cortisol, b) 
testosterone and c) the cortisol:testosterone ratio at rest in subjects 
with either high or moderate serum cortisol concentration at 
baseline…………………………………………………………………….. 
 
 
 
 
 
143 
 
 LIST OF TABLES 
 
  Page 
Table 4.1 Changes in lymphocyte subpopulation counts in response to the 
training intervention…………………………………………….................... 
 
 
87 
 
Table 4.2 Serum concentrations of selected endocrine parameters and 
relationships between these parameters over time………………………. 
 
 
89 
Table 4.3 Associations between testosterone concentration and lymphocyte 
subpopulation counts and activation status……………………………….. 
 
 
89 
Table 4.4 Mean weekly outdoor training volume and intensity, as well as number 
of training sessions per week both outdoors and indoors……………….. 
 
 
90 
Table 5.1 Characteristics for 11 sedentary subjects .....…………………………….. 
 
100 
Table 5.2 Average immune and endocrine parameters measured at two time 
points one week apart……………………………………………………….. 
 
 
101 
Table 5.3 Average immune and endocrine parameters in the stress group 
compared to that of the control group……………………………………… 
 
 
103 
Table 7.1 Effects of stress, Sutherlandia treatment and interaction on 
concentrations of parameters measured………………………………….. 
 
 
121 
Table 8.1 Total and differential WBC counts at sacrifice……………………………. 
 
132 
Table 8.2 Correlations between LPS-induced IL-6 secretion by PBMCs in culture 
and serum IL-1β and corticosterone concentration………………………. 
 
 
134 
 
 
 LIST OF ABBREVIATIONS  
 
ACSM  American College of Sports Medicine 
ACTH  adrenocorticotrophic hormone 
AIDS  acquired immune deficiency syndrome 
ANOVA  analysis of variance 
APC  antigen presenting cell 
BMI  body mass index 
CBG  corticosteroid binding globulin 
CD  cluster designation 
CD45RO marker for helper T memory cells 
CHO  carbohydrate 
ConA  concanavalin A  
CRH  corticotrophin releasing hormone 
CRP  C reactive protein 
DHEA  dehydroxyepiandrosterone 
DHEAs  dehydroxyepiandrosterone-sulphate 
DOMS  delayed onset muscle soreness 
EDTA  ethylenediaminetetraacetic acid 
ELISA  enzyme-linked immunosorbent assay 
GABA  gamma-aminobutyric acid 
GR  glucocorticoid receptor 
HDL  high-density lipoprotein 
HPA-axis hypothalamo-pituitary-adrenal axis 
IFN  interferon 
IgG  immunoglobulin class G 
IL  interleukin 
IL-1ra  interleukin-1 receptor antagonist 
LPS  lipopolysaccharide 
MHC  major histocompatibility complex 
MR  mineralocorticoid receptor 
 mRNA  messenger ribonucleic acid 
NIDDM  non-insulin dependent diabetes mellitus 
NK  natural killer lymphocyte 
PBMC  peripheral blood mononuclear cell 
PCR  polymerase chain reaction 
PBS  phosphate-buffered saline 
PHA  phytohaemagglutinin  
PPO  peak power output 
PWM  pokeweed mitogen 
1-RM  one-repetition maximum 
RPMI  Roswell Park Memorial Institute 
SD  standard deviation 
SEM  standard error of the mean 
SHBG  sex hormone binding globulin 
SST  serum separation tubes 
TAT  tyrosine aminotransferase 
TGF-β  transforming growth factor-beta 
TH1  helper T lymphocyte type I 
TH2  helper T lymphocyte type II 
TH3  helper T lymphocyte type III 
TNF  tumour necrosis factor 
5TT  5 km time trial 
40TT  40 km time trial 
VO2max  maximum oxygen consumption 
WBC  white blood cell 
 
 
 
 
 
 
 
 
 Chapter 1 
 
Introduction 
 
1.1 General Introduction 
 
Ever since participation in sport changed from an amateur game to a professional career, 
athletes have found themselves under ever-increasing demand to improve their 
performance. In their quest for gold however, the ever-increasing volume and intensity of 
training, and therefore simultaneously decreasing recovery time, may become 
counterproductive. 
 
Theoretically, an “ideal” training regimen would allow for enough recovery time between 
exercise bouts, for the athlete to start each training session without negative influences of 
residual strain from the previous session.  However, this is neither the reality, nor the “ideal” 
in the modern competitive environment of sport.  Rather, the athletes intentionally overload 
to adapt to a higher level of performance. In the process, they cope with the increased levels 
of stress (both physiological and psychological), rebound from episodes of overreaching, or 
fail in one way or another.  It is the latter that is of particular concern to exercise 
physiologists, since the inability to rebound from training overload may result in the full-blown 
overtraining syndrome, which is characterised by among others, long-term decreased 
performance, chronic inflammation, immunosuppression and abnormal resting hormonal 
profiles (Barron et al., 1985; Fry et al., 1991b; Gabriel et al., 1998; Hartmann & Mester, 
2000; Ketner & Mellion, 1995; Kuipers & Keizer, 1988; Urhausen & Kindermann, 2002), all of 
which prevent an athlete from excelling. In addition, adaptation to training in favour of one 
system in the body is often to the decrement of another, which may in the long term have 
serious health implications, such as the development of e.g. autoimmune diseases or 
chronic fatigue syndrome, which are equally daunting to a career in sports. For this reason, 
researchers have been searching for markers to monitor training load and to issue a timely 
warning when any of these possibly pathological conditions are imminent, so that the 
 necessary precautionary steps may be taken. Such markers would allow athletes to train 
optimally, thereby also improving performance maximally. 
 
The earliest reported, and probably the most widely known, marker/indicator of increased 
stress is the hormone cortisol.  However, the theory of general adaptation suggested by 
Hans Selye - that increased cortisol concentration is a central and general response to 
stress which could explain all stress related illnesses (Selye, 1978; Viru, 2002) - has been 
considerably modified over the years. One of the reasons for this is that stress is not an 
easily defined condition with clear causes and effects.  Rather, “stress” is the general term 
describing any demand that is outside the norm, be that physical or psychological.  A second 
reason is that different individuals may experience the same stressor at different levels of 
perceived intensity, thereby causing a great variation in the response of individuals to a 
specific stressor.  Thirdly, the stress response is a cascade of events involving several 
organs and systems, so that differences between individuals, or adaptation, may be the 
result of differences or changes that may occur at many different sites. Fourthly, while one 
individual may be able to adapt and cope with an ongoing stress, so that in effect it becomes 
a lesser stressor in the long term, another individual may not be able to adapt to it and may 
then suffer a chronic negative effect as a result.   
 
Therefore, since the postulation of Selye’s theory, it has become clear that stress is a 
complex condition which does not only affect the catabolic endocrine system, and that the 
body’s response to it requires interaction of several additional systems.  The purpose of this 
thesis is therefore to further elucidate the physiological response and adaptation to stress, 
and to investigate associations between two systems involved in the acute and long-term 
processes, namely the immune system and the endocrine stress-axis.   
 
In this chapter I will give a basic overview of these two systems, which are both intimately 
involved in and influenced by the stress response.  Since these systems are in themselves 
also complex, I will indicate which sub-aspects are particularly relevant to the scope of this 
thesis.  In the next chapter I will provide an overview of the available literature on the 
interaction of these systems in the short-term response and longer-term adaptation to stress, 
with specific focus on the athletic population and exercise-induced stress.  However, due to 
 the additive nature of various stressors, the effects of psychological stress, which 
accompanies high-level sport, will also be addressed. 
 
1.2  Overview of the immune system 
 
The immune system may be divided into three parts, namely the immune organs (bone 
marrow, spleen, and lymph nodes), the cellular compartment (white blood cells) and the 
messenger system (cytokines). The latter two are of importance for the purposes of this 
thesis, and brief overviews of the most relevant components of each part are given below, as 
well as the ways in which they interact to mount an inflammatory response to enable the 
body to resist the challenge of pathogenic invasion. I will also discuss the principles of 
assays most frequently used to investigate and assess these functions of the immune 
system. 
 
1.2.1 White blood cells 
 
White blood cells (WBCs), or leukocytes, may be functionally divided into two groups, 
namely phagocytes and immunocytes.  Phagocytes include granulocytes (mainly 
neutrophils, but also eosinophils and basophils) and monocytes, while the different types of 
lymphocytes makes up the circulatory immunocyte population.  Since the role of the non-
specific immune system, and in particular that of neutrophils, in the response to stress has 
been extensively investigated and reported on (more detail in Chapter 2), this thesis will 
focus on mainly monocytes and lymphocytes, but a short overview of all three cell types is 
provided below. 
 
Monocytes originate in the bone marrow, where they differentiate and mature for 16 – 26 
hours.  After leaving the bone marrow, monocytes remains in circulation for up to 7 days, 
after which they move into tissues, where they are known as macrophages, which have a 
lifespan of several months or even years.  Macrophages have the ability to proliferate to a 
small extent at sites of inflammation.  Although dendritic cells are known to play a pivotal role 
as antigen presenting cells, monocytes and macrophages have the ability to phagocytose 
bacteria and other larger particles, and also play a cardinal role in immunity because of their 
 ability to present ingested antigens on their surfaces so that they may be recognised by 
lymphocytes, and the cell-mediated antigen-specific immune response may be initiated. In 
addition, monocytes contain large quantities of lipase, that can degrade bacteria that have a 
lipidic capsule (Hoffbrand & Pettit, 1994a), since these bacteria (which includes e.g. 
Haemophilus influenzae and Streptococcus pneumoniae) are not susceptible to destruction 
by lysozymes or the complement pathway (Bester, 1991).  Of specific interest to the stress 
response, is the ability of monocytes and macrophages to secrete the pro-inflammatory 
cytokines IL-1 and IL-6 (Baumann et al., 1984).  Given the long lifespan and variety of 
immune functions of monocytes, their adaptative response to stress is of great significance 
for the maintenance of immune competency. 
 
Neutrophils originate in the bone marrow, from the same stem cell type as monocytes.  In 
peripheral circulation, neutrophils account for more than 90 % of all granulocytes, and more 
than 60 % of all leukocytes.  Their main function is phagocytosis of foreign substances in 
tissues following their migration from the blood compartment.  The ingested particle is then 
destroyed by release of intracellular granules, containing amongst others, enzymes and 
substances such as myeloperoxidase, acid phosphatase, collagenase, lactoferrin and 
lysozyme.  The time mature neutrophils spend in circulation is about 10 hours, and their 
lifespan is limited to 1-3 days. They do not seem to have the ability to recharge their killing 
mechanism once they have reacted to a challenge (Hoffbrand & Pettit, 1994a).  Therefore, 
although important role players in the acute non-specific response to stress, this cell type is 
probably less important in the longer-term adaptive processes of the immune system in 
response to stress. 
 
Lymphocytes make up about 25 – 35 % of all circulating leukocytes and originate from the 
general stem cells in the bone marrow, as well as from the thymus. Maturation takes place in 
the peripheral lymphoid organs (lymph nodes, tonsils, spleen, appendix, Peyer’s patches in 
the gut), after which the mature cells enter the circulation again.  Different subpopulations 
exist, which may be distinguished by the characteristic markers on the cell membrane, called 
cluster of differentiation (CD) markers (Hoffbrand & Pettit, 1994a).  T cells (originating from 
the thymus) make up the largest portion of all circulating lymphocytes – 66 to 88 %, while 
about 12 to 24 % are made up by B cells (originating from the bone marrow).  While B cells 
 only survive in the circulation for a few days, T cells may live from 4 to more than 20 years. T 
and B cells cannot be distinguished morphologically, but only by specific laboratory 
techniques, such as immunohistochemistry and flow-cytometry (Hoffbrand & Pettit, 1994a).  
However, these two subgroups of lymphocytes have very different roles in immunity.  B 
lymphocytes, on stimulation, will differentiate further to form plasma cells, which secretes 
antibodies, and are thus important for humoral (antibody-mediated) immunity.  T 
lymphocytes, on the other hand, are important role-players in cellular immunity, delayed 
sensitivity reactions and graft rejections. T cells can be divided into subpopulations, including 
helper T, suppressor T and cytotoxic T cells. Helper T cells are further divided into a type I 
(TH1, initiates the cell-mediated immune response), type II (TH2, initiates the humoral 
immune response) (Mosmann & Coffman, 1989; Vander et al., 1998a) and type III (TH3, 
produces the inhibitory cytokines IL-10 and transforming growth factor (TGF)-β) (Fukaura et 
al., 1996).  The distribution of the different types of helper T cells influences the balance 
between the cell-mediated (mediated by TH1) and antibody-mediated (mediated by TH2) 
immune responses (Hoffbrand & Pettit, 1994b).  A summary of the main subpopulations of 
lymphocytes with their individual functions is given in Figure 1.1. 
 
 
 1.2.2 Immune cell function 
 
Although immune cells can be divided into phagocytes and immunocytes, as mentioned 
above, a different broad classification is the cell-mediated and the antibody-mediated arms.  
Cells involved in the cell-mediated arm of the immune system are monocytes/macrophages, 
NK cells, granulocytes, cytotoxic T lymphocytes and TH1 cells. These cells respond to 
invading pathogens by recognising general molecular patterns, and attack and destroy 
anything that appears foreign to the body, by processes such as phagocytosis and 
degranulation.  The main functions of this non-specific first line of defense are to contain 
foreign invasions until a more specific immune response can be launched, and to activate 
the appropriate specific immune response.  The antibody-mediated arm of the immune 
system provides a more targeted response against individual invading pathogens.  
Monocytes, B lymphocytes and TH2 lymphocytes are the cells most commonly associated 
with this arm of the immune system.  Immune competence has been defined as a proper 
balance between the humoral and cellular components of the specific immune system 
(Hässig et al., 1996), and changes in the balance of cells initiating these types of responses 
should therefore be considered in assessments of immune function.   
 
1.2.3 Cytokines 
 
These intercellular mediators were first named on the basis of their immune system function.  
When it became clear that these mediators were not only produced by lymphocytes and 
monocytes, but also a variety of other cell types, and that one specific mediator may have 
several functions, it was decided in 1979 to call these mediators “interleukins”, which literally 
means “between cells” (Mackinnon, 1999).  Cytokines are involved in regulation of the 
immune, haematopoietic, endocrine and nervous systems (Vander et al., 1998a).  Although 
all the physiological interactions are, as yet, incompletely identified and the interactive 
implications ever more poorly delineated, a basic overview of the origin and functions of the 
main cytokines are discussed below. 
 
Interferons (IFN) are a group of cytokines released to coat uninfected cells in a non-specific 
manner, in order to prevent them from becoming infected (Vander et al., 1998a). In this way, 
 viral replication may be inhibited. Apart from its antiviral properties, interferon may also 
enhance the immune response, depending on the subgroup of IFN:  IFN-α is produced by 
virus-infected monocytes and lymphocytes, IFN-β is mainly produced by virus-infected 
fibroblasts, and IFN-γ is produced by stimulated T-lymphocytes and natural killer (NK) 
lymphocytes (Mackinnon, 1992).  While IFN-α and IFN-β bind to the same receptor, IFN-γ 
has its own specific receptor.  All interferons induce cell growth, increase expression of 
major histocompatibility complex (MHC) class I, and activate cytotoxic T-cells and NK-cells.  
In addition, IFN-γ also increases expression of MHC class II, activates macrophages and 
neutrophils, activates the vascular endothelium to promote T and B cell differentiation, and 
increases secretion of IgG2, IL-1 and IL-2 (Vander et al., 1998a). These functions all form 
part of the T-helper 1 (TH1) response of the immune system. What has only become 
apparent more recently is that cytokines such as IFN-γ also interact with the endocrine 
stress-axis to increase secretion of ACTH and cortisol (de Metz et al., 1999).   
 
Interleukin-1 (IL-1) is produced mainly by macrophages (Solomon et al., 1990), but may 
also be secreted by other stimulated immune cells, such as type I CD4+ lymphocytes (TH1 
cells) (Mosmann & Coffman, 1989).  IL-1 stimulates cytokine (TNF, IL-6) and cytokine 
receptor (in particular IL-2 receptor) production by T cells, and also stimulates proliferation of 
B cells (Roitt, 1994).  Two forms of IL-1 exist, IL-1α and IL-1β, with the same basic function, 
but with quite different structures.  IL-1α seems to usually be membrane-associated, while 
IL-1β may also circulate in its free form.  Both forms bind to the same receptors, which occur 
mostly on blood and bone marrow cells, but also, of importance to the stress response, to 
brain cells and adrenal cells. IL-1 seems to be the most potent inducer of corticotrophin 
releasing hormone (CRH) (Watkins, 1994), and may also be able to directly release 
adrenocorticotrophic hormone (ACTH) from the pituitary (Sapolsky et al., 2000), thus 
stimulating the hypothalamic-pituitary-adrenal (HPA)-axis to respond to  a stressor. IL-1 
production is inhibited by the corticosteroids, such as cortisol.  Furthermore, its ability to bind 
to vascular endothelial and smooth muscle cells (Roitt, 1994) allows IL-1 to play a major role 
in characteristics of inflammation, such as vasodilation, fever and cramps.  It was also 
recently reported to contribute to the wasting syndrome (cachexia), by inducing adhesion 
molecule expression on vascular endothelium (Tisdale, 2001).  
 Interleukin-2 (IL-2) is secreted by some T cells after stimulation, as a result of antigen 
binding to receptors present on the T cell.  Within one to two days, these T cells start to 
secrete IL-2 and/or express high affinity receptors for IL-2.  Binding of IL-2 to these T cells 
initiates T cell proliferation, and complex changes in morphology, metabolism, receptor 
expression and production of cytokines.  Therefore, once IL-2 has activated a cell, that cell 
can promote clonal expansion of itself, as well as other T cells that cannot secrete IL-2, such 
as cytotoxic T cells and suppressor T cells.  However, it cannot act directly on unstimulated 
cells, since they do not express the IL-2 receptor (Roitt, 1994).  IL-2 also leads to increased 
secretion of IFN, activation of NK cell cytotoxicity and monocytes, and proliferation of B cells 
(Vander et al., 1998a). 
 
Interleukin-4 (IL-4) was shown to be a B cell proliferation cofactor in 1982 (Mackinnon, 
1999).  It may act as 1) activation factor, inducing resting B cells to increase in size and to 
express MHC class II, 2) proliferation factor, increasing replication of B cells, and 3) 
differentiation factor, inducing production of the immunoglobulin subclasses IgE and IgG1.  
However, apart from effects on B cells, IL-4 also plays a major role in T cell development 
(Vander et al., 1998a).  IL-4 secretion promotes differentiation of helper T cells into type 2 
(TH2) cells, which are themselves the major source of IL-4, during an immune response. Its 
action is inhibited in the presence of IFN-γ, which is secreted by TH1 cells. This interaction is 
an example of why the proper balance between TH1 and TH2 cells is so important. 
 
Interleukin-6 (IL-6) is secreted by a wide variety of cells, such as fibroblasts (May et al., 
1988), endothelial cells (May et al., 1989), keratinocytes (Baumann et al., 1984; Fujisawa et 
al., 1997) and peripheral blood mononuclear cells (PBMCs) (Baumann et al., 1984), more 
specifically monocytes and TH2 cells.  IL-6 is beneficial to the immune response by 
enhancing B cell differentiation into plasma cells for antibody secretion, by increasing NK cell 
cytotoxicity and promoting the inflammatory response (Vander et al., 1998a).  The main 
functions of IL-6 are pro-inflammatory and include increasing T cell proliferation and 
activating the release of other pro-inflammatory cytokine and acute phase proteins.  On the 
other hand, IL-6 was also reported to exert an indirect anti-inflammatory action by a) down-
regulating TNF release by negative feedback (Nukina et al., 1998), b) stimulating release of 
IL-1 receptor antagonist (IL-1ra) (Jordan et al., 1995), c) stimulating release of CRH and 
 ACTH from the hypothalamus and pituitary gland, resulting in the release of cortisol, and d) 
directly stimulating the adrenal glands to produce and secrete cortisol, which is a potent anti-
inflammatory hormone.  In this way, the inflammatory response can be both initiated and 
controlled.  Metabolic effects of IL-6 include promotion of liver glygogenolyis (Vaartjes et al., 
1990) and adipose tissue lipolysis (Petersen et al., 2004). 
 
Two types of tumor necrosis factor (TNF) have been identified to date: TNF-α (cachectin) 
and TNF-β (lymphotoxin).  Both types have cytotoxic activity directed against tumour cells. 
TNF-β is produced by activated T-cells and exerts both cytostatic and cytotoxic activity 
against tumour cells (Vander et al., 1998a).  TNF-α is produced by most peripheral blood 
mononuclear cells (PBMCs, monocytes and lymphocytes). Its main functions are antiviral 
activity and activation of macrophage killing of tumour cells (Vander et al., 1998a).  
Prolonged high concentrations of TNF-α may have harmful effects like chronic inflammation 
and cachexia (Alvarez et al., 2002; Costelli et al., 1993; Llovera et al., 1993).  Similar to IL-1, 
TNF also exhibits interaction with the endocrine system, since the hypthalamic-pituitary-
adrenal (HPA-) axis (more specifically ACTH and corticosterone) was reported to down-
regulate production of both types of TNF in rats (Fantuzzi et al., 1995).  New functions of 
TNF-α are still being elucidated. Recent reports indicate a role in stress-related 
neurodegeneration by up-regulation of inducible nitric oxide synthase expression via nuclear 
factor kappa B (NF-kappa B) activation in the brain cortex (Madrigal et al., 2002). 
 
1.2.4 Interaction between WBCs and cytokines  
 
The balance between processes mediated by different immune cells (TH1 or TH2 
lymphocytes, neutrophils and monocytes/ macrophages) and cytokines in the response to 
stress will determine: 1) whether the response is of short-duration or a longer-term 
adaptation, 2) the speed of the response (e.g. non-specific response is faster than the 
specific response) and 3) whether a shift in favour of one particular response will result in 
another response being compromised.   A summary of the interaction between cytokines and 
the various immune cells involved in the different types of immune responses are illustrated 
in Figure 1.2.   
 
 1.2.5 Immune functional tests 
 
Cell counts give an indication of the availability of immune cells that can possibly react to an 
immune insult. However, cell counts do not provide information on the ability of the cells that 
are present, to fulfil their functions.  In order to draw accurate conclusions regarding immune 
system competence, it is therefore necessary to consider changes in both immune cell count 
and function.    
 
Since the humoral stress response is the particular immune focus of this thesis, I will limit the 
overview of functional evaluation to that relevant to this part of the immune system. The 
humoral response is dependent on proper functioning of three consecutive steps. Firstly, 
after binding of an antigen to the antigen presenting cells (in peripheral blood predominantly 
monocytes), these cells must be able to react to this insult by producing cytokines and 
secreting them into the circulation. Secondly, lymphocytes must be responsive/ sensitive to 
these cytokine signals and become activated. Thirdly, the activated lymphocytes must be 
able to proliferate and differentiate to fulfil all their different functions, as discussed earlier.  A 
brief description of the assays used to evaluate each stage of these humoral responses 
follows below. 
 
Cellular production and secretion of cytokines: From the overview above, it is clear that 
cytokines are usually secreted by more than one cell type.  Measurement of changes in 
cytokine concentrations in plasma or serum is therefore not useful for the evaluation of cell 
function, since the specific source of the increased cytokine is unclear. To enable evaluation 
of type-specific cellular function, cell culture techniques are used (Alvarez et al., 2002; Pool 
et al., 2002; Tantak et al., 1991). In short, the cell type to be investigated is cultured in vitro, 
and challenged with a standardised antigen that will stimulate cytokine production.   The 
concentration of one or more cytokines is then measured in the culture supernatant of a 
stimulated vs. an unstimulated culture. The difference between the two measurements is the 
concentration of cytokine secreted specifically in response to the antigen. This value may be 
compared to that of control samples to determine abnormalities, or to previous samples from 
the same individual to monitor changes over time.  While this method has been in use since 
the 1970’s, more recent advances in technology, such as the flow cytometer, enable 
 researchers to also determine the concentration of cytokines produced intracellularly before 
being secreted, pinpointing the origin of these cytokines more specifically.  However, since 
the technology required for the latter is so expensive, the former technique is used quite 
commonly. 
  
Cell responsiveness: All circulating immune cells have already undergone primary 
differentiation, resulting in different subpopulations. When these cells are stimulated by 
cytokine action, and they are sensitised sufficiently to become activated, they are capable of 
secondary proliferation. Cells committed to secondary proliferation express the cellular 
surface marker CD69, which has been linked to their activation, proliferation and cytotoxic 
functions (Borrego et al., 1999a; Borrego et al., 1999b; Werfel et al., 1997).  CD69 is 
reported to be the earliest specific activation antigen expressed on the surface of T-cells in 
the circulation (Llera et al., 2001), and to be undetectable or present in very low 
concentrations in unstimulated lymphocytes (Werfel et al., 1997).  The cytoplasmic domain 
of CD69 was reported to induce TNF-α production in rat mucosal mast cells in culture 
(Sancho et al., 2000), but does not appear to provide information on events downstream, 
such as proliferation (Krowka et al., 1996). Nonetheless, it is an excellent screening tool to 
assess lymphocyte responsiveness, and specifically impaired responsiveness.  It correlates 
well with the 3H-thymidine assay for lymphocyte proliferation (see below), with the added 
advantage of requiring only a 4-6 hour incubation period, compared to the 72 hour incubation 
period of the 3H-thymidine assay (Mardiney, III et al., 1996).  CD69 expression may be 
determined for each lymphocyte subpopulation separately by flow cytometry.  See Appendix 
A for a description of the principle of flow cytometric analysis of whole blood and 
interpretation of results. 
 
Lymphocyte proliferative response: This assessment of immune cell function determines 
the rate of secondary proliferation in lymphocytes, by measuring the rate by which 
radioactively labelled precursors (3H-thymidine) are incorporated into lymphocyte DNA after 
in vitro stimulation. Different synthetic stimuli (mitogens) have been developed that are 
specific to certain lymphocyte subpopulations, to enable differentiation between proliferation 
rates of the different subgroups. The mitogens most frequently used in exercise-related 
studies are concanavalin A (ConA) and phytohaemagglutinin (PHA), which stimulate T cells, 
 pokeweed mitogen (PWM), a stimulator of B cell proliferation and lipopolysaccharide (LPS) 
which stimulates B cell proliferation in non-human species (Mackinnon, 1992).  This assay is 
however unable to distinguish between T cell subpopulations. 
 
1.3 Overview of the endocrine stress-axis 
 
1.3.1 The hypothalamic-pituitary-adrenal (HPA-) axis 
 
The hypothalamic-pituitary-adrenal (HPA-) axis is a major endocrine role-player in the stress 
response. The hypothalamus plays a key role in the regulation of pituitary function. It 
receives, sorts and integrates signals from a variety of sources, and directs them to the 
pituitary gland (Genuth, 1983b; Vander et al., 1998b). Afferent nerve impulses to the 
hypothalamus originate from the thalamus, the limbic system, the eyes and remotely from 
the neocortex, largely via the neurotransmitters nor-epinephrine, acetylcholine and serotonin. 
This input of sensations (of e.g. pain, sleep or wakefulness, emotion, stress, olfactory 
awareness, light and even thought), stimulates efferent impulses (via neurotransmitters 
dopamine, acetylcholine, gamma-aminobutyric acid (GABA), and beta-endorphin) which 
stimulate the release of releasing or inhibitory hormones.  One of these hormones is 
corticotrophin releasing hormone (CRH), a peptide hormone with 41 amino acids. CRH 
stimulates the anterior pituitary to release adrenocorticotrophic hormone (ACTH) via the 
cAMP second messenger system. ACTH is a peptide with 39 amino acids and its 
concentration shows a diurnal pattern, with peak values just before awakening, and the nadir 
just before or after falling asleep. ACTH circulates in plasma in an unbound form and has a 
half-life of only 15 minutes.  The main function of ACTH is to stimulate the secretion of 
cortisol by the adrenal cortex. It also promotes growth (in cell size rather than cell number) of 
zones in the adrenal cortex that are responsible for the secretion of steroid hormones.  The 
major hormones secreted by the adrenal cortex are 1) the mineralocorticoid, aldosterone, 
which is vital to maintenance of sodium and potassium balance, 2) precursors to the sex 
steroids, estrogens and androgens, which play important roles in establishing secondary 
sexual characteristics as well as being anabolic agents, and 3) the glucocorticoids, cortisol 
and corticosterone.  It is the latter two, androgens and glucocorticoids, which are of particular 
importance in the response to stress and the downstream effects of this stress response. 
  
The synthesis of glucocorticoids occurs mainly in the zona fasciculata, but also to a small 
extent in the zona reticularis of the adrenal cortex (Genuth, 1983a; Vander et al., 1998b). In 
humans, cortisol is the dominant glucocorticoid, while corticosterone is dominant in rodents. 
Cortisol is not stored in the adrenocortical cell, but rapidly released after production. 
Therefore, an acute need for increased circulating cortisol requires rapid activation of the 
entire synthesis and release sequence.    
 
Although not of direct relevance to the aims of this thesis, it is of interest to mention the role 
of catecholamines in the endocrine stress response.  These hormones, mainly epinephrine 
and norepinephrine, which are secreted by the adrenal medulla, are responsible for the early 
sympathetic changes seen in response to stress exposure, such as increased heart rate and 
blood pressure, increased glucose release from the liver, and increased blood flow to the 
heart, brain and skeletal muscle – the so-called “fight-or-flight” response.  These hormones 
are secreted by direct nervous activation, so that secretion occurs more quickly after 
exposure to a stressor than the glucocorticoids, which are only secreted at the end of a 
multi-step endocrine response pathway.  On the other hand, the clearance rate of 
catecholamines from the circulation is also much faster than that of the glucocorticoids, 
which therefore exert a much longer lasting effect on target cells. 
 
1.3.2 Cortisol receptors and binding globulins 
 
Although it is common practice to measure total serum cortisol concentration as an indicator 
of stress, this parameter alone may not be ideal, since several other peptides and hormones 
may influence its biological activity. For example, an earlier theory of heterogeneity in 
glucocorticoid receptors (GR) (Kahn et al., 1978) was recently confirmed by identification of 
two types of GR: type I, a high-affinity receptor which is also a mineralocorticoid receptor 
(MR), and type II, a more abundant low-affinity receptor that is more specific to both 
endogenous and synthetic glucocorticoids (Devenport et al., 1991; Devenport et al., 1993; 
Kellendonk et al., 2002; Spencer et al., 1996). Binding of glucocorticoids to MR is associated 
with anabolic effects, such as increased appetite and weight gain in rats (Devenport et al., 
1991), while binding to type II GR is thought to have a catabolic effect (Devenport et al., 
 1993; Spencer et al., 1996).  Therefore, since the type of GR is important in determining the 
effect of the cortisol bound to it, GR concentrations may be a desirable parameter to 
measure in conjunction with cortisol concentration. Unfortunately, this requires invasive 
procedures to obtain tissue samples for analysis, which is not ideal for competitive athletes.  
The previous finding of no relationship between the serum corticosterone concentration at 
rest and hepatic glucocorticoid receptors (Dellwo & Beauchene, 1990) could possibly be due 
to heterogeneity in receptor type.  GR (type II) has two isoforms, GR-α and GR-β, in humans 
and GR-β is thought to have a negative effect of GR-α transcriptional regulation, which may 
implicate glucocorticoid responsiveness, e.g. as illustrated in neutrophils (Strickland et al., 
2001). However, Spencer et al. subsequently reported no correlation between serum 
corticosterone level and splenic type II receptors (Spencer et al., 1996).  Therefore, our 
knowledge of the relationship between stress, cortisol concentration, GR receptor number 
and type is too incomplete to warrant tissue sampling in competitive athletes.  More 
preliminary work in other mammalian models is required, and is indeed proceeding, albeit 
slowly. 
 
In the same rat study by Spencer et al. (1996) however, there was a correlation between the 
splenic type II receptor and plasma corticosteroid binding globulin (CBG) concentrations, 
but not between GR and corticosterone concentration.  This may indicate that CBG plays a 
larger role than GR in regulation of the biological activity of corticosterone.  CBG is 
synthesised in the liver (Feldman et al., 1979), endometrium (Misao et al., 1994) and lungs 
(Hammond et al., 1987), but the reason for this widespread distribution is not clear.  Neither 
is it clear whether or not other tissues are also involved.  About 80 % of total cortisol in 
circulation is transported bound to CBG (Brien, 1981), which renders the cortisol biologically 
inactive by inhibiting its binding to receptors.  Cortisol concentration positively correlated with 
CBG concentrations in humans at rest (r = 0.88; P < 0.0001) and after exposure to a stressor 
(r = 0.64; P < 0.001) (Dhillo et al., 2002). This suggests that the net effect of an increased 
cortisol concentration may be misinterpreted or overestimated, unless the parallel increases 
in CBG concentration are also considered. This has major implications for studies 
investigating sensitivity to glucocorticoids, or function of the HPA-axis. It may therefore be 
more useful to express the combination of cortisol and CBG concentrations as a ratio to 
enable more accurate interpretation of catabolic status.  A finding that has never been 
 confirmed but is also of relevance to the theme of this thesis, is that elastase, expelled 
during the degranulation of activated granulocytes in the inflammatory process, has the 
ability to cleave CBG and release cortisol from CBG, rendering the glucocorticoid biologically 
active (Hammond et al., 1990).  Therefore, elastase could be considered a pro-cortisol 
immune agent.  Of more general importance is that cortisol action is promoted or inhibited by 
several other agents that on first consideration have other primary functions. 
 
1.3.3 Endocrine anti-glucocorticoid agents 
 
Testosterone is produced by the Leydig cells in the testes and its primary function is related 
to reproduction, which is not within the scope of this thesis. However, another function, which 
is of interest, is the anabolic effect of testosterone, which counteracts in part the catabolic 
effects of cortisol (Genuth, 1983a). This anabolic effect of testosterone is mainly achieved by 
stimulation of growth hormone and insulin-like growth factor release, both of which are 
essential for protein synthesis not only in growth, but also in repair of bone and skeletal 
muscle.  However, more recently additional beneficial effects of testosterone have become 
evident, such as its role in the limitation of the extent of muscle catabolism after severe 
stress.  An example of this is the finding that although testosterone administration to trauma 
patients with severe burns did not affect protein synthesis rate, it was associated with a 2-
fold decrease in protein catabolism (Ferrando et al., 2001). The exact mechanism(s) by 
which testosterone has its anabolic effect on target cells or organs are not clear yet. 
However, a recent review postulated that testosterone promotes the commitment of 
pluripotent stem cells into the myogenic lineage and inhibits their differentiation into the 
adipogenic lineage (Bhasin et al., 2003), a theory that could possibly explain the 
testosterone-induced decrease in fat mass (Wang et al., 2004) and increase in myonuclear 
and satellite cell number (Sinha-Hikim et al., 2003) recently reported. Similar to cortisol, 
testosterone may also circulate either in its free form, or bound to a binding globulin, namely 
sex hormone binding globulin (SHBG). However, while ≈ 80 % of cortisol in circulation is 
bound to CBG, only ≈ 44 % of testosterone in plasma is bound to SHBG (Hackney, 1996), so 
that SHBG likely plays a relatively smaller role than CBG in the control of bioactive hormone 
concentration. 
 
 Although it is clear that testosterone has functions opposing the effect of the glucocorticoids, 
the regulation of testosterone production may also influence its anti-glucocorticoid effect.  
Synthesis of sex steroid precursors occurs mainly in the zona reticularis.  The main 
androgen produced in the adrenal gland, is dehydroxyepiandrosterone (DHEA). DHEA 
circulates in human blood in the sulphated form, DHEAs, at a higher concentration than any 
other steroid hormone.  It is metabolised to its active form (DHEA) by the enzyme steroid 
sulphatase (Vander et al., 1998b).  DHEA serves as prehormone for the biosynthesis of 
androgens and is converted to e.g. testosterone in peripheral tissues.  Both DHEA and 
glucocorticoids are synthesised from cholesterol, with a common intermediate - 17-hydroxy-
pregnenolone (Genuth, 1983a). Therefore, their synthesis is initially similarly controlled, but 
then separately after this branch point in the shared synthetic pathway.  
 
Since an increase in DHEA synthesis may result in subsequent decreased glucocorticoid 
synthesis, DHEA should be regarded as an indirect antagonist to glucocorticoids. For 
example, while elevated corticosterone concentration was shown to be essential in 
maintaining the overweight nature of Zucker rats (Alarrayed et al., 1992), another study in 
these rats illustrated that short-term DHEA administration increased the mitochondrial 
respiratory rate in the livers of both lean and obese Zucker rats (Mohan & Cleary, 1988) to 
create a negative energy balance.  This report suggests a direct anti-glucocorticoid, anti-
obesity action of DHEA.  The exact mechanism of DHEA’s anti-glucocorticoid action remains 
unclear, since DHEAs alone was reported to be unable to prevent the activation of 
glucocortiocoid-inducible enzymes such as tyrosine aminotransferase (TAT) in Zucker rat 
liver and kidney (Wright et al., 1992). However, given the recent reports of an imbalance in 
the relationship between cortisol and DHEA in various pathological conditions related to the 
endocrine and immune systems, such as HIV and depression (Christeff et al., 2000; 
Gallagher & Young, 2002; Valenti, 2002), it may be of interest to consider changes in both 
the DHEA and glucocorticoid concentrations, or changes in the ratio between the two, when 
investigating the stress response. 
 
 1.4  Involvement of the endocrine stress-axis and immune system in the 
general stress response 
 
1.4.1 Immune response 
 
Monocytes and macrophages carry a common receptor (CD14) for different bacterial 
components on their surface membrane (Kreutz et al., 1997). When an antigen, such as 
endotoxin, binds to this site, the cell becomes an antigen presenting cell (APC), presenting 
the antigen to helper T lymphocytes (which cannot bind directly to an antigen, since they lack 
the CD14 site) (Kreutz et al., 1997). These helper T cells then become activated and secrete 
a range of cytokines: Type 1 helper T cells (TH1 cells) secrete IL-2, IL-12 and IFN-γ, causing 
a positive feedback to activate more monocytes and macrophages, while TH2 cells secrete 
IL-1, IL-10, IL-4, IL-5, IL-13 and a small amount of IL-6. IL-1 activates more monocytes to 
secrete large quantities of IL-6. IL-6 has several functions, both pro- and anti-inflammatory. 
Pro-inflammatory actions include stimulating the release of acute phase proteins which result 
in fever, stimulating T cell proliferation and B cell differentiation into immunoglobulin-
secreting plasma cells. On the other hand, IL-6 was reported to also have anti-inflammatory 
actions, e.g. controlling the level of pro-inflammatory cytokines such as TNF-α, but not that 
of the anti-inflammatory cytokines such as IL-10 (Xing et al., 1998), reducing the neutrophilia 
commonly associated with inflammation (Xing et al., 1998), and acting on both the 
hypothalamus and pituitary gland in the HPA-axis to increase ACTH and cortisol secretion 
(Vander et al., 1998a), and so increases the neutrophilia associated with exercise.   
Therefore, the inflammatory response to a bacterial stimulus results in a general stress 
response.  However, the stress response may also be activated in the absence of an 
infectious agent.   Exposure to a psychological stressor may also directly activate the 
interactions of cytokines and the HPA-axis.  Perception of stress stimulates the 
hypothalamus to secrete corticotrophin releasing hormone (CRH), which in turn stimulates 
the anterior pituitary to secrete ACTH, initiating the general stress response. 
 
 1.4.2 Anti-inflammatory response 
 
Cortisol has several anti-inflammatory functions, namely a) to inhibit prostaglandin-mediated 
vasodilation and increased vascular permeability, to prevent swelling in the area of damage 
or infection, b) to inhibit the margination and migration of white cells from the circulation to 
injury sites, c) to inhibit the leukotriene-facilitated phagocytic and bactericidal burst of 
neutrophils and d) to decrease the number of circulating helper T cells (Genuth, 1983a).  
Apart from these actions aimed at reversing inflammatory processes, cortisol also plays 
other roles in limiting the magnitude of the inflammatory response by inhibiting the action of 
TNF (Fantuzzi et al., 1995), IL-1, IL-2 and IFN-γ, and causing arrest of lymphocyte 
proliferation in cell stages G0 and G1 , and lymphocyte apoptosis (Vander et al., 1998a).  
 
Although the anti-inflammatory functions of cortisol are required to prevent reactions that 
may seriously harm the organism, such as autoimmune reactions, chronically elevated levels 
of cortisol may in turn result in increased susceptibility to infection. Furthermore, cortisol has 
a number of other metabolic functions (see 1.4.3), which, although necessary in a stress 
situation, may in the long run not be beneficial to the organism.   
 
1.4.3 Other stress-associated effects of glucocorticoids 
 
Cortisol increases the conversion of amino acids (predominantly alanine and glutamine) to 
glucose in the liver. The increased gluconeogenesis helps to maintain liver glucose output 
and prevent hypoglycaemia during prolonged exercise. However, a chronically elevated 
cortisol concentration may lead to increased muscle breakdown above that required for 
conversion to carbohydrates, which may lead to cachexia, which itself has been linked to 
increased morbidity and mortality in various chronic diseases (Anker et al., 1997; Anker & 
Sharma, 2002; Kotler et al., 1989; Kotler, 1994; Zinna & Yarasheski, 2003). In human 
subjects, cortisol infusion was recently reported to result in prolonged changes in skeletal 
muscle amino acid patterns, similar to those reported early in protein catabolism 
(Hammarqvist et al., 2001), illustrating a direct link between cortisol and skeletal muscle 
breakdown.  
 
 Another debilitating effect of chronically elevated cortisol is its down-regulation of osteoblast 
proliferation and collagen type I synthesis, which results in osteoporosis (Delany et al., 
1995). IL-6 was recently reported to up-regulate cortisol receptors in osteoblast-like cell 
lines, suggesting an interaction between cortisol and IL-6 in the progression of osteoporosis 
(Angeli et al., 2002). Glucocorticoid-induced osteoporosis is a common complication of 
pathological conditions characterised by long-term sustained hypercortisolaemia, such as 
Cushing’s syndrome (Di Somma et al., 2003), or malnutrition, e.g. anorexia nervosa (Misra & 
Klibanski, 2002). However, osteoporosis may also be a secondary condition after long-term 
glucocorticoid replacement therapy, e.g. in Addison’s disease (Jodar et al., 2003). Bone loss 
of up to 15 % may occur within the first 3 to 6 months of chronic glucocorticoid therapy 
(Saag, 2004).  Although female athletes, specifically those in sports requiring low body 
mass, are known to have an increased risk for suffering from osteoporosis, its cause in this 
population is most likely eating disorders, rather than chronically elevated cortisol (Warren & 
Goodman, 2003). 
 
According to a recent review (Peters et al., 2004), the mechanisms by which these negative 
long-term effects of increased circulating glucocorticoids occur is likely to be related to a 
stress-related “resetting” of the balance, or setpoint,  of the limbic-hypothalamic-pituitary-
adrenal axis, which is determined by the balance between high-affinity MR and low-affinity 
GR in the system.   Therefore, development and progression of chronic diseases such as 
NIDDM and the metabolic syndrome, may be as a result of chronic stress-related disruption 
of the balance between the different types of glucocorticoid receptors. 
 
1.5 Summary  
 
It is clear that a situation of chronic stress, such as endurance training, may have severe 
consequences to many physiological systems.  It is therefore imperative to study the 
mechanisms of and associations between systems involved in these responses, to limit long-
term damage to an athlete’s body.  Although the stress response has been researched 
extensively, the concept of exercise as more than simply a metabolic stressor is relatively 
new, and many questions are still unanswered.  Since a large part of the stress-related 
literature reports on studies performed in individuals with an underlying pathology or disease 
 state, results cannot always be extrapolated to a healthy, athletic population.  Thus, 
population-specific and stressor-specific investigations should allow a more comprehensive 
understanding of the stress that exercise places on physiological systems in athletes.   
 
However, since many of the long-term effects of exercise may be obscured by the great 
variability introduced by every-day life stressors, some studies using protocols of more 
extreme stress are warranted.  In order to control the daily environment, most of these 
studies are done in animal models of stress (e.g. inescapable tail shock).  However, the 
results obtained in these studies cannot necessarily be extrapolated to situations of exercise 
stress, since the severity of the stressor may override the influence of coping mechanisms 
which may be sufficient under physiological conditions of stress. Therefore, it is necessary to 
use mild stressors if the purpose of the investigation is to model the exercise stress 
response.  
 Chapter 2 
 
Literature review 
 
An acute stressor results in physiological changes that are, at least with regard to the 
immune system and endocrine stress-axis, usually only transient.  Changes in immune 
competence for example, return to baseline after a few hours of recovery, rendering the body 
fully able to react to a new onslaught. However, when repeated stressors occur in short 
succession without sufficient recovery time, which is characteristic of a strenuous exercise 
training regimen or a continuously stressful occupation, these transient changes in immune 
and hormonal parameters do not always have enough recovery time to return to baseline 
between challenges. This may result in transient effects becoming more chronic, thereby 
rendering the body either unable to react competently to additional challenges for prolonged 
periods of time, or unable to down-regulate the stress response, leading to other chronic 
diseases. At least to a certain extent, the number and intensity of previous stressors will 
determine whether the body has adapted to cope with such an acute stressor, or whether 
previous onslaughts have resulted in a pathologically altered stress response.   
 
This chapter will provide an overview of the available literature on the responses of the 
specific immune system and endocrine stress-axis to acute stressors, and their adaptation to 
chronic stressors.  Particular attention will be paid to exercise as a stressor, but since the 
additional effects of psychological life stress cannot be excluded in a human population, I will 
also provide a brief overview of relevant literature pertaining to psychological stress.  The 
effects of stress on the immune system and endocrine stress-axis will first be discussed 
separately, followed by an integration to point out interactions between these systems. 
 
 2.1 Immune and cytokine system responses to exercise stress 
 
2.1.1 Responses to acute exercise stress 
 
Cytokine response: Acute, long-duration, strenuous exercise such as a marathon or 
distance triathlon, has been shown to result in systemic endotoxaemia, due to leakage of 
intestinal E.coli lipopolysaccharide (LPS) into the circulation (Bosenberg et al., 1988; 
Jeukendrup et al., 2000). This occurs when the vascular wall loses integrity due to the 
ischaemia associated with strenuous exercise, when blood flow to non-vital systems is 
decreased in favour of skeletal muscle and skin.  The endotoxin in circulation binds to 
monocytes and results in increased release of IL-6. Increases in plasma IL-6 concentration 
of up to 128-fold have been reported after exercise (Jeukendrup et al., 2000; Ostrowski et 
al., 1999; Steensberg et al., 2001b), but the site of increased cytokine production remains a 
point of debate.  Possible sources of exercise-induced IL-6, other than in response to 
endotoxaemia, will be discussed below.  
 
In endurance athletes, monocytes isolated from blood collected before, immediately after 
and 20 minutes after a VO2max test (cycling) were incubated in a cell culture (Rivier et al., 
1994). Spontaneous secretion of TNF-α and IL-6 was increased immediately after exercise, 
and that of IL-6 was still increased from baseline after 20 minutes of recovery, indicating that 
monocytes are a source of IL-6 during and immediately after exercise. A deficiency in this 
study design was that serum IL-6 concentration was not measured. Therefore, it was not 
possible to assess whether the magnitude of the contribution of monocyte IL-6 could be 
significant for the total increase in serum IL-6 seen after exercise in other studies 
(Jeukendrup et al., 2000; Pedersen et al., 2001; Steensberg et al., 2001b).   Spontaneous 
release of both TNF-α and IL-6 were positively correlated with maximum oxygen 
consumption (VO2max), maximum ventilation and peak power output (PPO), suggesting that 
for monocytes, the stimulus to release these cytokines is dependent on the intensity of an 
exercise effort.   
 
 Muscle damage was previously named as another contributing factor to the increased 
plasma IL-6 concentration seen after exercise, with eccentric exercise resulting in a 
significantly greater increase in plasma IL-6 concentration compared to concentric exercise 
in healthy males (Bruunsgaard et al., 1997).  However, a subsequent study in rats indicated 
that contracting muscle exhibited an increase in IL-6 mRNA, independently of whether the 
muscle performed concentric or eccentric exercise (Jonsdottir et al., 2000). While both 
concentric and eccentric muscle contraction in the rat study were controlled by electrical 
stimulation, that of the human study (forward and backward pedaling on a cycle ergometer) 
may not have represented stressors of equal magnitude, which may explain the 
inconsistency in results obtained by Bruunsgard et al. (1997) and Jonsdottir et al. (2000).  
 
Another study in human subjects (Steensberg et al., 2000) indicated that during one-legged 
concentric exercise, the femoral artery-femoral vein (a-v) difference in IL-6 concentration in 
the exercising leg paralleled the net increase in mixed venous circulating IL-6 concentration, 
while no a-v difference was observed in the non-exercising leg. This led to the conclusion 
that muscle contraction, and not endotoxemia, was responsible for the post-exercise 
increase in IL-6 concentration.  I propose that since these subjects were exercising only one 
limb at 40 % of maximum effort, the intensity of exercise was probably not enough to result 
in gut ischaemia with endotoxaemia or muscle damage, or to result in a significant 
endocrine-immune stress response. The study design does not make it possible to consider 
these confounding factors and the results should be considered conclusive only for low 
intensity exercise.  Although another, earlier study is in agreement with the suggestion that 
PBMCs are not responsible for IL-6 increases (Ullum et al., 1994), on the grounds of finding 
no change in PBMC mRNA concentrations for TNF-α, IL-1α, IL-1β and IL-6 after a 1-hr cycle 
at 75 % VO2max, there are several confounding factors contributing to the conclusions of this 
study. Firstly, the method used, detection of IL-6 mRNA in purified PBMCs by Northern 
blotting analysis, may not have been sensitive enough for detection of very small changes.  
In comparison, the highly-sensitive quantitative competitive PCR techniques used more 
recently, measured increased IL-6 mRNA in skeletal muscle after exercise in rats (Jonsdottir 
et al., 2000).   Secondly, while electrical stimulation of skeletal muscle, as used by Jonsdottir 
et al. (2000), results in homogenous stimulation of muscle cells, exercise does not 
necessarily activate IL-6 production in all monocytes and TH2 lymphocytes, and a sample of 
 isolated PBMCs will also contain cells which are not capable of secreting IL-6, such as NK 
cells and TH1 lymphocytes.  Therefore, the availability of mRNA would be much lower in the 
PBMC sample compared to a skeletal muscle sample, which makes detection of small 
changes in response to exercise less likely.   Thirdly, the analyses for the various cytokine 
mRNAs were performed for only 1-3 of the 17 athletes participating in the study by Ullum et 
al. (1994), which further decreases the likelihood of detecting stress-induced changes in 
mRNA. These results therefore do not conclusively exclude PBMC involvement in the IL-6 
release seen after exercise.  On the other hand, more recent studies, using flow cytometry, 
more clearly illustrated that prolonged strenuous exercise results in decreased monocyte 
production of IL-6 (Starkie et al., 2001a; Starkie et al., 2001b).  Therefore, we conclude that 
acute, strenuous exercise is likely to suppress monocyte-mediated inflammatory capacity 
directly post-exercise. 
 
Oxidative stress was recently suggested as the major stimulus for exercise-induced cytokine 
production (Vassilakopoulos et al., 2003), since a blunted plasma cytokine response (TNF-α, 
IL-1β and IL-6) to exercise was observed in healthy non-athletes after administration of oral 
antioxidants for 2 months. In addition, the authors argued against a role for monocytes in 
exercise-induced cytokine release, since they found no effect of either their exercise protocol 
(45 minutes cycling at 70 % VO2max) or antioxidant administration on monocyte count or 
monocyte intracellular cytokine production from pre- to post-exercise.  However, monocyte 
counts reported tended to be increased immediately after exercise. It is possible that 
statistical significance was not achieved as a result of the low subject numbers (n = 6), 
combined with the high variability in monocyte counts reported and the short duration of the 
exercise protocol.  A significantly increased post-exercise monocyte count was reported 
previously after longer-duration exercise in both athletes and non-athletes, using larger 
subject numbers (n = 9 to 17 per study) (Rhind et al., 2001; Rohde et al., 1996; Ullum et al., 
1994).  Also, insufficient data is provided on the performance or fitness level of subjects at 
the two time points, or their participation in exercise in-between, to enable assessment of 
changes in fitness levels, which may have been a confounding factor.   Although the blunting 
effect of antioxidants on plasma cytokine concentration is a valid and important finding, 
which may be useful in precautionary supplementation regimens, more investigation is 
 necessary before monocytes can be excluded as modulators in the cytokine response to 
exercise. 
 
Considering the results of all studies mentioned in this section, muscle damage seems 
unlikely as a sole cause of post-exercise circulating serum IL-6 concentration, while 
endotoxaemia-stimulated monocytes and contracting muscle have now both been 
established as contributors to IL-6 secretion, and therefore initiation of inflammation during 
exercise.  The relative importance of these contributors may depend on the exercise protocol 
itself. Further investigation is warranted to determine the role of oxidative stress and muscle 
damage in the changes in circulating cytokine concentrations after exercise. 
 
The cytokine response to an acute exercise bout is only transient, with both pro-inflammatory 
cytokines, particularly IL-6, and anti-inflammatory cytokines, such as IL-10, reported to reach 
peak plasma concentrations within 2-3 hours after starting an exercise bout and then to 
decline steadily during recovery (Ostrowski et al., 1999).  The magnitude of IL-6 secretion 
was also shown to be dependent on the mode of exercise, fitness and nutritional state of the 
athlete (for a recent review, refer to Shephard, 2002). 
 
White cell quantitative response:  Immune cells are able to undergo rapid demargination 
and redistribution between compartments, resulting in changes in the number of cells in 
circulation even without any proliferation. This process is the result of mechanical sheer 
stress on vascular walls (Bierman et al., 1952; Foster et al., 1986) and neuroendocrine  
signals (McCarthy & Dale, 1988) associated with exercise.  The latter signals are mediated 
mainly by the activation of the sympathetic nervous system and the hypothalamic-pituitary-
adrenal axis, i.e. via release of catecholamines and glucocorticoids (Miller et al., 1998).  
Although heat has been suggested as the cause of exercise leukocytosis, thermal clamping 
studies enabled researchers to exclude a core temperature rise as a critical mediator of 
lymphocyte redistribution (Rhind et al., 1999).   
 
Prolonged endurance exercise of moderate intensity (60 – 80 % VO2max for 2 – 2.5 hours) is 
associated with a leukocytosis during or immediately after exercise, depending on the 
duration of the bout (McCarthy & Dale, 1988; Shephard & Shek, 1996). Although 
 lymphocytes show greater relative (percentage) increases, neutrophils are the biggest 
absolute contributors to this exercise-induced leukocytosis. Exercise of shorter duration and 
higher intensity elicits a similar response.  For example, one study reported an average 
increase of 114 ± 20 % in total lymphocyte count after incremental treadmill running to 
exhaustion, while neutrophil count increased by a relatively moderate 34 ± 7 % (Gleeson et 
al., 1995).  
 
The extent of exercise-induced lymphocytosis was shown to be related to both exercise 
intensity (Nieman et al., 1993) and exercise duration (Natale et al., 2003).  For example, 
after 45 minutes of exercise at either 50 % or 80 % VO2max, the higher intensity exercise was 
associated with a greater increase in the proportion of NK cells from pre- to post-exercise 
(Nieman et al., 1993).   Also, while both long duration endurance exercise (2 hours cycling at 
60 % VO2max) and short-duration high-intensity exercise (5 minutes cycling at 90 % VO2max) 
resulted in an increased lymphocyte count, the effect of the longer-duration exercise was of 
greater magnitude when compared to the short-duration exercise (Natale et al., 2003).  Not 
all lymphocyte subpopulations contribute equally to this lymphocytosis.  Despite the fact that 
increased recruitment of NK cells into the circulation is the main contributor (Mazzeo et al., 
1998; Nieman et al., 1993), relatively greater increases occur in B compared to T cells, 
resulting in a lowered T:B cell ratio (McCarthy & Dale, 1988; Shephard & Shek, 1996). 
Immature T lymphocytes are more cortisol-sensitive than mature T cells (Hoffbrand & Pettit, 
1994a; Vander et al., 1998a). The relative decrease in T cells reported in stress situations 
may be the result of increased sequestration of these cells to the bone marrow (Hässig et al., 
1996).  Furthermore, greater increases occur in CD8+ than in CD4+ T cell counts (Natale et 
al., 2003; Shephard & Shek, 1996), so that the CD4+:CD8+ ratio decreases with exercise.  
The magnitude of this change in ratio was shown to be independent of exercise type, since 
similar results were obtained after eccentric (Pizza et al., 1995b), aerobic concentric 
(Nehlsen-Cannarella et al., 1991a; Nieman et al., 1995) and anaerobic concentric (Deuster 
et al., 1999) exercise.   Resistance exercise (3 sets of 10 repetitions at 60 – 70 % of 1-RM) 
and high-intensity cycling (5 minutes at 90 % VO2max) were shown to have a longer-lasting 
effect on CD4+:CD8+ ratio when compared to submaximal endurance exercise (2 hours 
cycling at 60 % VO2max) (Natale et al., 2003).  Therefore, the decreased CD4+:CD8+ ratio 
may be one of the most consistent immune system responses to acute exercise.  
 Given the controversy around plasma cytokine concentration increases in response to acute 
exercise, it has become more important in the recent past to consider results of in vitro cell 
culture studies to assess the influence of exercise on the ability of immune cells to secrete 
cytokines. In order to assess whether non-specific and specific immune functions are 
affected similarly, some studies specifically assessed changes in T cell cytokine production.  
Variable results have been obtained, depending on the study design.  A study in mice 
investigated possible links between increased incidence of infection after strenuous exercise 
and changes in the specific T cell cytokine response (Kohut et al., 2001). Mice were 
subjected to acute exhaustive treadmill running, after which they were infected with a herpes 
simplex virus (upper respiratory infection), and sacrificed on days 2 and 7 post-infection. Two 
days post-infection, spleen cell cultures exhibited suppressed cytokine production of both 
TH1 (IL-2, IFN-α and IL-12) and TH2 (IL-10) cytokines, as well as decreased NK cell 
cytotoxicity, when compared to non-exercising control mice.  All parameters were similar to 
controls on day 7.  Similarly, in humans, exhaustive exercise decreased the capacity of white 
blood cells in a whole blood culture to secrete IFN-γ, IL-1β and TNF-α immediately post-
exercise in response to LPS (Baum et al., 1997), again suggesting general inhibition of T cell 
function.  Also, IFN-γ, IL-6, TNF-α, IL-1 and IL-2 release after in vitro stimulation with LPS or 
PHA in whole blood culture were reduced after 68 minutes of exhaustive exercise in 
triathletes (Weinstock et al., 1997).  On the other hand, a single session of high intensity 
cycling exercise (8x 10-second maximum effort cycling bouts separated by 5 minutes) was 
reported to result in inflammation (increased IL-6 and CRP concentration), with some 
biological markers of inflammation (increased CRP) persisting for more than 24 hours after 
cessation of exercise (Meyer et al., 2001).  Similarly, in vitro studies using whole blood 
culture techniques reported increased mitogen-induced cytokine (IFN-γ and IL-2) secretion 
after moderate intensity exercise (30 minutes cycling at 70% anaerobic threshold) (Baum et 
al., 1997).  Therefore, while acute exhaustive exercise seems to suppress both TH1 and TH2 
cytokine secretion, acute moderate or intermittent exercise appears to have the opposite 
effect.  
 
Although the above-mentioned in vitro studies provide indirect information on possible 
changes in cytokine concentrations in circulation, it is unclear whether such changes could 
 be a result of changes in individual cell function, or changes in cell count.  Some studies 
have investigated these issues in vivo by assessing cell type-specific cytokine production 
after exercise, in order to more fully explain the effect of exercise on immune cells.  For 
example, an acute bout of strenuous exercise (2.5 hours at 75 % VO2max) resulted in a 
decreased CD4+ T cell count during recovery, which was accounted for by a decrease in 
mainly TH1 cell numbers, and thus decreased capacity for cell-mediated immunity 
(Steensberg et al., 2001a). Similar results were subsequently reported after 1.5 hr running at 
70% VO2max, with an unaltered TH2 response (IL-2 and IL-4), but decreased TH1 response 
(IFN-γ) (Ibfelt et al., 2002). Both the cytokine and endocrine systems seem to contribute to 
these changes, since IL-6 correlated positively with the number of TH2 cells secreting IL-4 in 
the first study (Steensberg et al., 2001a), thus enhancing TH2 lymphocyte-mediated 
immunity, while epinephrine correlated negatively with the number of TH1 cells secreting IL-2 
(Steensberg et al., 2001b; Steensberg et al., 2001a), which may indicate a suppressive role 
of epinephrine on cell-mediated immunity.    
 
Taken together, these results imply that while moderate duration, moderate intensity 
exercise seems to enhance immune function, prolonged, strenuous exercise has the 
opposite effect, with the TH1 lymphocyte-mediated immune system suffering the greatest 
negative effect.  A recently published review (Smith, 2003) supports this conclusion. 
 
During recovery after exercise, the leukocytosis of exercise is reversed, with the CD4+ cell 
count recovering to resting concentrations, while CD8+ cell counts are usually lower than 
baseline. This was suggested to be the result of migration of these cells to either injured 
muscle or lymphoid tissue (Shephard & Shek, 1996), but it has not been substantiated. 
While the neutrophilia may persist for up to 24 hours post-exercise (Nieman et al., 1989a), 2 
– 3 hours of recovery is usually sufficient for most lymphocyte subpopulation counts to return 
to baseline, in a manner seemingly independent of the duration of the exercise bout, since 
similar time frames for lymphocyte recovery have been reported after 45 minutes, 1.5 and 3 
hours of endurance exercise (Natale et al., 2003; Nieman et al., 1989a; Nieman et al., 1994).  
 
There is still some controversy surrounding the influence of muscle microdamage after 
exercise, on immune parameters in circulation during recovery. For example, a reduced 
 circulating cell count may be due to infiltration of these cells into injured muscle.  A recent 
study showed that the immunological changes in skeletal muscle after delayed onset muscle 
soreness (DOMS)-inducing eccentric cycling exercise were characterised specifically by 
increased macrophage and neutrophil infiltration into muscle, illustrated by immunostaining 
of biopsy samples, with a peak infiltration evident at 24 hours post-exercise (Malm et al., 
2000).  No change from baseline was evident in muscle total T or B cell concentrations.  One 
possible explanation for this result is that muscle microdamage only impacts on the non-
specific immune system. On the other hand, baseline biopsy samples had very low 
concentrations of lymphocytes, and changes in T cell distribution are exercise-intensity 
dependent. Therefore, the moderate-intensity, short duration protocol followed in this study 
(250-300 W for 30 minutes), although of eccentric nature and sufficiently severe to result in 
DOMS, may not have represented a stressor severe enough to result in muscle lymphocyte 
infiltration of sufficient magnitude to allow for changes in cell counts to be detected in needle 
biopsy samples.  The former opinion is most likely, since changes observed in the circulating 
immune cell counts support the theory of an effect only on the cell-mediated immune system: 
neutrophil, monocyte, suppressor/cytotoxic T cell and NK cell counts were all increased 
immediately post-exercise, while CD4+ T cell and B cell counts were not affected.  Therefore, 
I suggest that skeletal muscle microdamage is not a significant contributor to the activation of 
the specific immune system after exercise. This is supported by previous studies (discussed 
earlier) which together illustrated no additional effect of eccentric exercise on exercise-
induced changes in CD4+:CD8+ ratio (Deuster et al., 1999; Nehlsen-Cannarella et al., 1991a; 
Pizza et al., 1995b). 
 
Although the reported post-exercise changes in total white cell counts and subpopulation 
distribution give an indication of the availability of cells which may react to a pathogenic 
challenge during recovery, these data are not sufficient to draw conclusions on changes in 
actual responsiveness of immune cells, and changes in cell function should also be 
considered. 
 
T cell functional response: High intensity exercise (45 minutes level running at 80 % 
VO2max), but not moderate exercise (45 minutes graded treadmill walking at 50 % VO2max), 
resulted in a 21 % decrease in ConA-stimulated (T cell) lymphocyte proliferative response at 
 1 hour post-exercise (Nieman et al., 1994).   Similarly, 45 minutes of walking at 60 % VO2max 
did not affect the T cell lymphocyte proliferative response in fit females (Nehlsen-Cannarella 
et al., 1991b), while 2.5 hours of running at 75 % VO2max decreased T cell proliferative 
response in experienced marathon runners (Nieman et al., 1995).  This depressed function 
lasted for more than 3 hours post-exercise.  These different studies clearly indicate that 
endurance exercise is not detrimental to T cell functional response unless the intensity 
and/or duration are quite extreme. The observed continuation of this depressed function into 
the recovery period has led to the “open window” theory for increased infection risk (Nieman 
& Pedersen, 1999).  
 
Although endurance athletes or endurance exercise is most frequently studied, other types 
of exercise have also been reported to affect immune function.  Acute supra-maximal interval 
training sessions (25 x 1-minute bouts of running or kayaking, with 2-minute rest in between 
bouts) in athletes varying from recreational to high-performance level, were shown to 
decrease T cell proliferative response post-exercise, but only transiently, with values 
returning to baseline by 2 hours post-exercise (Fry et al., 1992).  Lymphocyte proliferative 
response therefore seems to be negatively affected by various types of extreme exercise 
bouts, i.e. either continuous or intermittent high intensity, or long duration bouts. 
 
Although assessment of change in the lymphocyte proliferative rate is an accepted, useful 
functional test to assess changes in immune ability, it cannot differentiate between T cell 
subpopulations, and therefore provides information about total T cell function only. However, 
it is possible that some subpopulations with opposing functions, such as CD4+ and CD8+ T 
cells, are affected differently by exposure to a stressor, so that one cell type has depressed 
function and another enhanced function.  Although this would return a net result of “no 
change” in the lymphocyte proliferative response assay, it clearly does not provide the full 
picture.  An alternative test, assessing cell activation by measurement of the activation 
marker CD69, a more upstream event, is able to differentiate between T cell subpopulations, 
enabling more comprehensive analysis and interpretation of changes in immune function.  
Few studies have investigated changes in T cells’ reactivity, as indicated by CD69 
expression, in response to exercise. Gabriel et al. investigated the effect of a 240 km cross-
country cycle race or an ultra-triathlon in 12 endurance athletes, by measuring the CD69 
 response at rest and after acute exhaustive exercise two weeks before and 8-9 days after 
the racing event (Gabriel et al., 1993).  No changes were apparent in NK and non-NK cell 
CD69 expression in response to the racing event.  This was the first exercise study to use 
CD69 expression as a functional test, and there were several factors in the protocol making 
it difficult to fully interpret results. Firstly, follow-up samples were taken 8-9 days after the 
event, at which time CD69 expression was similar to baseline, but this does not illuminate 
whether a change in CD69 expression may have occurred at an earlier post-race time point. 
Secondly, results reported seem to be pooled data for resting and post-exercise samples, 
which may mask changes. Thirdly, T cells were divided into only 2 subgroups, namely NK 
and non-NK, which may mask alterations in relative activation between e.g. CD4+ and CD8+ 
cells.  These results are therefore not useful in determination of T cell activation status in 
response to strenuous exercise. 
 
A recent report by the same research group investigated both CD69 expression and 
lymphocyte proliferation rate in response to acute exercise (Green et al., 2003). Similar 
counts for CD4+CD69+ and CD8+CD69+ cells were reported at rest and after 1 hour of 
moderate intensity treadmill running (95 % of ventilatory threshold).  Lymphocyte proliferative 
response was decreased after exercise, but was similar to the resting response when 
corrected for changes in lymphocyte count. This resulted in the conclusion that this type of 
exercise did not influence T cell function. However, it is doubtful whether the moderate 
exercise intensity protocol used would have elicited a stress response in the well-trained 
subjects who participated in the study, given the results of studies discussed on the previous 
pages. Therefore, these findings still do not elucidate whether or not CD69 expression is a 
useful marker of immune status in athletes who are used to high-intensity training. 
 
Studies by other groups do report suppressive effects of acute bouts of exercise on 
lymphocyte activation. One of these studies reported decreased CD69 expression on CD4+ 
and CD8+ cells after acute exhaustive exercise (Vider et al., 2001).  Of importance is that the 
T lymphocyte proliferative response immediately after exercise was also decreased in this 
study. Similarly, repeated bouts of cycling on the same day (75 minutes at 75 % VO2max, with 
3 hours recovery between bouts) were reported to have a cumulative suppressive effect on 
the percentage of NK cells expressing CD69 post-exercise (Ronsen et al., 2001c).  The 
 report of no significant change in the percentage of CD4+ and CD8+ cells expressing CD69 in 
the same study  is not inexplicable, since the exercise protocol used in the latter study was 
less strenuous than the one used by Vider et al. (2001).  Unfortunately, absolute CD69+ cell 
counts were not provided in the study by Ronsen (2001b), so that the influence of exercise-
induced changes in cell count cannot be integrated in my interpretation of their results. A 
subsequent study investigated the effect of 3 hours vs. 6 hours of recovery between acute 
bouts of endurance exercise (again 75 minutes cycling at 75 % VO2max) (Ronsen et al., 
2002).  Although no significant differences in proportions of either NK, CD4+ or CD8+ T cells 
expressing CD69 were found between the two recovery protocols, the longer recovery 
protocol was associated with a smaller exercise-induced increase in the absolute number of 
CD8+ cells expressing CD69 when compared with the shorter recovery protocol.  This finding 
stresses the importance of assessing cell counts in conjunction with functional assays, since 
the net effect of changes in cell count and function should be interpreted for a 
comprehensive understanding of immune changes. These reports suggest that the immune 
system may not recover to baseline levels for several hours after an acute bout of strenuous 
exercise, stressing the importance of sufficient recovery time between strenuous training 
sessions to ensure maintenance of immune competency.  In addition, the longer recovery 
protocol was also related to a smaller catabolic hormone response to the second bout (see 
2.3.1), indicating the necessity for combined assessment of the immune and stress hormone 
systems. 
 
2.1.2. Responses to chronic exercise stress (training) 
 
Susceptibility to infection: Earlier investigations suggest progressively increased 
susceptibility to infection with chronic training at intense levels over the course of a season 
(Tomasi et al., 1982), with ultra-marathon athletes reportedly suffering a significantly greater 
number of upper respiratory tract infections (URTI) than a control group (Peters & Bateman, 
1983; Shephard & Shek, 1993), and faster athletes reporting more episodes of illness than 
slower runners. On the other hand, participation in moderate exercise does not seem to 
precipitate illness, but rather to shorten the duration of illness, and to increase the resistance 
to infection (reviewed by Shephard and Shek, 1993).   Although there is general acceptance 
of this “J-shaped hypothesis” of infection risk (Mackinnon, 1992; Nieman, 1994) – according 
 to which, light to moderate exercise decreases URTI risk, while extreme exercise increases 
risk for URTI – not all researchers are in agreement.  Some groups argue that athletes adapt 
to their chronic training regimens, since an epidemiological study has shown that elite skiers 
suffer a similar number of episodes of infectious disease (of which 74 – 93 % were URTI) 
when compared to non-trained individuals (Berglund & Hemmingsson, 1990).   
 
Reports on the effect of training on immunoglobulin release and mucosal immunity are 
varied. Some research groups report a steady decline in salivary immunoglobulin 
concentrations with chronic exposure to endurance exercise (running, cycling, swimming and 
cross-country skiing), with resting concentrations of IgA, IgG and IgM decreasing 
significantly over time, as well as decreased IgA secretion after acute exercise bouts in elite 
swimmers (Gleeson et al., 2000; Gleeson, 2000).  However, in elite female rowers, IgA 
concentrations at rest were reported to be 77 % higher when compared to a non-athlete 
control group, with no effect of acute exercise (2 hours of rowing training) on salivary IgA 
concentrations or secretion rates measured before, immediately after and 1.5 hours after 
exercise in the elite athletes (Nehlsen-Cannarella et al., 2000). In addition, the same group 
reported 20% increases in resting IgA, IgG and IgM concentrations in sedentary subjects 
after moderate training (5 sessions of 45 minutes walking per week) for 6 weeks, but which 
was attenuated after 15 weeks of training (Nehlsen-Cannarella et al., 1991a).  Other studies 
showed no differences in salivary concentrations of IgA, IgG and IgM of endurance athletes 
at rest, after graded maximal exercise or during recovery, or compared to sedentary controls 
(Kajiura et al., 1995; Nieman et al., 1989c). Although hydration status may influence results, 
the results obtained from saliva samples in the mentioned studies seem to be dependent on 
the research group reporting it, suggesting that values obtained were most likely influenced 
by inter-laboratory differences in the technique of sample collection, resulting in the varied 
findings reported. For these reasons, I have not been able to draw a conclusion from the 
available literature on the effect of training on immunoglobulin secretion. Therefore, I would 
not recommend measurement of salivary immunoglobulin concentrations as an indicator of 
immune status. 
   
Cytokine response: During the early stages of acute local inflammation, macrophages and 
fibroblasts secrete cytokines and chemokines which result in changes in the expression of 
 adhesion molecules and inflammatory receptors on vascular endothelial cells supplying the 
inflamed tissue. This results in recruitment of large numbers of leukocytes to the injured 
tissue (Butcher et al., 1999).  However, for tissue repair to take place, the redundant or dead 
cells need to be cleared.  A second effect of chemokine release is activation of dendritic cells 
to migrate with the antigen (and antigen presenting cells) to draining lymph nodes, where a 
specific immune response takes place. This transition from the inflamed area to the lymph 
nodes coincides with tissue repair and leads to immune memory (Buckley et al., 2001).  
However, during chronic local inflammation, this transition does not take place due to failure 
of fibroblasts to stop the production of chemokines, resulting in increased chemokine release 
and thus increased recruitment and prolonged retention of leukocytes in tissue, preventing 
repair (Buckley et al., 2001). This in turn results in chronic systemic inflammation, which was 
recently proposed to be the major cause of the overtraining syndrome (Smith, 2000). 
 
Furthermore, monocytes of endurance trained individuals were reported to be more sensitive 
to LPS at rest than the monocytes of untrained individuals, so that they secreted similar IL-6 
concentrations compared to the monocytes of untrained individuals (168.4 ± 29.9 pg/ml vs. 
160.1 ± 34.4 pg/ml), but in response to much lower concentrations of added LPS in culture 
(0.003 μg/ml for endurance athletes vs. 0.03 μg/ml for untrained subjects) (Duclos et al., 
1999).  In addition, PBMCs of endurance athletes also exhibited increased sensitivity to 
stimulation by exogenous glucocorticoids at rest.  These results suggest an upregulation of 
the immune response to stress after exercise training, possibly to cope with a chronic low-
grade exposure to LPS during training and racing. However, this increased sensitivity at rest 
was abolished after exercise in the same study.  I suggest that this may be due to some 
counter-regulatory mechanism, which prevents “overshoot” of the immune response in 
response to an additional acute stressor.  Although such a protective mechanism may be 
beneficial in preventing severe inflammation after e.g. competitive events, the long term 
effect of this “immune suppression” remains to be elucidated.  Also, it is possible that this 
capacity for counter-regulation is not always successful.  This issue should be further 
investigated, as it may support, at least in part, the hypothesis of increased IL-6 release as 
cause of the overtraining (underperformance) syndrome (Robson, 2003). 
 
 White cell response: Both short-term (Pizza et al., 1995a; Verde et al., 1992) and longer 
term training (Baj et al., 1994; Shore et al., 1999) were reported to significantly decrease 
resting total T cell count, CD4+ T cell count and CD4+:CD8+ ratio.  In a study on rats 
(Hoffman-Goetz et al., 1986), chronic exercise stress was shown to reduce splenic T 
lymphocyte proliferation in response to mitogen stimulation, which suggests that the 
decreased resting CD4+ cell counts reported in human training studies, may be the result of 
decreased release of cells from the spleen into circulation. In elite runners, 3 weeks of 
training at 138 % of usual training volume, also had suppressive effects on resting CD4+ 
counts and the CD4+:CD8+ ratio, but not on the lymphocyte proliferative response, when 
compared to baseline (Verde et al., 1992).  However, an acute bout of exercise (30 minutes 
high-intensity) after the training period resulted in a transient depression of lymphocyte 
proliferation rate that was not apparent after a similar acute exercise test at baseline.  
Similarly, in runners, a 40-day period of increased training load (increased volume, or 
increased intensity, or both) resulted in a decrease in CD4+ T cell count and the CD4+:CD8+ 
ratio at rest, the magnitude of which was more dependent on training intensity than training 
volume (Kajiura et al., 1995). After a period of taper, the CD4+:CD8+ ratios had returned to 
baseline values in both studies (Kajiura et al., 1995; Verde et al., 1992), suggesting 
reversibility of training-induced changes in immune competence. However, these studies do 
not enable a conclusion with regard to the combined effects of long-term training and 
insufficient recovery time on immune competence. 
 
Not all published papers are in agreement with the results obtained in the above studies. 
Recently, ten weeks of training in competitive cyclists, which included volume-building (6 
weeks), high-intensity (18 days) and unloading (10 days) phases, were reported to have no 
effect on resting total T cell count, T cell subpopulation counts, relative distribution of T cell 
subpopulations, serum concentrations of IL-1β, IL-6 and TNF-α or urinary excretion of 
cortisol and testosterone (Dressendorfer et al., 2002).  This led the authors to conclude that 
immune status is maintained during training.  However, 36-44 hours of recovery were 
allowed after each phase, prior to each resting immune assessment. My interpretation of the 
available literature is that during intense training, the main reason for chronically altered 
immune parameters, is the fact that athletes do not allow themselves sufficient recovery 
periods between strenuous bouts.  The results of the latter paper suggest that immune 
 parameters may recover to baseline after 1.5 – 2 days of recovery from a short-term 
increased training program (10 weeks). However, since few or no elite athletes afford 
themselves this much rest on a regular basis, the results of this study cannot be seen as the 
typical effect of training stress, but they do show that athletes could benefit from two days of 
rest prior to competition, and worked into their within-season periodisation.   
 
It is important to note, once again, that the decreased T cell counts reported after training do 
not necessarily indicate decreased immune function. Although the resting CD4+ cell count 
was shown to decrease after training (Baj et al., 1994), in vitro stimulation of white blood 
cells with PHA and ConA revealed an increased T lymphocyte proliferation rate in endurance 
trained athletes at rest in the same (Baj et al., 1994) and other studies (Fry et al., 1992; 
Verde et al., 1992).  I propose that this may be a compensatory mechanism for the 
decreased CD4+ cell numbers.  Therefore, changes in cell count and cell function should 
preferably be considered in combination, to enable accurate assessment of immune 
competency. Although it has been established that T cell proliferation rate increased in 
response to training, it is unclear whether CD4+ and CD8+ T cell subpopulations are affected 
similarly, or whether these reported changes are subpopulation specific, since measurement 
of the lymphocyte proliferative response does not allow distinction between T cell 
subpopulations.  Although these distinctions could be made with assessment of CD69 
expression in T cells in response to training, this has not been investigated. This parameter 
could provide more information regarding the specific site of training-induced adaptation, i.e. 
whether it is at the level of cell activation (CD69) or downstream (cell proliferation), as well 
as which subpopulations are affected most, or which may be unresponsive to training stress.  
Since CD8+ cells are either immune suppressive (suppressor cells) or part of the cell-
mediated immune response (cytotoxic cells), while CD4+ cells have their function in the 
antibody-mediated immune response, investigating the effect of training on responsiveness 
of these two parameters separately (i.e. using CD69 expression instead of lymphocyte 
proliferative response) could provide more useful information pertaining to the balance 
between the different sections of the immune system and its implication for overall immune 
competency. 
 
 
 2.1.3. Responses to overreaching and overtraining 
 
Before considering the symptoms of the overtraining syndrome (OTS), it is necessary to 
clarify some terms that are commonly confused. Overtraining is a short-term overworking of 
an athlete, during which training is at abnormally high volume or intensity, with insufficient 
recovery time between bouts, leading to a decline in work capacity (Brown et al., 1983; 
Ketner & Mellion, 1995). Overtraining is very common in athletes, who often try to correct the 
decline in performance by training harder, rather than allowing themselves rest. Several 
reports of athletes giving their best performances after a period of illness or forced rest, 
supports this contention (Brown et al., 1983).  Overreaching is a controlled form of 
overtraining that often forms part of a specific phase in a training program (Ketner & Mellion, 
1995), with the aim of supercompensation during a planned phase of decreased training 
following the overreaching. While the symptoms of both overreaching and overtraining can 
be reversed if a sufficient recovery and regeneration period is allowed, the overtraining 
syndrome (also called the unexplained underperformance syndrome) is the final stage of 
increasingly severe chronic fatigue, which develops as a result of long-term overtraining 
(Ketner & Mellion, 1995). This syndrome has many long-lasting symptoms, including 
decreased performance (Urhausen & Kindermann, 2002), disturbances in mood state 
(Urhausen & Kindermann, 2002), chronic lymphadenopathy and immunosuppression 
(Barron et al., 1985; Fry et al., 1991b; Kuipers & Keizer, 1988), resulting in an increased 
frequency of infection and illness. This syndrome requires several months of recovery (Fry et 
al., 1991b; Kuipers & Keizer, 1988; Lehmann et al., 1998). Apart from the obvious problems 
associated with illness, frequent interruptions in training or the inability to compete in 
competitions also have negative financial and competitive ranking implications for an athlete. 
It is therefore vital to understand the sequence of events leading to the overtraining 
syndrome, so that it can be recognised and managed in its early stages.  
 
Cytokine response: The OTS has been likened to a “chronic acute phase response” 
(Eichner, 1995).  Cytokines, in particular the pro-inflammatory cytokines IL-1β, TNF-α  and 
IL-6, have been suggested to be key role players in the development of the OTS (the 
cytokine hypothesis of overtraining) (Robson, 2003; Smith, 2000). However, resting serum 
IL-1 and IL-6 concentrations were reported to be similar in overtrained athletes compared to 
 controls (Parry-Billings et al., 1992). Resting concentrations of plasma IL-6 and TNF-α were 
recently reported to remain unchanged after overreaching in endurance-trained cyclists 
(Halson et al., 2003), which does not support these hypotheses of the mechanisms for 
overtraining. However, the overreaching period in this study lasted only two weeks, and was 
preceded by baseline training. This relatively short period of overreaching, after a period of 
relatively moderate training, may simply have been too short to be sufficiently stressful to 
result in chronic cytokine elevations at rest.   
 
White cell response: In a study on 10 overtrained athletes from various sporting 
backgrounds, total white cell count and differential counts at rest were within the normal 
ranges, with the only significant exception a high monocyte count in one of the athletes 
(Rowbottom et al., 1995).  Lymphocyte subpopulation distribution was within the normal 
range, suggesting no direct effect of overtraining on the immune cell counts.  Markers of 
immune cells’ functional capacity have been determined in only two studies of overtrained 
endurance athletes.  These athletes, who exhibited no differences in lymphocyte counts or 
distribution, also did not differ for lymphocyte activation at rest or after an acute bout of 
exercise, when compared to non-overtrained controls (Gabriel et al., 1998).    However, in 
the latter study, CD45RO expression on T lymphocytes was increased in the overtrained 
athletes, which may suggest that these athletes were suffering from infections. Therefore, no 
conclusion can be drawn from these results.  
 
Most studies are of cross-sectional nature and report white blood cell counts and function 
within the normal range, rather than change over time. This is understandable since the OTS 
is relatively rare, has a long aetiology and cannot be ethically inflicted for research purposes.  
However, this may explain the contradictory results reported, since more subtle changes in 
the white blood cell count, while staying within the normal range, may nevertheless 
significantly impact on an individual’s ability to mount an immune response.  
 
Another problematic issue which complicates the interpretation of studies investigating the 
effects of exercise stress in humans, is that these individuals may also be exposed to other 
additional stressors, such as occupation-related stress, or the constant psychological 
pressure to excel. Given the general nature of the stress response, various different 
 stressors may impact on the immune or endocrine system fairly similarly, and thus additively, 
if present at the same time.  Since psychological stress may contribute significantly to the 
overall stress status of athletes, it is therefore necessary to also consider the effect of 
psychological stressors on these systems. 
 
2.2 Immune and cytokine responses to psychological stress 
 
As mentioned in the previous paragraph, many scenarios in life may elicit a stress response, 
including various forms of psychological stress. For the purposes of this thesis, I will first 
provide a brief description of typical models of psychological stress used for research, 
followed by an overview of the results obtained in studies using these models. 
 
In human subjects, stress prior to examinations is the model most commonly used to 
investigate the effect of psychological stress on immune function. However, mental stress 
may also be experimentally induced, by subjecting participants to mental tests, such as the 
Stroop colour-word interference task, mirror tracing tasks, or mental arithmetic in front of an 
audience.  In rats, immobilisation stress and social stress models are most commonly used.  
With the models for immobilisation stress, various levels of severity may be achieved by 
either prone restraint (a severe stressor), where the animal is taped down on a wooden 
board, or immobilisation in a tube or small chamber (a mild stressor).  For the model of social 
stress, male-female pairs of rats are housed together (one pair per cage) for a few weeks. 
When taking one of these males from his female and placing him with another male-female 
pair, social confrontation for dominance results between the intruder and the resident male.  
Indicators of subdominance (e.g. retreat, flight and a full defensive posture) are noted for a 
specific time period. A dominance index is calculated, by scoring the number of subdominant 
events the intruder male has displayed himself, or triggered in the resident rat.  If this score 
is <0.5, the intruder rat is named a loser (subordinate) rat, otherwise it is named a winner 
(dominant) rat. The effect of stress in loser rats may be assessed by comparison of results to 
baseline values for the same rats, or by comparison to control rats, which were left 
undisturbed with their females, or by comparison to winner rats.  In the next section, I will 
provide a brief overview of results from representative studies using these models. 
 Cytokine response: With regard to the physiological response to psychological, work-
related stress in human subjects, most previous studies have focused on mental health itself 
and cardiovascular disease risk (Spurgeon et al., 1997).  Other potential conditions related to 
psychological stress, such as musculoskeletal symptoms and immune suppression, have 
received very little attention. However, a few studies are available on the acute, as well as 
the more long-term, effects of examination stress in students. The psychological stress of 
academic examinations was reported to result in increased circulating concentrations of the 
pro-inflammatory cytokines IL-6, TNF-α and IFN-γ, as well as the TH1-cell inhibitor, IL-10 
(Maes et al., 1998). In addition, students with higher stress perception had significantly 
higher concentrations of TNF-α and IFN-γ when compared to students with lower perceived 
stress close to the examination (one day before), but not at baseline one month before. In a 
similar study, neither circulating concentrations of IL-1β, nor mitogen-stimulated IL-1β 
secretion changed in response to the stress of an oral academic examination (Lacey et al., 
2000). However, no other plasma cytokine concentrations were determined in this study. It is 
possible that, similar to the study by Maes et al. (1998), plasma IL-6 concentrations were 
increased, which would down-regulate IL-1β secretion. A recent review suggested that brief 
(minutes) or short-term (< 24 hours) psychological stress may cause a shift in favour of a 
TH1 response, while longer term stress may result in a cytokine production shift in favour of a 
TH2 response (Matalka, 2003).  This suggestion is, in part, supported by the findings of Maes 
et al. (1998).  More directly supporting the theory of Matalka (2003), acute experimentally 
induced psychological stress resulted in a transient, but significant increase in NK cell count 
immediately after the experimental stress tests (Owen & Steptoe, 2003).  However, IL-6 
concentrations were significantly increased from baseline at 45 minutes post-stress, arguing 
against the theory that a shift is a longer-term response.  Therefore, it is still unclear whether 
the acute and long-term responses of the cytokine system to stress are similar or not.   
 
The results from the studies above are varied, with the different models yielding different 
results. There is more than one reason for this: Firstly, similar to variations in the intensity of 
exercise stress, psychological stress also varies in severity. Unfortunately, it is much more 
difficult to categorise psychological stress, since individuals also have different levels of 
stress perception to a similar stressor.  Secondly, differences in the duration of stressors and 
the timing of blood samples are varied.  Therefore, the only conclusion that can be made is 
 that, similar to exercise stress, psychological stress in human subjects also results in an 
inflammatory cytokine response. However, due to the lack of availability of more studies 
using similar protocols, a more comprehensive interpretation of results is not possible.  
Some researchers have turned to animal models of stress to more easily control the stress 
intervention.  Also, in these models experimental tools such as “cytokine-blockers” are 
available. 
 
In mice, acute immobilisation stress in conjunction with anti-IL-6 antibody treatment, resulted 
in increased TNF-α concentrations compared to non-treated immobilised rats immediately 
after, and one hour after cessation of 2 hours of acute immobilisation stress (Nukina et al., 
1998). Treatment with anti-IL-6 however did not change the ACTH or corticosterone 
responses to stress. This led to the conclusion that IL-6 down-regulates TNF-α 
concentrations to restore homeostasis after exposure to an acute stressor, without having an 
effect on the endocrine parameters measured.  However, IL-6 concentration was not 
determined in this study so that it is unclear to what extent IL-6 function was blocked by the 
administered antibody. A more comprehensive study is needed to elucidate the role of IL-6 in 
the inflammatory response to immobilisation stress in both acute and more long-term 
(chronic) exposure.  
 
White cell response: In studies investigating the effects of acute (2 hours) and chronic (48 
hours) social stress in rats (Stefanski, 2000; Stefanski & Engler, 1999), after 2 hours of 
confrontation all rats had highly increased concentrations of granulocytes,  decreased CD4+  
and CD8+ cell counts with resultant elevated CD4+:CD8+ and T:B cell ratios, lowered T cell 
proliferative response and reduced NK cell cytotoxicity when compared to control rats.    
Although chronic social stress again resulted in increased granulocyte and decreased CD4+  
and CD8+ cell counts, CD4+:CD8+ ratio was unaffected, and T:B cell ratio was decreased.  T 
cell proliferative response was also lowered after 48 hours, although to a lesser extent when 
compared to the acute response.   These results suggest a similarity in the habituation to 
stress between psychological and physiological stress: in both situations, adaptation to the 
stressor occurs which results in a blunted immune response.  
 
 Furthermore, in a study of two groups of graduate students, T cell proliferative response was 
reduced when compared to the control group 6-8 weeks before an oral examination.  
However, this immune suppression was not evident 1 hour before, although cortisol 
concentrations indicated greater stress closer to the oral examination (Lacey et al., 2000).  I 
speculate that the T cell proliferative response was down-regulated in chronic stress, similar 
to the down-regulation seen in PBMCs’ reactivity to mitogen activation at rest in trained 
individuals.  This would effectively prevent chronic activation of the immune system despite 
ongoing stress. However, as seen for PBMCs after additional exogenous challenge, this 
down-regulation is lifted in the presence of an acute stressor, i.e. close to the examination.    
 
In summary, although these studies are quite varied with regard to protocol and results, 
together they appear to indicate many similarities in the immune responses to exercise 
stress and to psychological stress.   Therefore, everyday life stress is likely to contribute to 
total stress in athletes through the same immune and endocrine mechanisms. However, 
more studies are needed to fully substantiate this. 
 
2.3  Responses of the endocrine stress-axis to exercise stress 
 
2.3.1 Responses to acute exercise stress 
 
A number of studies have been designed to investigate some of the most important 
questions regarding the endocrine response to exercise stress, such as a) whether the 
stress response is more sensitive to exercise intensity or exercise duration, or both, b) 
whether a similar exercise stress test will affect all individuals to the same extent, c) whether 
repeated exercise bouts have a cumulative stress effect and whether this may be influenced 
by the duration of recovery time, and d) whether the anabolic:catabolic balance is disturbed 
in response to exercise stress, or whether the concentrations of endogenous anti-catabolic 
agents also increase in parallel to that of cortisol.  In this section, I will review the most 
important findings from these studies. 
 
The most consistent change reported in earlier studies investigating the endocrine response 
to an acute exercise stressor, is that of increased circulatory cortisol (Kuoppasalmi et al., 
 1980; Nieman et al., 1994; Pestell et al., 1989), the magnitude of which, according to some 
papers, appears to be dependent mainly on the intensity of exercise rather than the duration 
(Kuoppasalmi et al., 1980; Nieman et al., 1994).  However, some groups report greater 
increases in cortisol concentration after long duration low intensity exercise (≈ 3 hr at 55% 
VO2max) compared to shorter duration higher intensity exercise (on average 37±19 minutes at 
80% VO2max) (Robson et al., 1999).  Although these results seem to be contradicting, the 
shorter duration exercise in the latter study showed an increase in cortisol concentration of 
about 33% from baseline to post-exercise. This is similar to that observed in response to the 
two shorter duration exercise protocols used in the study by Kuoppasalmi et al. 
(Kuoppasalmi et al., 1980), who reported 27% and 43% increases after 90 minutes and 45 
minutes respectively.  Therefore, these results suggest that for shorter duration exercise (up 
to 90 minutes), intensity may play a larger role than duration in the stress response. 
However, for exercise of very long duration (e.g. 3hr), the cortisol response duration is 
greater than for any of the shorter protocols: an 73% increase in cortisol concentration from 
baseline was observed after 3 hours of exercise (Robson et al., 1999).  This may have been 
due to added metabolic stress, or simply a longer duration for cortisol to accumulate. 
 
Not all reports agree with the assumption that the cortisol response to exercise is similar in 
all athletes after a standardised exercise test.  The possibility of one or more different typical 
profiles for HPA-axis responsiveness to stress was tested in healthy, moderately trained 
men.  Subjects could be classified as either low or high responders on the basis of their 
ACTH secretion in response to strenuous treadmill exercise after administration of a mild 
dose of the synthetic glucocorticoid dexamethasone (Petrides et al., 1997). High responders 
exhibited significantly greater ACTH and cortisol responses to strenuous exercise (90 % 
VO2max) when compared to low responders. In another study without dexamethasone, an 
acute exercise bout (10 min running at 70% VO2max) after a prolonged endurance exercise 
bout (2 hours of running) resulted in increased serum concentrations of cortisol in 50% of 
participants, while the other 50% showed either no change or a decrease from baseline 
concentrations (Viru et al., 2001). Given the greater magnitude of change in hormone 
concentrations in the first vs. the second group, it is possible that the first group may be 
similar to the high responders to exercise stress in the study by Petrides et al. (1997).   A 
third test, a 1-minute anaerobic test, was performed before the 2 hours running and after the 
 post-exercise acute aerobic test, to assess anaerobic muscle power.  This showed that 
anaerobic muscle power in the first group was higher after the 2 hour run than at baseline, 
while it was significantly lower in the second group.  Together, these results suggest that, 
although the acute aerobic exercise test was set relative to each individual’s maximum, the 
two groups responded differently to this fatiguing stressor.  The fact that the group who were 
still able to mount a cortisol response to increased exercise stress after 2 hours of 
endurance exercise, could also perform better in a 1-minute anaerobic test, suggests that 
the less active pituitary-adrenal axis is abnormal and cannot  respond appropriately to the 
second stressor.  Whether this is an innate inability or an acute down-regulation, or a pre-
pathological condition as a result of prior chronic stress exposure is unknown. More 
investigation is needed to gain additional information about this divergent response to stress, 
since ability to identify high- and low responders amongst athletes early could impact hugely 
on individualised approaches to training.   
 
In contrast to that of cortisol, serum testosterone concentrations may remain unchanged 
during exercise, but decrease in the recovery period (Kuoppasalmi et al., 1980), and may 
take up to 24 hours of recovery to return to baseline concentrations (Fry et al., 1991a). 
Therefore, while the activity of the pituitary-adrenocortical system during exercise appears to 
be a good indicator of the capacity to respond to stress, pituitary-testicular system changes 
occurring during the recovery period may more accurately reflect the effort expended.   
 
The effects of repeated bouts of exercise, and the influences of recovery duration between 
successive bouts, were recently investigated in elite endurance athletes. Repeated bouts of 
exercise (separated by 3 hours) were shown to have an additive stress effect, with increases 
in cortisol concentrations in response to the second bout of exercise that were much greater 
than those reported after the first bout (Ronsen et al., 2001a). In a similar study by the same 
group, the additive effect of exercise was influenced by the duration of recovery allowed 
between bouts.  Subjects had smaller increases in cortisol, ACTH, epinephrine and 
norepinephrine concentrations in response to a second exercise bout after 6 hours of 
recovery between bouts than after only 3 hours of recovery (Ronsen et al., 2002).  
 
 In contrast to this cumulative effect of repeated exercise bouts on the catabolic stress 
hormone response, concentrations of anabolic hormones such as growth hormone and 
testosterone were reportedly unaffected by the number of bouts per day or the recovery time 
between bouts (Ronsen et al., 2002).  However, these anabolic agents were determined only 
immediately after exercise, and not during recovery, which was earlier established to be 
more useful (Kuoppasalmi, 1980), so it is not possible to make such a clear-cut conclusion 
regarding the anabolic response to multiple bouts of exercise. 
 
Although total cortisol concentration is commonly used as an indicator of stress, the total 
concentration of cortisol in the circulation does not necessarily reflect the concentration of 
bio-available (unbound) cortisol at tissue level. Futhermore, the effect of anti-catabolic 
agents may also contribute to lessen the net effect of cortisol released in response to stress.  
Very few studies have investigated these issues in athletes. In highly trained athletes, 
cortisol concentrations were increased after an ultramarathon as expected, but CBG 
concentrations remained unchanged from baseline, indicating that the net effect was that of 
increased free cortisol (Pestell et al., 1989). In addition, SHBG was reported to be unaffected 
by either short, high-intensity, or longer, moderate-intensity exercise, so that changes in total 
testosterone concentrations were associated with parallel changes in the fraction of free 
testosterone in the circulation (Kuoppasalmi, 1980).  However, very little is known about the 
role of CBG in the response to different exercise intensities or more chronic exercise stress. 
These issues should be investigated more thoroughly, since CBG may have important 
regulatory functions in the response to stress.  
 
Another anti-catabolic agent which may have a regulatory role in the cortisol response to 
stress is DHEA. In rats, administered DHEA was shown to have anti-glucocorticoid action, by 
blocking the dexamethasone-mediated activation of the glucocorticoid-inducible enzymes 
tyrosine aminotransferase (TAT) and ornithine decarboxylase (ODC), but this blocking effect 
was not effective after additional experimentally-induced stress (dexamethasone injection) in 
rats (Wright et al., 1992). It is therefore possible that DHEAs does not increase in response 
to glucocorticoids.  However, since it is difficult to assess the overall, integrated response in 
the dexamethasone model, this result is difficult to interpret.  In elite female athletes, an 
acute bout of exercise (simulated handball match) did not alter DHEA concentrations (Filaire 
 & Lac, 2000), suggesting that DHEA is not responsive to a whole body stressor, but there is 
not enough data available to substantiate this theory.  Also, the recent finding that an acute 
endotoxin injection increased the serum cortisol:DHEAs and cortisol:17OH-progesterone 
ratios in a dose-dependent manner in patients suffering from chronic inflammatory disease  
(Straub et al., 2002), suggests that in response to a stressor, cortisol production may be 
favoured at the expense of the adrenal androgens. More investigation is needed to 
determine if these parameters are possible regulators of the net effect of cortisol and 
testosterone in response to exercise stress. Taken together, the results of the studies 
mentioned above, suggest that expression of the concentration of cortisol as a ratio to either 
CBG or DHEAs concentrations, may possibly be better indicators of changes in catabolic 
status than measurement of cortisol concentration alone, and should be investigated more 
comprehensively in exercise stress and other stress models. 
 
2.3.2 Responses to chronic exercise stress (training) 
 
Moderate exercise training regimens should not influence the endocrine system negatively, 
since enough time for the physiological recovery (and adaptation to the exercise) should be 
allowed between bouts. In a study comparing the effect of endurance, sprint and mixed 
training protocols lasting 10 weeks each (Kraemer et al., 1989), the results indicated that 
higher intensity endurance training with bouts of short duration (80% VO2max for 30 minutes, 
3 times per week) did not alter resting cortisol concentrations, or the cortisol response to 
maximal exercise. However, both interval sprint training (2x4 20-second sprints at 96% of 
maximum heart rate, 3 times per week) and a combination of the two (alternating endurance 
and interval sprint protocols, 6 times per week) resulted in increased resting cortisol 
concentrations (baseline: ≈ 330 vs. post-training: ≈ 450 nmol/L for both groups).  This would 
suggest that higher intensity and higher volume training, especially that which includes sprint 
training on several days per week, results in a higher stress condition at rest. However, when 
comparing pre-training mean resting cortisol concentrations, those of the interval sprint 
group and the combined protocol group were significantly lower than that of the endurance 
group (≈ 330 vs. 540 nmol/L), while post-training resting cortisol concentrations were similar 
in all groups. Since the subjects used in this study were healthy active individuals randomly 
divided into the three training categories, previous training experience should not have been 
 a confounding factor. However, the higher initial resting cortisol concentrations reported in 
the endurance protocol group may have been a confounding factor, leading to this group 
appearing to be the only group unresponsive to training.  The fact that ACTH concentrations 
remained similar at rest and in response to an acute exercise test (VO2max test) in all groups, 
while there were significant training-induced increases in cortisol concentrations at rest in at 
least two of the groups investigated, may suggest that 10 weeks of training is not sufficient in 
duration, or not of strenuous enough intensity, for ACTH adaptation to take place   In 
addition to these results after a 10-week training protocol, a training study of shorter duration 
also reported unchanged resting concentrations of cortisol and ACTH after a 100% increase 
in training volume for ten days in cyclists (both exercise type specific and cross-training 
protocols were used) (Pizza et al., 1995a), which may indicate that 10 days is not sufficient 
time to result in chronic changes in cortisol concentration at rest. 
 
The net effect of cortisol does not only depend on factors playing a role in its release, such 
as ACTH, but also on agents with an opposite effect to that of cortisol, such as DHEA and 
testosterone. It is therefore necessary to take into account changes in the concentrations of 
these parameters relative to that of cortisol, after training.  Results obtained in human 
studies investigating this issue are varied. For example, 10 days of increased training 
volume (100 % increase) in well-trained distance runners resulted in a significant decrease in 
DHEAs concentration at rest, although resting cortisol concentration was not affected (Flynn 
et al., 1997).  Similarly, resting salivary DHEA concentrations were shown to be lower in elite 
athletes when compared to sedentary controls (Filaire & Lac, 2000).  A third study that also 
reported decreased resting DHEAs concentration after 3 months of endurance training in 
previously sedentary females, also showed a decreased resting testosterone concentration 
post-training (Keizer et al., 1987). On the other hand, in previously sedentary subjects, three 
months of exercise that induced a negative energy balance resulted in a significant increase 
in resting DHEAs and testosterone concentrations, although again with no effect on resting 
cortisol concentration (Pritchard et al., 1999). This result was also true for elite female 
athletes, whose resting salivary DHEA concentrations were increased significantly after 16 
weeks of training, while salivary cortisol concentrations remained similar. This resulted in an 
increase of more than 30 % in the DHEA:cortisol ratio (Filaire et al., 1998).  The fact that 
both sedentary and elite athletes showed a similar response in the latter two studies, 
 suggests that the DHEAs response is not related to fitness level.  Rather, I propose that the 
results from all the above studies indicate that the initial DHEAs response to unaccustomed 
training workloads, as in the studies of Pritchard et al. (1999) and Filaire et al. (1998), is an 
increased DHEAs concentration that could counteract the effects of repeated transient 
elevations in the circulating cortisol concentration in response to the repeated training bouts. 
However, DHEAs concentrations decrease over time in response to chronic exercise 
training, which may suggest that changes in the DHEAs concentration at rest may be a more 
accurate marker of exercise stress than cortisol concentration itself.  This interpretation of 
the exercise literature is in support of the earlier suggestion in the medical literature that the 
cortisol:DHEAs ratio may be a useful indicator of risk of long-term stress-related pathology 
(Hechter et al., 1997).  
 
Another marker of anabolic potential, namely resting testosterone concentrations, also 
decreased in response to 10 days of training at 200 % of normal training volume, while 
resting cortisol concentration remained similar (Pizza et al., 1995a). These data are indirect 
evidence that doubling of training volume may lead to an inability of the endocrine system to 
maintain a net anabolic effect, which may be detrimental to exercise performance. It may 
therefore also be useful to calculate the ratio of cortisol to testosterone at rest, to give a 
better indication of changes in the anabolic-catabolic balance in response to a training 
programme. 
 
The usefulness of measuring the cortisol:testosterone ratio in response to exercise training 
was investigated in professional cyclists (Hoogeveen & Zonderland, 1996).  Three months of 
performance-enhancing intensive training with progressively increasing volume (1 month 
each of cycling 405 km/wk, 510 km/wk and 740 km/wk) resulted in a 26 % increase in the 
cortisol:testosterone ratio at rest in these athletes. This was the result of both a 39 % 
increase in resting cortisol and a 15 % decrease in resting testosterone concentrations. 
However, training did not have a significant effect on either the cortisol or the testosterone 
response to an acute bout of exhaustive exercise.  An earlier study reported that more than 
24 hours of rest may be required for hormone concentrations to return to baseline 
concentrations after an acute bout of exercise (Fry et al., 1991a).  Furthermore, in endurance 
athletes, repeated bouts of acute exercise on the same day were shown to have cumulative 
 effects on the neuroendocrine response, with higher increases in epinephrine, 
norepinephrine, ACTH, cortisol and growth hormone concentrations during, and larger 
decreases in testosterone concentration after the second bout of exercise (Ronsen et al., 
2001a). In a subsequent study, this cumulative effect was reported to be inversely related to 
the recovery time allowed between bouts (Ronsen et al., 2002).  Therefore, the discrepancy 
in the results from the studies discussed on the previous 2 pages may be the result of 
cumulative increases in cortisol and decreases in testosterone concentrations, after repeated 
exercise bouts with insufficient recovery in between bouts.    Although not enough 
information regarding the rest periods before each blood sampling is provided in all the 
above studies to enable critical assessment in this regard, these results highlight the 
importance of obtaining proper resting blood samples to prevent confounding effects of prior 
acute exercise bouts, to ensure accurate interpretation of data regarding the effects of 
chronic exercise. 
 
In summary, the significance of an increased resting DHEAs concentration after chronic 
unaccustomed increase in exercise training load remains to be elucidated. However, these 
results supports the earlier theory that there is a shift away from androgen and towards 
glucocorticoid production at times of increased physiological or psychological stress (Parker 
et al., 1985).  
 
2.3.3 Responses to overreaching and overtraining 
 
Due to ever-increasing competitive standards set in professional sports today, training 
workloads may be detrimental to performance in the long run, due to inability of the 
endocrine system to cope with this chronic stressor.  An overtraining syndrome may then 
develop, with symptoms such as failure to improve performance, lethargy, weight loss, 
elevated resting heart rate and blood pressure and insomnia (Barron et al., 1985; Brown et 
al., 1983; Kuipers & Keizer, 1988). The diagnosis of OTS appears to be done by 
investigating symptoms and excluding other possible causes, rather than using specific 
objective indicators.  Very few studies are available with data generated on actual OTS 
sufferers.  Most information available originates from interpretation of, and extrapolation 
 from, short-term overreaching studies, which will be discussed in the next few paragraphs, 
along with the few studies available on truly overtrained athletes. 
 
Increased cortisol concentrations were proposed to indicate acute high physiological strain 
during normal training (Kraemer et al., 1989; Kuoppasalmi et al., 1980; Urhausen et al., 
1987).  The author of a review on overtraining suggested that decreased cortisol 
concentrations may indicate long-duration chronic strain and overtraining (Lehmann et al., 
1998).  In a study searching for an objective marker for overtraining, 10 previously diagnosed 
overtrained athletes had an average resting cortisol concentration of 396 ± 74 nmol/L, which 
is within the normal range of 220 – 750 nmol/L (Rowbottom et al., 1995).   However, there 
are more than one possible explanation for this finding: firstly, by a counter-regulatory 
mechanism, as a protective measure against the negative effects of a chronically elevated 
cortisol concentration. The mechanism by which this may occur is not clear. Possibilities 
include decreased adrenal sensitivity to ACTH and catecholamines, which is reported in 
overtrained individuals, as reviewed earlier (Lehmann et al., 1998), or a shift from cortisol to 
androgen (e.g. DHEA) production.  The latter option is also likely, given the finding of 
increased DHEAs concentrations after chronic severe exercise stress, as discussed in the 
previous section.  However, insufficient data is available to enable a clear-cut conclusion.  A 
second possibility is that these athletes may have decreased their performance and became 
symptomatic as a result of the inability of their HPA-axis to keep pace with the stress of 
exercise, by increasing cortisol secretion during training sessions.  Hence the tested cortisol 
concentration was not abnormal.  Alternatively, cortisol production may have been 
decreased earlier on in the development of the overtraining syndrome, but was no longer 
outside the normal range by the time of diagnosis.  However, this parameter alone is not 
sufficient to make a diagnosis, especially since many available studies were recently 
reviewed to show that results regarding the cortisol response at rest and after exercise in 
overtrained endurance athletes were very varied (Urhausen & Kindermann, 2002).  The 
study by Rowbottom et al. (1995) clearly illustrates the difficulties in interpretation of data 
obtained in already overtrained athletes.   Therefore, in order to be able to prevent the 
occurrence of the OTS by early identification, it is crucial to monitor changes in resting 
hormone concentrations, even within the normal range, to allow early detection of a 
 decrease or lack in endocrine responsiveness to stress.  The latter would indicate inability to 
cope with the stressor, even before the other characteristic symptoms of OTS develop. 
 
In another study, not only plasma concentrations of cortisol, but also that of epinephrine and 
norepinephrine were reported to remain unchanged over the course of a training season in 
10 elite swimmers (Hooper et al., 1993). Nevertheless, epinephrine concentration was 
positively correlated to exercise volume in these athletes. Three swimmers were diagnosed 
with OTS during the course of this season, and exhibited higher epinephrine levels 
compared to the other swimmers from mid-season onwards, which may indicate a possible 
role for epinephrine as indicator of the OTS.  
 
In a study in cyclists subjected to an overreaching training protocol (2 weeks each of normal 
training, intensified training and recovery) (Halson et al., 2002), no change was reported in 
the resting plasma catecholamine concentration in response to training, although 
performance in maximal tests, intermittent tests and time trial tests were reduced.  (Blunting 
of the cortisol and adrenaline response to acute exhaustive exercise was reported after 
short-term overreaching in the same study.) More studies are required to investigate the 
possibility of using epinephrine as a marker for overtraining, but this study indicates that 
performance decrements may precede changes in the endocrine response.  This is further 
supported by a study in resistance trained men (Fry et al., 1998).  No changes were reported 
in resting cortisol, testosterone and growth hormone concentrations after participation in a 2-
week resistance training protocol designed to induce overtraining, although performance 
decreased significantly, suggesting a state of overtraining, or at least overreaching.  In 
addition, these athletes showed no significant training-induced change in the responses of 
cortisol, testosterone, growth hormone or ratios between testosterone and cortisol, to an 
acute bout of exercise (Fry et al., 1998).  These results suggest that blunting of the 
endocrine response to exercise stress may occur late in the development of OTS, while 
decreases in performance occur earlier, possibly in a phase where symptoms are still 
reversible.  Therefore, early detection of a persistent blunted endocrine response may 
enable timely intervention (e.g. changes to the training workload) to prevent the development 
of the full-blown syndrome.  
 
 In order to determine whether the endocrine adaptation to overreaching or overtraining is 
dependent on the type of exercise, a 2-week overreaching training protocol in runners was 
followed (Flynn et al., 1997).  Runners were required to either perform running exercise only 
(200% of usual training volume), or to cross-train (running at 100 % of usual training volume 
plus cycling to yield an added 100 % of energy expenditure as per usual running training).  
Similar to results from other more moderate training studies, resting ACTH and cortisol 
concentrations remained unchanged during both training protocols. However, resting 
testosterone concentrations decreased significantly by day 5.  There was no difference in 
this measure between the two protocols, indicating that the endocrine response to excessive 
training is not exercise type specific, at least not when both types of exercise are endurance 
exercises.  The decreased testosterone concentration indicates the possibility that, although 
cortisol concentration was not increased, overreaching may coincide with a decreased 
anabolic status, which may in part explain the decrement in exercise performance seen in 
the OTS.   
 
Psychological stress elicits a similar endocrine stress response when compared to exercise, 
at least pertaining to the HPA-stress axis.  The results of the previous study show that two 
different moderate exercise stressors together have similar effects on the endocrine stress 
response to that of one severe exercise stressor.  Since athletes are under severe 
psychological pressure to perform, even when training, this chronic psychological stressor 
may contribute to the effects of exercise stress in increasing their overall stress status.  It is 
therefore also important to take into account the added effects of psychological stress in an 
athlete population, especially since it may be more prolonged than the exercise training 
sessions themselves. 
 
2.4   Endocrine responses to psychological stress 
 
Inducing psychological stress in human subjects in an experimental situation is not as simple 
as in laboratory animals, since the effects of prior exposure to stress in human subjects are 
difficult to control and may have confounding effects on the results obtained. Therefore, 
animals are often used as a more standardised model to investigate the physiological 
responses to psychological stress.   
  
Studies in rats determined that immobilisation stress of different severities (tube restraint vs. 
prone restraint on wooden board) yielded different magnitudes of corticosterone response 
(Garcia et al., 2000).  Furthermore, peak corticosterone concentrations were only achieved 
after stressors of more than 1 hour in duration (Garcia et al., 2000; Hu et al., 2000), after 
which these peak concentrations were maintained for the duration of the immobilisation 
protocol (Hu et al., 2000).  With chronic intermittent stress protocols, the corticosterone 
concentration after acute stress increased with each successive episode, but recovery to 
baseline concentrations was more efficient over time (Garcia et al., 2000; Marti et al., 2001), 
indicating both enhanced responsiveness and enhanced clearance.  However, this 
habituation of recovery was shown to be stressor-specific, since a novel stressor elicited a 
typical “acute” stress response again (Garcia et al., 2000; Marti et al., 2001).  To summarise, 
these reports suggest that the magnitude of the corticosterone response to immobilsation 
stress is sensitive to both the severity and the duration of each episode, as well as the 
number of repeated episodes, and that a chronic, stressor-specific response is characterised 
by quicker return of corticosterone concentrations to baseline after removal of the stressor.  
Therefore, the speed of recovery of corticosterone concentrations to baseline may be a good 
indicator of adaptation to a psychological stressor.   
 
Similar to the results obtained in rodent models (Garcia et al., 2000; Marti et al., 2001), 
repetition of experimentally-induced psychological stress in healthy humans (2 sessions, 
including the Stroop Color Word Interference task, public speaking and mental arithmetic in 
front of an audience, separated by 7 days) was recently reported to result in habituation, with 
smaller increases in ACTH and cortisol concentrations in response to the stress on day 8, 
while epinephrine and norepinephrine did not habituate (Gerra et al., 2001). The ACTH and 
cortisol responses to both acute experimentally-induced and chronic work-related 
psychological stress could be divided into two distinct patterns, one of low-response and one 
of high-response, with the high-responders showing a highly variable diurnal response with 
high early morning cortisol concentrations and several peaks during the morning, with a 
much lower evening cortisol concentration (the typical normal diurnal curve), and low-
responders showing low diurnal variability and low morning cortisol concentrations (a 
flattened diurnal curve) (Gerra et al., 2001; Rosmond et al., 1998).  This was observed 
 despite similar values for perceived stress in the two responder groups.  The implication of 
these two studies for our understanding of exercise-stress is that it may not be possible for 
training studies to group all athletes together without confounding the results.  Indeed, high- 
and low-responders have also been reported in response to acute exercise stress (Petrides 
et al., 1997). 
 
In a study comparing 19 patients suffering from the chronic fatigue syndrome (CFS) to 10 
healthy controls (Scott et al., 2000), basal DHEA and cortisol concentrations, as well as the 
cortisol:DHEA ratio, were found to be similar in the two groups at rest. However, 30 minutes 
after administration of 1 ug of ACTH, there were some significant differences in the adrenal 
responses. While there was no significant difference in the DHEA response (average 
increase of 28 ± 7 ng/L in CFS vs. 27 ± 10 ng/L in controls), there was a significant 
difference in the magnitude of change in cortisol concentrations between the two groups 
(average increase of 272 ± 31 nmol/L in CFS vs. 360 ± 27 nmol/L in controls; P = 0.05).  The 
differences between groups were also reflected in the cortisol:DHEA ratio, which had a 
tendency to be decreased in CFS patients when compared to controls, in response to the 
ACTH challenge.  Long duration stress seems to be characterised by decreased adrenal 
sensitivity to ACTH, similar to the response reported after chronic exercise stress in the early 
stages of overtraining (Lehmann et al., 1998). 
 
Although the cortisol:DHEA ratio may give an indication of the availability of “anti-catabolic” 
precursors relative to the cortisol concentration, the net biological activity of cortisol may also 
be dependent on the concentration of CBG.  In a study investigating the effects of social 
stress in rats (model discussed in 2.2) on the endocrine and immune systems, no correlation 
was reported between CBG and corticosterone concentrations after 7 days of social stress 
(Stefanski, 2000). However, while corticosterone concentrations were stable in both 
dominant and subordinate rats, CBG concentration was decreased in subordinate rats, but 
not in dominant rats, resulting in a relative increase in free corticosterone concentrations in 
subordinate rats. Another study on chronic social stress in rats reported decreased CBG 
concentrations in subordinate (-70 %) as well as in dominant (-40 %) rats after 2 weeks 
when compared to controls, while only subordinate rats had significantly higher 
corticosterone concentrations after 2 weeks when compared to the control group (Spencer et 
 al., 1996).  In addition, CBG concentrations were correlated positively with type II 
corticosteroid receptors in the spleen, so that lower CBG concentrations (during higher 
stress) were associated with lower receptor numbers. Furthermore, in a study on the effect 
of inescapable tailshock in rats, CBG concentrations were decreased and corticosterone 
concentrations increased (Deak et al., 1999), suggesting a similar CBG response to a variety 
of non-exercise related stressors. Together, these results suggest that chronic stress results 
in greater increases of free glucocorticoid, which may impact on vital organs.   
 
The significance of a parallel decrease in splenic corticosteroid receptors is difficult to 
interpret, but may be the result of down-regulation in response to increased binding in the 
presence of high free cortisol concentrations. It is of interest to note that CBG concentrations 
in all these studies were determined using a competitive binding procedure. However, during 
inflammation, serine proteases on the surface of activated neutrophils are able to cleave the 
CBG molecule into a form with lower affinity for corticosteroids (Hammond et al., 1990; 
Pemberton et al., 1988). Therefore, it is unclear whether the CBG concentrations were in fact 
decreased, or whether chronic stress resulted in a decreased capacity for binding of 
corticosteroid to its binding globulin.  Although the mechanism remains debatable, the end 
result is clearly that of an increased free glucocorticoid concentration after chronic stress.  
Similar to the studies mentioned above, serum CBG concentrations (also measured by 
competitive binding assay) were decreased after acute exposure to ether anaesthesia 
(Tinnikov, 1999). In addition, the decrease in CBG concentration was greater when this 
stressor was combined with cold exposure or fasting (i.e. conditions requiring mobilisation of 
spare fuel). This suggests that the mechanism for glucocorticoid regulation of fuel 
mobilisation may not always be to change cortisol concentration itself, but rather to regulate 
free glucocorticoid concentration by manipulation of CBG concentration.  Few studies of 
stress within a physiological rather than an extreme range have added CBG to the analyses. 
 
 2.5   Relationships between the immune system, endocrine stress-axis and 
anti-catabolic agents in the stress response 
 
In the previous sections, it has been established that exercise stress results in a shift away 
from androgen production, in favour of cortisol production. Since cortisol has direct negative 
effects on some immune cells (e.g. decreasing CD4+ cell count), it is possible that a 
disturbance or shift in the anabolic:catabolic balance may also result in a shift within the 
immune system, so that some parts of it may become either more activated or compromised.  
In the next section, I will discuss studies that have investigated the relationships between 
parameters of the endocrine and immune systems, in response to both acute and chronic 
exercise stress.  
 
2.5.1 Relationships measured in the response to acute stress 
 
Changes in immune capacity may be demonstrated by changes in cell availability (either cell 
count, or relative distribution, or both), or changes in cell function (such as cytokine 
production and/or secretion).  In the next section, I will discuss previous studies which have 
reported associations between stress-induced changes in the concentration of cortisol or 
anti-catabolic agents, and changes in immune cell availability and function.  
 
In marathon runners, 2.5 hours of running resulted in increased post-exercise plasma 
cortisol concentrations for more than 3 hours into recovery, when compared to non-
exercising controls (Nieman et al., 1995).  At 3 hours, cortisol concentrations were reported 
to be positively correlated with the neutrophil:lymphocyte ratio, which suggests that 
increased stress results in a shift in the availability of immune cells in favour of the non-
specific immune component.   Unfortunately, the correlations between these parameters at 
the other time points were not provided, so that a more comprehensive interpretation, 
including e.g. also the relationship immediately after exercise or at rest, is not possible.  The 
results of this study were therefore not conclusive evidence of a consistent association 
between shifts favouring non-specific immunity and stress.  However, a subsequent study 
reported higher percentages of CD8+ and NK cells and lower percentages of CD4+ cells at 
 rest in subjects who were previously identified as cortisol high-responders when compared to 
low-responders (Deuster et al., 1999).  Together these two studies suggest that it is 
informative to assess the immune response to severe stress at rest and that there is likely to 
be i) an association between the cortisol response and the immune response, and ii) a shift 
in the lymphocytes in circulation even in a resting condition, to those that are mostly non-
specific.  This may imply a relatively decreased capacity for the antibody-mediated specific 
immune response, which may impact on the resistance of athletes such as those in the study 
by Deuster et al. (1999) to chronic illnesses, but certainly indicates that immune system 
function does not remain unaltered in the face of stress.   
 
Post-exercise increases in cortisol concentrations were also reported to be positively 
correlated with the peak amounts of IL-6 produced by lymphocytes in response to an 
ionomycin and PMA challenge in vitro (Steensberg et al., 2001a). Similarly, a cloned T cell 
culture capable of secreting both IL-2 and IL-4, secreted reduced concentrations of IL-2 and 
increased concentrations of IL-4 after exposure to cortisol (Daynes et al., 1990).  Although 
these assays do not fully distinguish the cell types responding, the implication seems to be 
that the lymphocytes available after acute stress have increased functional capacity to 
activate the antibody-mediated immune response, which in turn results in a relative inhibition 
of activation of the cell-mediated immune response.  However, several reports of altered 
cytokine profiles in vivo exist, which suggest a shift away from a TH1 cytokine response, in 
association with increased cortisol concentrations.  HPA-axis high-responders were reported 
to have lower IL-6 concentrations at rest when compared to low-responders (Deuster et al., 
1999).  Also, in a study investigating the acute effects of mild psychological stress (Kunz-
Ebrecht et al., 2003), the inflammatory cytokine response (IL-6 and IL-1ra) to acute 
psychological stress was inversely related to the cortisol response, with cytokine 
concentrations in response to stress reported to be much higher in the low-responder group 
compared to the high-responder group.  Thus, while in cortisol high-responders the 
enhanced cortisol response decreased the inflammatory cytokine response by negative 
feedback, this was not the case in the low-responders.  It was recently hypothesised that this 
dual response to stress may be the result of stress-exposure at critical times during 
development, which may induce structural and functional changes in the nervous, immune 
and endocrine systems, leading to altered responses to subsequent stressors (Hurwitz & 
 Morgenstern, 2001), but this remains to be substantiated.  Unlike acute exercise stress, 
chronic stress may down-regulate the cortisol response, thus allowing an increased 
inflammatory response.  
 
In addition to these effects of cortisol on immune function, testosterone was also reported to 
enhance CD8+ cell function (Tanriverdi et al., 2003) and to increase CD8+ cell count, with a 
parallel decrease in CD4:CD8 ratio (Yao et al., 2003).  A suppressed T cell proliferative 
response was also reported in response to testosterone administration in the latter study, 
which seems to contradict this finding. However, measurement of T cell proliferation rate 
does not allow differentiation between subpopulations. Therefore, it is not clear whether the 
suppressed response was due to suppressed function of CD8- cells, such as CD4+ cells.   
 
The altered cytokine profile in response to stress may also be linked to changes in the 
concentration of DHEA.  Macrophages were shown to be, at least in part, responsible for 
conversion of DHEAs to its metabolically active form, DHEA (Hennebold & Daynes, 1994).  
This acitvation of DHEA was further shown to be inhibited by TH1, but not TH2 cytokines, in 
the same study. Therefore, when the cytokine response shifts in favour of TH2 cytokines in 
response to acute exercise, an increased concentration of DHEAs will be converted to 
DHEA, so that a larger anti-catabolic effect is possible. Furthermore, a number of in vivo and 
in vitro studies reported that both testosterone and DHEA enhanced the TH1 response, e.g. 
by enhancing secretion of IL-2 (Daynes et al., 1990; Hässig et al., 1996; Malkin et al., 2003; 
Regelson et al., 1994; Straub et al., 2002), with resultant enhanced immune resistance to 
viral and bacterial infections.  This may suggest a role for DHEA in reversing the cortisol-
induced shift away from a TH1 response after exercise. Also, testosterone was reported to 
increase monocyte secretion of IL-10, indicating an enhanced anti-inflammatory function, in 
addition to suppression of secretion of inflammatory cytokines such as IL-6 and TNF-α 
(Malkin et al., 2003).  Therefore, a decrease in testosterone or DHEA after training may 
contribute to a greater net inhibitory effect of cortisol on the TH1 immune response. 
 
Epinephrine was also shown to be an important regulator of total leukocytes, lymphocytes, 
and CD3+, CD4+, CD8+, and CD3-CD16+/56+ subpopulation redistribution after acute 
exercise in humans (Rhind et al., 1999).  While epinephrine has been shown to play a role in 
 acute exercise-induced changes in lymphocyte number and function, epinephrine infusion 
alone could not mimic the changes in plasma IL-6 observed after exercise (Steensberg et al., 
2001a).  Therefore, it is unlikely that epinephrine is a major regulator of immune function in 
response to acute exercise, but it may have been indirectly associated in the study of Rhind 
et al. (1999). 
 
Taken together these results indicate important roles for both DHEA and testosterone in 
reversing the negative effects of cortisol on immune competence.  Therefore, it is important 
to consider changes in the availability of these parameters in the circulation, in conjunction 
with changes in the cortisol concentration, not only for a more comprehensive assessment of 
endocrine stress status, but also as indirect indicators of changes in immune system 
functional capacity. 
 
2.5.2 Relationships measured in response to chronic stress 
 
In HIV-infected patients, cortisol concentrations have been shown to be chronically elevated 
at rest, while that of DHEA is decreased, leading to the hypothesis that the imbalance in 
these hormones may be responsible for the progression of the disease from HIV infection to 
full-blown AIDS (Clerici et al., 1997).  Subsequent to this hypothesis, changes in 
cortisol:DHEAs ratio have been shown to correlate negatively with CD4+ count in this 
population (Christeff et al., 2000; Grinspoon et al., 2001). The changes in the cortisol:DHEAs 
ratio were mainly due to reductions in DHEAs concentration, which were previously also 
shown to correlate positively and independently with CD4+ counts (Wisniewski et al., 1993). 
Thus decreased DHEAs concentration is associated with decreased specific immune 
function at least in this population.  It was established earlier that glucocorticoids enhanced 
in vitro secretion of TH2 cytokines by directly stimulating secretion of IL-4 and inhibiting IL-2 
secretion (Daynes & Araneo, 1989).  The progression of HIV infection to AIDS is also 
characterised by a shift in production away from TH1 (cell-mediated immunity: IFN-γ, IL-2, IL-
12) toward TH2 cytokines (humoral immunity: IL-4, IL-5, IL-6 IL-10)(Clerici & Shearer, 1993; 
Clerici & Shearer, 1994). While TH2 cytokines have been shown to render CD4+ lymphocytes 
more susceptible to programmed cell death (Clerici et al., 1994), IL-6 specifically was shown 
to up-regulate the production of the HI-virus (Shephard, 2002).  Also in combination with 
 TNF-α, IL-6 can induce the production of the virus in latent infected cells (Shephard, 2002).  
These studies suggest that changes in the balance between endocrine parameters 
contribute at least in part to the chronically decreased immune ability observed in HIV-
infected individuals, possibly through increased activation of programmed cell death in CD4+ 
cells. Furthermore, from these reports it is clear that the chronic effects of exercise and 
psychological stress are in many ways, although much milder, similar to HIV-induced 
changes in both the endocrine stress-axis and immune system.  Therefore, although this 
disease is pathogen-induced, and results obtained in this model can therefore not directly be 
extrapolated to other non-pathogenic stress conditions, results obtained in HIV-related 
studies may provide additional information useful in other areas of stress research. 
 
 2.6  Summary 
 
A schematic presentation of the interactions between cytokines, the immune system and the 
endocrine stress-axis in the response to exercise stress is given in Figure 2.1.  A brief 
summary of the reviewed literature is provided in the next section. 
 
Figure 2.1 Interaction of immune, cytokine and endocrine systems in the response to exercise stress. 
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 2.6.1 Immune and cytokine system responses to stress 
 
From the available literature, both acute psychological stress and acute exercise stress 
increase pro-inflammatory cytokine production. In addition, excessive exercise training 
seems to result in an increased pro-inflammatory capacity.  Cytokines, and in particular IL-6, 
have been named as key role players in the development of the OTS (Robson, 2003; Smith, 
2000), although no concrete evidence has been presented to prove this in an overtrained 
subject population. However, the magnitude of the role played by the immune system in 
facilitating the increase in circulating cytokines, specifically IL-6, remains debatable.  This 
may be in part because IL-6 is produced by immune and non-immune cells, but also 
because the immune and endocrine response to exercise is complex and not yet fully 
understood.  In particular, an integrated understanding of in vitro and in vivo cytokine data 
has not been achieved. 
 
Acute exercise stress results in a lowered T:B lymphocyte ratio, as well as a lowered 
CD4+:CD8+ ratio, the magnitude of which is dependent on both exercise intensity and 
duration.  Training has been shown to result in a chronically decreased CD4+:CD8+ ratio at 
rest, which is more dependent on training intensity than volume, but T cell numbers in 
athletes suffering from the OTS are similar to those of non-sufferers.  Psychological stress 
elicits similar responses to exercise stress on immune cell number.  Recent technological 
advances now also make it possible to assess the functional capacity of immune cells. 
 
White cell proliferation rate was shown to be enhanced by acute moderate exercise, but 
depressed by high-intensity or long-duration bouts of acute exercise.  Moderate training 
appears to enhance lymphocyte proliferative responsiveness – making it possible to 
compensate for chronically decreased cell numbers.  However, since the lymphocyte 
proliferative response assay is not T cell subpopulation specific, it does not give sufficient 
information to draw conclusions on downstream effects of this change in immune capacity.  
Measurement of CD69 expression is T cell subpopulation specific; however, very few 
research groups are assessing this parameter. Similar to results obtained for lymphocyte 
proliferation, acute strenuous exercise was shown to depress CD4+, CD8+ and NK cell 
expression of CD69. In addition, the depressed CD69 expression exhibited a cumulative 
 effect of successive bouts of exercise when insufficient recovery time was allowed.  
Unfortunately not enough reliable data is available on the CD69 response to training or 
overtraining, to understand whether chronic training induced changes in lymphocyte function 
are T cell subpopulation specific.  Furthermore, no conclusive results are available on the 
effect of psychological stress, either acute or chronic, on white cell function. 
 
2.6.2 Responses of the endocrine stress-axis to stress 
 
Psychological and physiological stressors seem to elicit a similar response from the 
endocrine stress-axis. Cortisol concentration increases after an acute stressor, in a manner 
dependent on both intensity/severity and duration, with cumulative effects of repeated bouts.  
However, the cortisol response adapts to a moderate stressor over time, with cortisol 
concentrations reaching lower peak values and returning to baseline concentrations quicker 
after each successive stress exposure.  This effect was shown to be stressor-specific, so 
that a new type of stressor will again increase the cortisol response.  However, a severe 
stressor does not seem to allow habituation, with cortisol concentrations remaining elevated 
after subsequent exposures. In addition, a divergent response of cortisol to a stressor was 
described after both physical and psychological stress exposure, that of low- and high-
responders.  Highly elevated cortisol levels seem to indicate high strain, while low or 
decreased cortisol levels may indicate long-duration chronic strain, and possibly overtraining 
or the chronic fatigue syndrome. This warrants further investigation, particularly since the 
separation of adaptation and maladaptation to exercise stress on the basis of blood 
measurements is not currently possible. 
 
In contrast to cortisol, testosterone concentrations only change after cessation of the stress 
exposure, and decrease during recovery. Testosterone concentration may be a useful 
parameter to measure as indicator of recovery status, since it returns to baseline after 
sufficient recovery, but remains decreased after severe stress exposure with insufficient 
recovery. 
 
Available literature suggests that binding globulins may play a significant role in regulating 
the amount of metabolically active hormones available in circulation. Investigation of the role 
 of CBG and SHBG in the stress response may therefore be useful to determine the net 
change in biologically active cortisol and testosterone in these situations.  Also, stress seems 
to increase glucocorticoid production at the expense of androgen production – both 
testosterone and DHEAs. Therefore, measurement of the ratios between concentrations of 
cortisol and testosterone at rest, or between that of cortisol and DHEAs, may prove more 
useful than measurement of cortisol alone. 
 
2.6.3 Relationship between the immune system, endocrine stress-axis and anti-
catabolic agents in the stress response 
 
From the literature consulted, increased cortisol concentration is associated with decreased 
circulating lymphocyte counts, as well as increased IL-6 production in PBMCs in culture. 
However, despite increased PBMC production of IL-6 in vitro, circulating IL-6 concentration 
was negatively correlated to cortisol concentration, possibly due to rapid negative feedback 
by cortisol. 
 
Both increased testosterone and DHEAs concentrations seem to enhance the TH1 response, 
which results in increased resistance to viral and bacterial infection.  In addition, testosterone 
has been associated with suppression of the inflammatory response by regulating the 
actions of both pro- and anti-inflammatory cytokines, and DHEAs was negatively correlated 
with circulating IL-6 concentration, suggesting a possible down-regulatory effect of 
androgens on the inflammatory response.  In addition, testosterone was reported to increase 
both CD8+ cell count and activity, and to decrease the CD4+:CD8+ ratio.  Testosterone was 
also shown to suppress the lymphocyte proliferative response, which seems to contradict the 
previous statement. However, this assay cannot distinguish between T cell subpopulations, 
so that the target cells of the suppressive action of testosterone remain unclear. 
 
In HIV patients, an increase in the cortisol:DHEAs ratio was associated with decreased CD4+ 
count and progression of disease. Since this change in ratio was mainly due to a decreased 
DHEAs concentration, DHEAs may be important for maintenance of immune function.  
Similarly, IL-6 (which may be down-regulated by DHEAs) was shown to increase 
 susceptibility of CD4+ cells to apoptosis.  However, these relationships between cytokines, T 
cells and androgens have not been investigated in non-HIV-related stress conditions. 
 
2.7 Current challenges for immune-endocrine exercise physiologists 
 
Assessment of changes in absolute white blood cell counts in response to stress is 
insufficient to draw conclusions pertaining to changes in immune status. Different types of 
immune cells do not function independently of each other. For example, suppressor T 
lymphocytes inhibit the overall activation of the helper T lymphocyte-mediated immune 
response. Although research on patients with e.g. HIV or leukaemia, emphasises the 
importance of the ratio between CD4+ and CD8+ cells, the literature on exercise and stress 
does not.  
 
 Another reason not to rely only on assessment of cell counts is that their functional 
capacities may also be affected by exercise or stress.  Although new methods are being 
developed to assess functional capacity, we still don’t fully understand the interpretation of 
the results obtained with these assays. This is, in part, because some of the assays are quite 
non-specific and in part, because some of the assays have not been used to 
comprehensively assess the more chronic effects of exercise.  
 
The functional responses of the non-specific immune cells, such as neutrophils and NK cells, 
to exercise have been extensively investigated.  Also, the proliferation rate of the general T 
cell population in response to a stressor has been investigated. However, the latter cannot 
differentiate between subpopulations with potentially opposing effects, and does not provide 
information about activation of monocytes, which occurs upstream from T cell activation.  
Recently, new technology was developed to allow for assessment of immune cell functional 
capacity (responsiveness to a mitogenic stimulus) in a T cell subpopulation-specific manner, 
by determination of CD69 expression on activated cells.  Assessment of PBMCs capacity to 
secrete pro-inflammatory cytokines in vitro is another rather non-specific assay. However, it 
is the only functional assay available that allows for assessment of changes in the 
responsiveness of the inflammatory response to stress.  
 Although it has been established that PBMCs  exhibit decreased ability to secrete IL-6 after 
exercise, the longer term effects of exercise training on PBMC function is not known. It is 
unclear whether exercise training-induced increased PBMC activity at rest may render 
PBMCs less capable of reacting to an additional, exogenous stressor.  This possibility may 
have a significant effect on the risk of athletes for infections in the “open window” period after 
exercise, during which the specific immune response is also suppressed.  However, an 
alternative possibility is that exercise primes the PBMCs so that an excessive response 
results. 
 
The endocrine system may also impact on immune system functionality, but the effects of 
different endocrine parameters on immune function are often interpreted independently of 
each other. Therefore, the net effects of several role-players with opposing functions, such 
as catabolic (e.g. cortisol) vs. anti-catabolic (e.g. testosterone and DHEAs), are not clear.  
Assessing changes in the ratios of these different parameters in response to stress, and 
investigating relationships between these ratios and immune parameters will allow for a 
more integrated interpretation and application of results. 
 
Communication between the endocrine and immune systems is influenced in part by the 
messenger system, the cytokines.  IL-6 has a central role in activation of both the pro- 
inflammatory and subsequent anti-inflammatory responses to stress.  However, these 
processes are characterised by many interactions and feedback mechanisms between the 
various role players. This may explain why controversy exists about the importance of IL-6 in 
the response to exercise stress and promotion of chronic disease.  These controversies are 
also the motivation for exercise physiologists to focus investigations on this cytokine.  
 
Some of the confounding factors alluded to above include varying levels of every-day 
psychological stress, large day-to-day intra-individual variation, as well as substantial inter-
individual variation in parameters commonly used to assess stress and immune status. 
Therefore, many investigators have turned to protocols of extreme stress, many of these 
using animal models, in order to more clearly study the effects of stress.  Although these 
studies provide valuable information, results obtained cannot necessarily be extrapolated to 
 a more physiological level of stress.  Therefore, in order to more accurately model the 
physiological response to stress, models of mild stress should be used.   
 
In order to investigate and attempt to answer some of these questions, transient changes in 
and/or adaptations of the various relevant endocrine and immune parameters to stress were 
assessed in various models.  These include a) a model of extreme acute stress in humans 
(Chapter 3), b) a high-intensity training intervention in cyclists (Chapter 4) and c) a model of 
chronic psychological stress in sedentary male subjects (Chapter 5).  We also developed an 
animal model of mild, psychological stress (Chapter 6) and confirmed its effectiveness in the 
assessment of altered stress status (Chapter 7). This model was also implemented in a 
mechanistic study to study the role of IL-6 in the inflammatory stress response (Chapter 8). 
  
 Chapter 3 
 
Determination of the functional ability of peripheral blood mononuclear 
cells to secrete interleukin-6 using a whole blood culture technique, in 
samples from athletes participating in an ultra-distance triathlon  
  
3.1 Introduction 
 
Interleukin-6 (IL-6) is a pro-inflammatory cytokine and is released into the circulation in larger 
quantities than any other cytokine in response to exercise (Pedersen & Hoffman-Goetz, 
2000).  This previously led to the hypothesis that the increased blood IL-6 concentration 
post-exercise was an immune response to exercise-induced processes, including muscle 
damage, which require an inflammatory response to be resolved.  However, no correlation 
has been reported between peripheral blood IL-6 levels and indicators of muscle damage 
(Jonsdottir et al., 2000); rather IL-6 was shown to be released during exercise as a result of 
skeletal muscle contraction itself (Ostrowski et al., 1998). Also, another group (Moldoveanu 
et al., 2000) have shown that IL-6 mRNA concentrations in peripheral blood mononuclear 
cells (PBMCs) were not influenced after 3 hours of moderate intensity exercise, despite 
increased plasma concentrations of IL-6. These lines of evidence lend the conclusion that a 
large percentage of the increased plasma IL-6 concentrations seen immediately after 
exercise can be accounted for by increased release of IL-6 from exercising muscle, 
independent of an inflammatory response (Jonsdottir et al., 2000; Ostrowski et al., 1998; 
Steensberg et al., 2000).  It follows that measurement of plasma IL-6 concentrations do not 
provide accurate information on the immune cell-mediated inflammatory response of an 
athlete to a specific bout of exercise, or the ability of an athlete to mount an inflammatory 
response during recovery from exercise.   
 
Jeukendrup et al. (2000) recently studied elite athletes who completed an Ironman long 
distance triathlon and reported a 27-fold increase from baseline in mean plasma IL-6 
concentration immediately post-race.  An increase in circulatory lipopolysaccharide (LPS) 
concentration was reported immediately post-exercise, peaking at 1 hour post-exercise. 
 Also, a decrease in serum IgG anti-lipopolysaccharide levels was reported 2 hours post-
exercise, which gradually decreased up to 16 hours post-exercise. From these results it was 
concludedthat lipopolysaccharide (LPS) enters the circulation of athletes during an ultra-
endurance event and causes an immune response. Therefore, both immune cells’ responses 
to LPS entering the circulation and muscle contraction may contribute to the highly increased 
plasma IL-6 concentrations reported by Jeukendrup et al. (2000).   The magnitude of 
exercise stress and gut ischaemia in individuals completing an Ironman triathlon may be 
much greater compared to that induced by controlled moderate intensity laboratory exercise 
and this difference may explain the seemingly conflicting results reported by Jeukendrup et 
al. (2000) and Moldoveanu et al. (2000).  Although Jeukendrup et al. established that 
participants in ultra-endurance events may suffer endotoxaemia, no study has investigated 
the effect of such an endurance event on the ability of cytokine-secreting immune cells, in 
vitro, to respond to additional stress, although one group previously reported decreased 
cytokine release by monocytes after participation in a marathon (Starkie et al., 2001a). 
Therefore the purpose of this study was to investigate the functional response of PBMCs in 
vitro before and after an ultra-endurance event. 
 
The ability of PBMCs in a whole blood culture to release IL-6 spontaneously and also to 
release IL-6 in response to an endotoxic stimulus (E.coli LPS) added in vitro was 
determined. While the former measurement serves as indication of the spontaneous state of 
excitation of PBMC, the latter provides information regarding changes in the ability of these 
immune cells to react to mitogens.  This is of importance to ultra-endurance athletes, since a 
decrease in immune cell reactivity after a competitive event may weaken host defence and 
add significantly to their risk of infection.  
 
3.2 Methods 
 
Subjects: Twelve triathletes (nine male and three female) took part in the study.  Written 
informed consent was obtained from all volunteers prior to the study. This study was granted 
ethical approval by the University of Stellenbosch Sub-Committee C ethics committee. 
 
 Sample collection: Whole blood samples were obtained on three occasions from twelve 
triathletes participating in the South African Ironman competition (3.8 km swim, 180 km 
cycle, 42.4 km run): one day prior to the race, within 30 minutes of completing the race, and 
one week post-race. Subjects were instructed not to exercise for 24 hours prior to resting 
blood sampling, i.e. the pre- and one-week post-race samples.  At each sample time point, 
4.5 mL blood was obtained by venepuncture from an antecubital vein, into a pyrogen-free 
lithium heparin Vacutainer tube (BD Vacutainer Systems, Plymouth, UK). Samples were kept 
at room temperature and analysed within 4 hours after collection. 
 
Whole blood culture IL-6 assay: Heparinised whole blood was cultured 1:4 in either RPMI 
1640 medium (Highveld Biologicals, South Africa) only (unstimulated culture), or in RPMI 
1640 medium containing 4.8 units/mL LPS (stimulated culture).  After incubation at 37 ºC, in 
98 % humidity and in the presence of 5 % CO2 for 18 hours, according to the method of Pool 
et al. (Pool et al., 2002).  After incubation, the supernatant was drawn off and analysed for 
IL-6 concentration using an in-house ELISA, which was previously validated by comparison 
to results obtained using a commercially available IL-6 ELISA kit (Amersham)(Pool, 1999). 
For a detailed description of the ELISA assay, please refer to Appendix B. 
 
Nomenclature of in vitro samples: Samples analysed from wells incubated in medium only are 
termed ‘spontaneous’, whereas samples analysed from wells incubated in LPS-containing 
medium are termed ‘activated’. Endotoxin-induced release of IL-6 was calculated by 
subtracting spontaneous concentrations from activated concentrations.  (Although the values 
obtained in this assay, and specifically the ‘spontaneous’ value, include the amount of IL-6 
present in plasma prior to the incubation period, this amount of IL-6 is negligibly small in 
comparison to the amount of IL-6 secreted during the 18 hour incubation period.) 
 
Data analysis: Data were analysed using repeated measures one-way analysis of variance 
(ANOVA), with a Tukey post hoc test, and Pearson’s correlations (Statistica 5.5, StatSoft Inc, 
OK, USA).  The accepted level of significance was P < 0.05.  All results are reported as 
mean ± standard error of the mean (SEM), unless otherwise indicated. 
 
 
 3.3 Results 
 
Physical characteristics of the subjects were as follows (mean ± SD): age, 34 ± 5 years, 
height, 179 ± 12 cm and body mass, 77 ± 13 kg.  
 
No significant differences were found for the spontaneous release of IL-6 in vitro between 
any time points (Figure 3.1).  All spontaneous IL-6 concentrations were elevated (above 200 
pg/mL) when compared to the results obtained for sedentary subjects at rest (6 ± 8 pg/mL) in 
a previous study using the same methods (Pool et al., 2002).  Spontaneous release of IL-6 
by PBMC at rest before the race correlated with spontaneous IL-6 release at rest one week 
after the race (r = 0.57, P < 0.05), but neither was correlated with immediately post-race 
spontaneous IL-6 release (r = -0.13 and r = 0.40 respectively). 
 
Figure 3.1 In vitro spontaneous PBMC IL-6 release obtained before, immediately after 
and one week after an ultra-endurance triathlon.  
 
 
 
 
 
 
 
 
Error bars indicate SEM. 
The first and final samples were taken in a properly rested condition 
at least 24 hours after the previous exercise bout, whereas the 
middle sample was within 30 minutes post-race.   
 
LPS-induced release of IL-6 was not different pre-race and one week post-race (Figure 3.2). 
However, induced release of IL-6 after in vitro stimulation with E.coli LPS was significantly 
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 higher in samples taken immediately post-race compared to both pre-race (P < 0.01) and 
one week post-race (P < 0.0001) samples (Figure 3.2). 
 
Figure 3.2 LPS-induced IL-6 release by peripheral blood mononuclear cells (PBMC) 
before (rested condition), immediately after (within 30 minutes) and one week after (rested 
condition) an ultra-endurance triathlon.  
 
 
 
 
 
 
 
 
Error bars indicate SEM. 
 
Pre-race spontaneous IL-6 release correlated negatively with induced IL-6 release at the 
same time point (Figure 3.3a) and again one week post-race spontaneously released IL-6 
tended to correlate negatively with induced IL-6 release at the same time point (r = -0.56, P = 
0.06).  However, the induced release of IL-6 in vitro immediately post-race was not 
correlated with spontaneous IL-6 release in vitro at the same time point (Figure 3.3b).   
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 Figure 3.3 The relationship between spontaneous IL-6 release by PBMC and mitogen-
induced IL-6 release by PBMC, (a) pre-race and (b) immediately post-race.  
 
(a) 
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3.4 Discussion 
 
The main findings of this study were 1) chronically elevated spontaneous activity of PBMC in 
vitro in highly trained triathletes that was not affected by participation in an ultra-endurance 
race, and 2) transiently enhanced ability to respond to a LPS challenge in vitro, immediately 
post-race. 
 
In vitro spontaneous production of IL-6 from blood samples taken at all time points was 
elevated in comparison to concentrations previously reported for sedentary subjects at rest 
(Pool et al., 2002).  Even one week post-race the comparative elevation in athletes was still 
more than 300-fold higher than previously reported in sedentary subjects. This indicates 
chronic excitation of white blood cells in endurance athletes during periods of high training 
volume and competitive events. This finding supports the findings of Sprenger et al., who 
reported raised concentrations of γ-interferon, IL-1β, tumour necrosis factor (TNF)-α and IL-6 
in the urine of well-trained endurance runners pre-race (Sprenger et al., 1992).  They 
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 speculated that regular endurance training might achieve a “training of leucocytes”, resulting 
in chronically increased circulating concentrations of various cytokines.   
 
Studies in rats and humans have shown that a balance exists between pro-inflammatory 
cytokines, such as IL-6, and their inhibitors (including but not exclusively the anti-
inflammatory cytokines), so that the magnitude and duration of an inflammatory response 
may be restricted (Ostrowski et al., 1999; Xing et al., 1998).  In marathon runners, for 
example, TNF-α, IL-1β and IL-6 release were shown to reach peak plasma concentrations 
within one hour after the race. At the same time, concentrations of cytokine inhibitors such 
as soluble TNF-α receptors and IL-1ra, as well as the anti-inflammatroy cytokine IL-10, were 
also significantly increased, to maintain a balance between the pro- and anti-inflammatory 
responses to exercise (Ostrowski et al., 1999).  We hypothesise that the lack of change in 
spontaneous IL-6 production as a result of the ultra-endurance event itself may have been 
due to the presence of a protective counter-regulatory mechanism that may also be 
chronically active in athletes doing so much endurance training.   
 
In rats, administration of exogenous endotoxin resulted in secretion of both pro-inflammatory 
IL-6 and anti-inflammatory IL-10 into the circulation (Xing et al., 1998).  We further 
hypothesise that the secondary effect of simultaneous anti-inflammatory adaptation may be 
sufficient to restrict the effect of further exercise stress (in the form of continued training or a 
competitive event) on the inflammatory response. This hypothesis is substantiated by our 
observation of no further influence of the race itself on spontaneous PBMC IL-6 release 
despite the likelihood of elevated PBMC counts post-exercise, as well as by the negative 
correlation that existed between spontaneous and mitogen-induced PBMC IL-6 release at 
rest, which indicated that a greater spontaneous activity could inhibit the mitogen-induced 
activity in PBMCs. 
 
However, a significant increase in in vitro LPS-induced IL-6 release by PBMC was observed 
immediately after the ultra-endurance event itself (159 ± 50 % higher than pre-race).   The 
absolute values obtained were similar to that reported in sedentary individuals at rest, in a 
previous study by our group (Pool et al., 2002), but since a control group was not included in 
this study, no direct comparisons in this regard is possible.  Moldoveanu et al. reported no 
 significant effect of exercise on IL-6 mRNA expression in circulating mononuclear cells after 
three hours of moderate intensity exercise, despite an increase in circulating IL-6 levels post-
exercise (Moldoveanu et al., 2000).  Therefore, one possible reason for the increased IL-6 
secretion measured in this study could be an increase in circulating monocytes rather than 
increased IL-6 release by existing monocytes. Increased circulating monocyte numbers were 
previously reported after exercise (Espersen et al., 1990; Nieman et al., 1989a).  However, 
since we did not measure monocyte count in this study, we cannot substantiate this 
specifically.  Of importance is that the chronic counter-regulatory effect was lost directly after 
the race, indicating that either the extent of the stress (either intensity, or duration, or both) 
overrode the level of adaptation, or that the newly circulating monocytes did not have this 
adaptation.   
 
3.5 Conclusion 
 
The spontaneous IL-6 results reported in the current study support the idea of Sprenger et 
al. (Sprenger et al., 1992), of a training effect on the chronic level of excitation of cytokine 
secreting immune cells. Our data provides sufficient evidence to hypothesise that such 
chronic spontaneous elevations may limit an exercise-induced pro-inflammatory response by 
activating endogenous counter-regulatory mechanisms to prevent further increases in 
circulating cytokine concentrations during training or racing, unless a severe mitogenic 
stimulus is experienced. Our results indicate that the proposed counter-regulatory 
mechanisms in vivo are not sufficient to prevent an ultra-endurance race from eliciting a  
post-race response to an exogenous stimulant in vitro in excess of the response typically 
elicited to the same exogenous stimulant at rest.  Further investigation is warranted to clarify 
the different mechanisms responsible for the chronic counter-regulation and the post-race 
attenuation of this counter-regulation.   
 
3.6 Limitations 
 
A limitation of this study is that total and differential white cell counts were not measured.  
Determination of total WBC counts would have enabled expression of LPS-induced IL-6 
 secretion normalised on a per cell basis. This would have allowed for interpretation of 
changes in counts as a result of exercise, as well as changes in cell function relative to cell 
number.   
 
Furthermore, measurement of plasma IL-6 concentration may provide information with 
regard to the contribution of immune cells to post-exercise changes in IL-6 concentration. In 
addition, in the PBMC assay, the dosage of LPS used followed convention of published 
studies. Therefore, the assay design does not allow for assessment of possible changes in 
PBMC sensitivity to LPS over time or as result of exercise. Since monocytes were previously 
shown to be more sensitive to LPS stimulation in athletes post-exercise when compared to 
pre-exercise values (Duclos et al., 1999), more than one concentration of LPS should be 
used at each time point in future studies to correct for such changes in sensitivity. 
 Chapter 4 
 
Effect of performance enhancing high-intensity cycling training on 
selected endocrine and immune parameters 
 
4.1 Introduction 
 
The ideal exercise training programme allows an athlete sufficient rest to recover between 
bouts of exercise.  Athletes should be able to start each training session sufficiently well-
rested, to be able to train at the desired intensity and with the desired perceived effort.  
However, due to the ever-increasingly high standards set in professional sports today, 
moderate training programmes are not sufficient for athletes to excel at their sport. Therefore 
athletes must include in their weekly programmes days of very strenuous high-intensity 
training, interspersed with sessions of longer duration, both of which may take their toll on, 
amongst others, the neuroendocrine-immune axis.  
 
Early epidemiological surveys in marathon athletes showing an increase in the incidence of 
upper respiratory tract symptoms after exercise (Nieman et al., 1989b; Nieman et al., 1990; 
Peters & Bateman, 1983), have stimulated interest in the effect of exercise on the non-
specific immune system.  Since these surveys, many studies have investigated and 
reviewed the suppressive effect of exercise stress on the non-specific immune response 
(Berk et al., 1990; Blannin et al., 1996; Gleeson et al., 1998; Heath et al., 1992; Nieman, 
1995; Nieman, 2000; Robson et al., 1999; Walsh et al., 2000) and these studies are in 
agreement that the exercise-induced changes in the non-specific immune function are only 
transient. However, much less information exists on the effect of stress on the specific, T 
cell-mediated immune response.  Since proper functioning of T cell-mediated immunity is 
vital to prevent long-term illnesses, which may be linked to either overactivation (e.g. auto-
immune disease) or underactivation (which may predispose an individual to suffer from e.g. 
cancer), it is important to understand the influence of chronic stress on this subsection of the 
immune system.  
 
 Lymphocyte counts, and more specifically T lymphocyte subpopulation counts, are reported 
to increase during acute exercise and to decrease to either baseline (Hoffman-Goetz et al., 
1990; Mazzeo et al., 1998; Ronsen et al., 2001b) or below baseline (Kajiura et al., 1995; 
Natale et al., 2003; Shore et al., 1999) following recovery after the exercise bout.  The 
magnitude of change in T lymphocyte subpopulation counts may be influenced by fitness or 
exercise intensity, or both, with long duration aerobic exercise resulting in the biggest 
change (Mackinnon, 1999; Natale et al., 2003).  However, since most acute exercise-
induced changes in lymphocyte counts have been shown to be transient, resulting in only a 
short “open window” period of altered immune status, the chronic response to the cumulative 
stress of training regimens may be more accurately reflected by changes in immune status 
assessed under rested conditions.   
 
Literature on the effect of training on resting immune cell counts is not consistent.  While 
experimentally controlled mild cycling training lasting 12 weeks was reported to decrease 
resting total T lymphocyte counts in previously sedentary male subjects, moderate training 
(same intensity, but more sessions per week) did not result in a decrease in resting T 
lymphocyte counts in another group. Neither of the two regimens affected CD4+:CD8+ T cell 
ratio (Shore et al., 1999).  On the other hand, other research groups reported that increased 
training volume in experienced or elite athletes either had no effect on total and 
subpopulation T-cell counts (Dressendorfer et al., 2002), or decreased the number of CD4+ 
and CD8+ cells in circulation (Baj et al., 1994; Verde et al., 1992).  It therefore remains 
unclear how and to what extent T cell counts respond to changes in training.   
 
Furthermore, immune competency relies not only on the number of cells present, but also on 
their functional capacity.  A number of studies investigated the lymphocyte proliferative 
response to either acute exercise bouts or training, or both (Baj et al., 1994; Fry et al., 1992; 
Shore et al., 1999; Verde et al., 1992), but again the results varied.  Acute anaerobic 
kayaking or running to fatigue, in both recreational and high-performance athletes, were 
reported to result in a transient decrease in mitogen-induced lymphocyte proliferative 
response in vitro (Fry et al., 1992).  All exercise-induced changes returned to baseline after 2 
hours of recovery. Similarly, the lymphocyte proliferative response that was measured in 
resting samples from previously sedentary male subjects before and after cycling training 
 (mild or moderate volume) lasting 12 weeks, was not affected by the training regimen (Shore 
et al., 1999).  These data seem to imply that only acute high-intensity exercise may be 
transiently detrimental to specific immune function.  However, in trained subjects, an 
increase in training volume and intensity resulted in an increase in the lymphocyte 
proliferation rate assessed in resting samples (Baj et al., 1994; Verde et al., 1992), indicating 
a more chronic effect. 
   
Furthermore, it is unclear whether the reported exercise-induced changes in lymphocyte 
proliferation rate are due to responsiveness of cells to mitogenic activation, or whether the 
regulation of proliferative capacity occurs downstream from activation.  An early step in 
activation of lymphocytes is expression of CD69, which was previously investigated before 
and after acute bouts of exercise (Gabriel et al., 1993; Green et al., 2003; Ronsen et al., 
2001c; Ronsen et al., 2001b; Ronsen et al., 2002; Vider et al., 2001). Four of these studies 
investigated mitogen-stimulated CD69 expression by helper and suppressor T cells in well-
trained or elite athletes, but results reported in the different studies are inconsistent: one 
study showed decreased proportions of PHA-stimulated CD4+ and CD8+ cells expressing 
CD69 after acute incremental exercise to exhaustion (Vider et al., 2001), and the others  
reported no effect of a single bout (Ronsen et al., 2001b; Ronsen et al., 2002) or repeated 
bouts (Ronsen et al., 2001c; Ronsen et al., 2002) of longer duration strenuous exercise on 
these cells’ activation status. The seemingly contradictory results suggest that CD69 
expression may only be sensitive to very high exercise intensities, but that this can result in 
compromise of both CD4+ and CD8+ cell responsiveness. These studies investigated only 
the acute effects of exercise, and the longer-term effect of exercise training on 
responsiveness of these cells at rest is still unknown.  However, since typical training 
programmes for performance enhancement include high intensity training and Vider et al. 
(2001) showed that acute high intensity exercise had a suppressive effect on lymphocyte 
CD69 expression, we hypothesise that the training programmes of competitive athletes are 
likely to have a cumulative negative effect. 
 
The acute immune response to exercise is hypothesised to be mainly a “side-effect” of the 
exercise-induced changes in cardiac output, controlled by catecholamine action (Foster et 
al., 1986; Malm, 2002) and exercise-induced fuel mobilisation controlled by e.g. cortisol 
 (Newsholme et al., 1993; Newsholme, 1994).  Therefore, if any chronic effects of training on 
the immune system are observed, they may also be mediated by the endocrine system.  It is 
well-established that (in the absence of overtraining or negative energy balance) endurance 
training has no effect on resting blood cortisol concentration (Kraemer et al., 1989; Urhausen 
& Kindermann, 1992), whereas testosterone concentrations are decreased during recovery 
for a period which may differ in duration from a few hours to several days (Urhausen & 
Kindermann, 1992). Since these changes are still only transient, it was suggested that 
hormonal monitoring of training stress is not useful (Urhausen et al., 1995).  However, since 
it is now known that white blood cells carry receptors to both androgens and glucocorticoids 
(Benten et al., 1999a; Benten et al., 1999b; Grasso et al., 1997; Vorobiev et al., 1996), the 
relationships between these parameters of the endocrine system and the chronic immune 
response to training should still be assessed.   
 
The purpose of this study was therefore 1) to determine whether a laboratory-based, 
controlled high-intensity training intervention, which is sufficiently strenuous to result in 
increased performance, would negatively influence the responsiveness of the specific 
immune system in recreational cyclists, and 2) to investigate whether increased training 
intensity may alter relationships between the endocrine and immune systems. 
 
4.2 Methods 
 
Subjects: Seven recreational, competitive male cyclists took part in the study, after giving 
their written, informed consent.  Ethical approval was gained from the Stellenbosch 
University ethics committee. Mean (± SD) age, height and weight were 22.6 ± 4.7 years, 180 
± 10 cm and 73.1 ± 6 kg respectively, and average cycling peak power output (PPO) and 
VO2max on entrance into the study was 354 ± 13 W and 56.1 ± 4.7 mL/min/kg .  
 
Training and performance testing intervention: The PPO test was performed on an 
electronically braked cycle ergometer, and consisted of incremental workloads to voluntary 
exhaustion, with initial workload determined by multiplying the subject’s body mass by 1.33, 
and subsequent workloads increasing by 30 watt each (protocol according to ACSM 
 guidelines).  VO2max was defined as the maximum oxygen consumption during the PPO test.  
The 6-week intervention entailed a 4-week period of controlled high intensity (HI) cycle 
training, with individualised load adjustment according to the change in PPO after 2 weeks. 
HI training consisted of 2 laboratory-based training sessions per week: 1) 5-8 bouts 
(increased by 1 bout each week) of cycling for 5 minutes at 80 % PPO, with 1 minute at 50 
% PPO between bouts, and 2) 2 bouts of cycling for 5 km at 90 % of 5 km time trial (5TT) 
speed, with 20 minutes cycling at 50 % 5TT speed between the two bouts.  This phase was 
followed by 2 weeks of controlled supra-maximal intensity (SMI) cycle training. SMI training 
consisted of 3 laboratory-based training sessions per week: 1) 8 bouts of cycling for 5 
minutes at 80 % PPO, with 1 minute at 50 % PPO between bouts, 2) 10 bouts of cycling for 
90 seconds at 110% PPO, followed by 3.5 minutes cycling at 50 % PPO, and 3) 3 bouts of 
cycling 2.5 km at 110 % 5TT speed, followed by 15 minutes cycling at 50 % 5TT speed. 
Subjects were instructed to maintain their usual outdoor training load during HI, to reduce 
outdoor training by only one session per week during SMI, and to refrain from exercising for 
24 hours prior to performance testing sessions.  Each subject kept a daily training diary from 
2 weeks prior to the study and throughout the study protocol, to enable validation of 
compliance.  PPO was performed on an electronically braked cycle ergometer (Bikerace, 
Technogym, Italy), at baseline (B), post-HI and post-SMI training.  Performance was 
assessed by 5TT and 40 km time trial (40TT) performed at B, post-HI and post-SMI, using 
the subject’s own bicycle on a time-trial ergometer (Spintrainer, Technogym, Italy) as 
previously described (Myburgh et al., 2001).  
 
Sample collection:  Subjects were instructed not to exercise for at least 24 hours prior to 
collection of resting blood samples.  Whole blood samples were taken fasted and at rest, at 
08h00 in the morning at B, post-HI and post-SMI. Blood samples were obtained from an 
antecubital vein by venepuncture, and collected into 4.5 ml EDTA Vacutainer tubes (BD 
Vacutainer Systems, Plymouth, UK) for determination of full blood count (FBC) and 
differential white cell count (diff), and into 4.5 ml lithium heparin Vacutainer tubes for 
determination of lymphocyte subpopulation distribution and CD69 expression on helper- and 
suppressor T-lymphocytes.  Blood was also collected into 4.5 ml SST Vacutainer tubes for 
determination of serum concentrations of cortisol, cortisol binding globulin (CBG), 
testosterone, sex hormone binding globulin (SHBG), and dehydroepiandrosterone-sulphate 
 (DHEAs).   All blood samples collected in SST tubes were allowed to clot at room 
temperature for 10 minutes and were subsequently centrifuged at 3000 rpm for 10 minutes 
at 4 °C, before being aliquoted into eppendorf tubes and frozen at –80 °C until subsequent 
batch analysis. 
 
Sample analysis:  All blood samples for immune analyses were analysed within three hours 
after collection.  EDTA-anticoagulated whole blood samples were analysed for FBC and 
differential white blood cell count (Coulter STKS, Beckman/Coulter, Fullerton, CA). Using 
heparinised whole blood, monoclonal antibodies (Multitest, SA Scientific Products, Jhb, SA) 
and three-colour flow cytometry, lymphocytes were divided quantitatively, into the following 
subpopulations: total T-cells (CD3+), T-helper cells (CD4+), T-suppressor/cytotoxic cells 
(CD8+), total B-cells (CD19+) and natural killer (NK) cells (CD16+/CD56+).  The activation of 
CD4+ and CD8+ cells in response to a stressor was determined by measuring the expression 
of the cellular activation marker, CD69, after in vitro exposure to a stimulant, as previously 
described (Breytenbach et al., 2001). Briefly, this entails incubation of whole blood in the 
presence of the synthetic stimulant phorbol-12-myristate-13-acetate (PMA) and ionomycin (1 
ug/mL). After 4 hours of incubation, the cells are labeled with a fluorescence-labelled 
monoclonal antibody specific for CD69 and fluorescent cells quantified using standard flow 
cytometry procedures (FACSCalibur, Becton Dickinson, New Jersey, USA).   
 
Chemiluminescent analytical procedures were performed for determination of cortisol 
(Access B81600, Beckman/Coulter, Fullerton, CA, USA), DHEAs and SHBG concentrations 
(Immulite I, Diagnostic Products, Los Angeles, CA, USA).  Testosterone concentration was 
determined by immunoassay (Advia Centaur, Bayer Diagnostics, Leverkusen, Germany) and 
CBG concentration by radioimmunoassay (CBG-RIA-100, Biosource, Nivelles, Belgium).  
Free testosterone concentration is derived from the law of mass action at equilibrium using a 
specially designed computer program containing a complex mathematical formulation 
(Rinaldi et al., 2002; Vermeulen et al., 1999). This method was not available, so instead the 
free androgen index (FAI), which is commonly used by clinicians, was calculated using the 
formula: 
  
Serum cortisol concentration, CBG concentration and CBG binding affinity constants were 
used to calculate the concentration of biologically active (unbound) cortisol, using the 
following previously validated  equation (Coolens et al., 1987): 
                   U = C*0.0122  C)-(T*0.182  0.0167 2 ++   - 0.0167 + 0.182 * (T - C), 
where U = unbound cortisol concentration, T = CBG (transcortin) concentration and C = total 
cortisol concentration (all units for concentration were converted to nmol/L). 
Data analysis: Data sets were compared using repeated measures analysis of variance 
(ANOVA) with Bonferroni multiple comparison post hoc tests, and Pearson’s correlation 
coefficients. Performance and endocrine results are reported as means ± SD, and immune 
results as means ± SEM. The level of significance was set at P < 0.05. 
 
4.3 Results 
 
Performance: Repeated measures analysis of variance indicated a significant effect of time 
on PPO (P < 0.01), 5TT (P < 0.01) and 40TT (P < 0.05). Bonferroni post hoc analysis 
indicated that PPO, 5TT and 40TT performances improved significantly from B to post-HI 
(PPO: 354 ± 13 vs. 366 ± 12 Watt; P < 0.05; 5TT: 443 ± 15 vs. 427 ± 13 seconds P < 0.05; 
40TT: 64.4 ± 3.0 vs. 61.7 ± 1.5 minutes; P < 0.05), and were maintained during SMI (Figure 
4.1).  
 
 Testosterone concentration 
FAI =                                                   x 100 
                 SHBG concentration 
 Figure 4.1 Improvement in (a) PPO, (b) 5TT and (c) 40TT performances in response to 
training intervention.   
(a)  
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Error bars indicate SD 
* Value significantly different from baseline (P < 0.05)   
 
T cell counts: Although the mean total WBC and means for all lymphocyte subpopulation 
counts tended to be lower post-HI compared to B, only that of the CD8+ cells was 
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 significantly decreased.  No cell counts assessed were different from any other time point 
post-SMI (Table 4.1). 
 
Table 4.1 Changes in lymphocyte subpopulation counts in response to the training 
intervention.  
 Units B Post-HI Post-SMI 
WBC  cells/uL 6414 ± 1189 5414 ± 1068 5714 ± 855 
CD3+ cells/uL 2628 ± 711 2277 ± 559  2034 ± 1035 
CD4+ cells/uL 1598 ± 461 1152 ± 302 1240 ± 628 
CD8+ cells/uL 846 ± 199 640 ± 147 * 727 ± 132 
CD4:CD8 ratio  1.82 ± 0.39 1.88 ± 0.60 1.72 ± 0.39 
CD16+/CD56+ cells/uL 692 ± 194 491 ± 178 583 ± 169 
 
Values are means ± SEM.  
* Value significantly different from baseline (P < 0.05). 
 
Spontaneous CD69 expression by CD4+ cells, but not CD8+ cells, was significantly increased 
post-HI (P < 0.05; Figure 4.2a), while the mitogen-induced CD69 expression was transiently 
decreased for both subpopulations at the same time point (P < 0.05; Figure 4.2b).  Both 
spontaneous and mitogen-induced CD69 expression for both CD4+ and CD8+ cells had 
returned toward baseline levels post-SMI.   
 
Figure 4.2 Changes in the (a) spontaneous and (b) mitogen-induced expression of CD69 
by CD4+ and CD8+ cells as a result of changes in training volume and intensity.   
(a) 
 
 
 
 
 
 
 
 
 
  
Error bars indicate SEM. 
* Value significantly different from baseline (P < 0.05). 
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Error bars indicate SEM. 
*Value significantly different from baseline (P < 0.05). 
 
Endocrine measures: No effect of the training intervention was found on any of the endocrine 
parameters measured at rest (Table 4.2).  However, a subsequent power analysis revealed 
that the low subject numbers in this study is not sufficient to exclude an effect of the 
intervention on these parameters. Unfortunately, since an estimated subject number in 
excess of 45 is required to yield an analytical power of 0.6 for the parameters assessed, 
testing sufficient numbers of athletes was not feasible. No correlations were found between 
any of the measured immune parameters and cortisol or DHEAs or CBG concentrations. 
However, several relationships existed between testosterone concentrations and immune 
parameters at B (Table 4.3), which were no longer evident after the training intervention.  In 
addition, while total serum testosterone was positively correlated with the unbound fraction of 
testosterone throughout the protocol (R=0.90, 0.71, 0.96 and P< 0.01, 0.05, 0.001 
respectively for B, post-HI and post-SMI), there was no correlation between the 
concentration of total and unbound cortisol at any time point.   
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 Table 4.2 Serum concentrations of selected endocrine parameters and relationships 
between these parameters over time.  
 B post-HI post-SMI 
Cortisol (nmol/L) 608 ± 63 621 ± 75 599 ± 139 
CBG (ug/mL) 51 ± 9 58 ± 12 52 ± 16 
Unbound Cortisol (nmol/L) 390 ± 170 340 ± 150 380 ± 170 
DHEAs (umol/L) 9.0 ± 2.3 7.9 ± 2.6 8.1 ± 2.6 
Cortisol:DHEAs ratio  0.07 ± 0.01 0.09 ± 0.03 0.08 ± 0.03 
Testosterone (nmol/L) 24 ± 6 20 ± 6 22 ± 6 
SHBG (nmol/L) 28 ± 8 34 ± 17 29 ± 6 
Free androgen index (%) 89 ± 11 68 ± 14 77 ± 8 
Cortisol:Testosterone ratio 26.3 ± 4.5 35.4 ± 15.2 31.3 ± 15.4 
 
Values are means ± SD 
Level of significance:  P < 0.05 
 
Table 4.3 Associations between testosterone concentration and lymphocyte 
subpopulation counts and activation status.   
 
Testosterone vs.: B Post-HI Post-SMI 
CD3+ 0.85** 0.37 - 0.03 
CD4+ 0.83* 0.44 - 0.07 
CD8+ 0.86** 0.22 0.04 
CD4:CD8 ratio 0.23 0.47 - 0.44 
CD16/CD56+ 0.84* 0.16 - 0.14 
Spontaneous CD4+CD69+ 0.79* - 0.01 - 0.21 
Spontaneous CD8+CD69+ 0.84* - 0.19 0.28 
Mitogen-induced CD4+CD69+ 0.84* 0.39 0.03 
Mitogen-induced CD8+CD69+ 0.90** 0.14 - 0.12 
 
Values are R-values. 
* P < 0.05; ** P < 0.01 
 Change in individual training volume and intensity: The training diaries (summarised in Table 
4.4) indicated that the participants in this study maintained their average weekly outdoor 
training volume (distance cycled) throughout the study, although there was a tendency to 
decrease individual training volume during SMI (P = 0.07). However, their training intensity 
outdoors (average speed) increased during HI and was maintained during SMI.  Individual 
outdoor training volume correlated negatively with CD4:CD8 ratio at B and post-HI, but not 
post-SMI (Figure 4.3).   
 
Table 4.4 Mean weekly outdoor training volume and intensity, as well as number of 
training sessions per week both outdoors and indoors. 
 
 
 Pre-B During HI During SMI
Volume (km cycled) 174 ± 93 177 ± 99 133 ± 60 
Intensity (average speed, km/h) 26 ± 2 29 ± 1* 28 ± 2* 
Training sessions per week 4.2 ± 0.6 6.2 ± 1.3* 5.9 ± 0.9 
 
Values are means ± SD. 
* Significantly higher than baseline value (P < 0.01).  
 
Figure 4.3 Relationships between training volume and the CD4:CD8 ratio at rest in 
recreationally competitive cyclists at (a) B, (b) post-HI training and (c) post-SMI training. 
(a)  
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4.4 Discussion 
 
The main findings of this study were that increased training intensity in the laboratory and 
outdoors with maintenance of individual outdoors training volume: a) increased performance 
significantly, b) was associated with decreased CD8+ T cell counts at rest, c) increased 
spontaneous activation of CD4+ and decreased mitogen-induced activation of CD4+ and 
CD8+ T cells at rest, but d) did not significantly affect the resting endocrine parameters 
assessed.  Although the performance and endocrine measures remained unchanged after a 
subsequent period of supra-maximal intensity laboratory training, immune parameters 
returned toward baseline values, as did the number of training sessions per week. 
 
Performance: The fact that all three performance measures improved after HI training was 
expected, since the HI training protocol used in this study was similar to those used in 
previous studies which reported both increased endurance performance and increased peak 
sustained power output post-training (Lindsay et al., 1996; Westgarth-Taylor et al., 1997).  
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 The second finding, that SMI training did not further improve performance, has more than 
one possible explanation. Firstly, the supra-maximal training sessions (at 110 % maximum) 
may have been of too severe intensity for the recreationally competitive athletes to recover 
sufficiently within the one day allowed prior to performance assessments. This is in 
agreement with the earlier finding of no improvement in performance (running economy,  
treadmill VO2max, time to fatigue and maximum distance, both run at minimal velocity 
associated with VO2max) after 4 weeks of unaccustomed supra-maximal intensity interval 
training (Billat et al., 1999).  Alternatively, the specificity of the performance tests was more 
applicable to high intensity, but sub-maximal training than to training at maximal or supra-
maximal intensities. This possibility is in agreement with an earlier training study, which 
reported increased 40 km time-trial performance after 3 weeks of interval training at 85 % 
PPO, but no significant change in this performance measure after 3 weeks of interval cycling 
training at 100 % PPO (Stepto et al., 1999).  Secondly, there was a tendency for subjects to 
reduce both the volume of their own individual training and training frequency during SMI, 
but to maintain their intensity of outdoor training while laboratory-based training increased in 
intensity (Table 4.4). The effect of 6 days of high-frequency taper (training daily) vs. 
moderate-frequency taper (training 2 – 3 times per week) on 800 m running performance 
was recently investigated in middle-distance runners (Mujika et al., 2002). (Taper consisted 
of an 80 % progressive reduction in high-intensity training.)  While high-frequency taper was 
associated with a significant increase in performance, moderate-frequency taper did not 
have an enhancing effect, possibly due to a detraining effect of training only 2 – 3 times per 
week. However, although slightly lower when compared to HI, the average number of weekly 
training sessions for our subjects during SMI (≈ 6) was still similar to the high-frequency 
regimen described by Mujika et al. (2002), so that changes in training frequency is unlikely to 
be the cause of our result of no performance improvement after SMI. Together, these results 
suggest that a decrease in high-intensity exercise with maintenance of training frequency is 
necessary to further enhance performance, while a high-frequency, high-intensity taper, 
while maintaining performance, does not result in further improvement. 
 
Immune parameters: The significant decrease in resting CD8+ lymphocyte count after HI 
training is in accordance with previous results of decreased T cell counts at rest after both 
short-term (5 days) and longer-term (12 weeks) submaximal training in previously sedentary 
 subjects (Hoffman-Goetz et al., 1990; Shore et al., 1999).  This suggests that the decreased 
lymphocyte subpopulation counts we report in this study were as a result of either 
unaccustomed training or the intensity of the training. However, recently no change in resting 
lymphocyte subpopulation counts during or after intensified cycling training (4 weeks 
baseline training, 6 weeks increased volume training, 18 days maximal intensity interval 
training, 10 days taper) was reported (Dressendorfer et al., 2002).  The difference in results 
is possibly due to the fact that the athletes who participated in the study by Dressendorfer et 
al. (2002) were more experienced cyclists (on average had 4.4 ± 2.1 years of competition 
experience) than our recreationally competitive individuals. Also, while our study took place 
at the start of the racing season, that of Dressendorfer et al. (2002) took place at the end of 
the racing season.  It is therefore likely that the training protocol followed by Dressendorfer et 
al. (2002) at the end of a competitive season did not represent an unaccustomed training 
load to subjects, while our high-intensity protocol at the start of a season was likely to 
represent an unaccustomed training load to our subjects, who have been doing maintenance 
training only during the off-season.  The normalisation of lymphocyte subpopulation counts 
and activation status after SMI, when subjects had become more accustomed to a higher 
intensity of training, supports this contention.   
 
Our data also clearly indicate decreased mitogen-induced CD69 expression by both CD4+ 
and CD8+ T cells in vitro post-HI. Although a different type of functional test, this is in 
accordance with previous reports of suppressed lymphocyte proliferative response after a 
few weeks of high intensity training (Verde et al., 1992).  Our results add to the literature by 
indicating that the changes in lymphocyte proliferation rate previously reported are not 
limited to a specific subpopulation of T cells, although the decreased in mitogen-induced 
CD69 expression was much greater for CD4+ T cells than for CD8+ T cells. Also, we show 
that training-induced decreases in resting lymphocyte function, previously reflected simply by 
decreased lymphocyte proliferation rate, are brought about by regulation of lymphocyte 
activation, rather than by a mechanism downstream from activation. Two recent studies 
assessed both CD4+ and CD8+ cell activation (CD69 expression) and T cell proliferative 
response on the same blood samples. In one study, an acute bout of exercise (60 minutes 
treadmill running at 90 % of ventilatory threshold) in well-trained endurance runners had no 
apparent effect on either of the two functional tests (Green et al., 2003), while in the other 
 study (Vider et al., 2001), exhaustive exercise resulted in a decrease in both CD69 
expression and lymphocyte proliferation rate in response to mitogen stimulation, illustrating 
that changes in activation do result in similar changes downstream.  Assessment of CD69 
expression may indeed be a more time-economical, direct and informative test for 
lymphocyte responsiveness.   
 
Apart from changes in mitogen-induced CD69 expression, which all groups investigating this 
parameter report, we assessed changes in spontaneous CD69 expression by T cells after a 
period of incubation without the presence of a mitogen. Although the proportion of cells 
expressing CD69 spontaneously is relatively small, these results may provide additional 
information on the chronic activation status of these cells in the absence of an additional 
stressor or immune challenge.  Our results indicate an increased spontaneous reactivity of 
CD4+ cells, but not CD8+ cells, post-HI, which returned to baseline post-SMI (Figure 4.2a). 
Chronically increased spontaneously active cells may contribute to chronic inflammation 
after long-term high-intensity training, or may contribute to an inability to mount an 
appropriate acute response to exogenous stimuli.  Although no significant correlation existed 
between spontaneous and mitogen-induced CD69 expression, the decreased average 
mitogen-induced CD69 expression post-HI compared to the capacity at baseline supports 
the latter possibility.  The implication of this finding on immune function warrants further 
investigation to elucidate its clinical importance. 
 
The relatively small percentage of cells spontaneously activated in comparison to the 
percentage of cells activated by mitogen stimulus (≈ 1.5 % vs. ≈ 49 %), implies that the 
regular stimulus provided by exercise training is mild. However, at the same time it was 
sufficient to result in general desensitisation of lymphocytes and a lower response to a 
mitogen challenge in vitro.  A candidate mechanism for the desensitisation of lymphocytes is 
the increased cortisol released in response to unaccustomed exercise.  Indeed, strenuous 
exercise was previously shown to result in decreased corticosteroid sensitivity of peripheral 
blood lymphocytes (decreased dexamethasone inhibition of LPS-induced IL-6 secretion in a 
whole blood culture)  (DeRijk et al., 1996).  Although one or two repeated bouts of strenuous 
exercise is insufficient to result in altered CD4+ and CD8+ lymphocyte responsiveness 
 (Ronsen et al., 2001c; Ronsen et al., 2002), we show that unaccustomed training over 
several weeks has a suppressive effect on lymphocyte function.    
 
The difference between our results, on blood samples taken at rest, and those of Ronsen et 
al. (Ronsen et al., 2001b), who illustrated no effect of seasonal training on CD4+ lymphocyte 
CD69 expression immediately post-exercise, illustrates the importance of investigating 
changes in immune measures at rest.  In some instances the acute effect of exercise may 
mask chronic changes in the immune status of athletes.  In addition, our results indicate the 
necessity of not only considering mitogen-induced CD69 expression, as previously done by 
other groups, but also spontaneous CD69 expression, for a more comprehensive 
interpretation of data.   
 
Endocrine parameters: Our result of no significant change in any measured endocrine 
parameter assessed at rest (Table 4.1) has previously been established in various studies 
(Kraemer et al., 1989; Urhausen & Kindermann, 1992; Urhausen et al., 1987; Urhausen et 
al., 1995).  However, acute strenuous exercise was shown to decrease peripheral blood 
mononuclear cell (PBMC) sensitivity to exogenous glucocorticoid action, so that a higher 
concentration of dexamethasone was required to inhibit IL-6 secretion in vitro post-exercise 
compared to pre-exercise (DeRijk et al., 1996).  If this reported acute glucocorticoid 
insensitivity of immune cells after exercise becomes chronic with excessive training, an 
unchanged cortisol concentration would be insufficient to suppress inflammation.  This may 
suggest, at least in part, a mechanism for the recent theory that chronic inflammation causes 
overtraining (Smith, 2000). 
 
Although we report no significant change in any endocrine parameter assessed, testosterone 
concentration correlated positively with several lymphocyte subpopulation counts and their 
activation at baseline (Table 4.3). While some studies report a stimulatory effect of 
testosterone on both white and red blood cell counts in sedentary humans (Ellegala et al., 
2003; Palacios et al., 1983), a study in rats reported a stimulatory effect of exogenous 
testosterone on CD8+ cell count only, with no effect on other T cell subpopulation counts 
(Yao et al., 2003). The resultant decrease in CD4+:CD8+ ratio suggested an 
immunosuppressive effect of testosterone.  The results obtained at baseline in the current 
 study support a general, rather than subpopulation-specific, stimulatory effect of testosterone 
on white cell counts, with no effect on CD4+/CD8+ ratio, arguing against the results 
previously obtained in rats, but in agreement with the findings in human studies mentioned 
above.  Furthermore, testosterone concentration at baseline correlated positively with the 
ability of both helper and suppressor T cells to become activated, but all these relationships 
were no longer apparent after training. Given the change in glucocorticoid sensitivity after 
exercise previously reported, one mechanism for the effect of testosterone may be a 
training-related change in T cell steroid receptor binding affinity for testosterone.  
Investigation into chronic alterations in the immune cell steroid receptor profiles of athletes 
after training is needed to further clarify this issue. 
 
The finding that total testosterone concentration represents parallel changes in the fraction of 
unbound testosterone at all time points, is also supported by earlier reports (Kuoppasalmi, 
1980), suggesting that measurement of SHBG is not necessary for interpretation. On the 
other hand, unbound cortisol concentration did not correlate with the concentration of either 
total cortisol or CBG at any time point.  Our results therefore support earlier suggestions 
(Breuner & Orchinik, 2002; Dhillo et al., 2002) that CBG concentration should be considered 
in conjunction with cortisol concentration for a more accurate interpretation of changes in the 
biological activity of cortisol.  However, our data suggest that even this addition to the test 
battery may not be helpful for assessment of athletes.  More complex assays could possibly 
be included, such as assessment of exercise-induced changes in glucocorticoid receptor 
number or binding affinity for cortisol on target cells such as skeletal muscle and 
lymphocytes. 
 
4.5 Conclusion 
 
The results obtained in our study indicate that the decreased lymphocyte proliferative 
response seen after exercise training is the result of decreased responsiveness in both CD4+ 
and CD8+ T cells. Furthermore, our in vitro results illuminate the importance of assessing 
both spontaneous and mitogen-induced responsiveness of immune cells for a more 
comprehensive representation of immune status in athletes. 
 Chapter 5 
 
A profile of selected endocrine and immune parameters in individuals 
exposed to chronic (occupational) psychological stress 
 
5.1 Introduction 
 
Acute exercise has been established as a stressor to both the endocrine and immune 
systems of athletes. In the previous chapter, we reported an increased immune activation 
status at rest after exposure to chronic exercise stress of unaccustomed volume and 
intensity, in athletes.  However, the effects of chronic exercise stress are complicated by the 
inability to separate physical stress from psychological stress, particularly in competitive 
athletes. Psychological stress could include non-physical, occupation-related stress, life 
stressors and the constant psychological pressure on athletes to excel at their chosen sport, 
for both competition ranking and financial reasons.  Therefore, it is necessary to evaluate the 
influence of psychological stress on the endocrine and immune systems, and to compare 
that to typical chronic responses previously reported in athletes.  
 
Short-term psychological stress increases the concentration of circulating cortisol (Gerra et 
al., 2001; Sapolsky et al., 2000).  Similar to results reported in response to acute exercise in 
athletes (Petrides et al., 1997), the cortisol responses to acute experimentally-induced 
psychological stress allowed for division of  subjects into either a high- or a low-responder 
group (Kunz-Ebrecht et al., 2003).  These results, obtained in models of acute stress, 
suggest similar effects of acute psychological and acute physiological stress on the 
activation of the HPA-axis, and thus an additive effect of psychological stress on the overall 
stress status in athletes is likely. However, since the endocrine effects of long-term 
psychological stress are commonly investigated in subjects suffering from stress-related 
illnesses, e.g. chronic fatigue syndrome (Scott et al., 2000) and metabolic syndrome X 
(Pickup et al., 1997), the chronic response to psychological stress in the absence of an 
underlying pathology is unclear.  It is also unclear how the endocrine effects result in the 
pathology, although interactions with the immune system are likely. 
 The immune response to chronic psychological stress in relatively healthy, non-athlete 
populations has been investigated to a certain extent. Prolonged psychological stress 
resulted in dysregulation of immune function in previously healthy individuals, with the 
cytokine response shifting towards a TH2 response (Matalka, 2003). Such a change in 
athletes, if prolonged, may have two undesirable outcomes: firstly, a reduced capacity for 
TH1 function, which is part of the vital early defense system against infection, and secondly, 
a chronic up-regulation of the TH2 response, which may predispose an athlete to 
overtraining. The former may contribute to the increased risk of athletes for URTI, as 
reported in epidemiological studies (Peters & Bateman, 1983; Tomasi et al., 1982), whereas 
the latter may contribute to chronic inflammation, which is hypothesised to be implicated in 
the development of the overtraining syndrome (Smith, 2000). 
 
Our recent studies on athletes indicate that direct, in vitro functional assessments of the 
immune system show changes in response to the stress of racing (Chapter 3) and increased 
training load (Chapter 4). Therefore, one of these may be suitable for monitoring changes in 
immune capacity in response to chronic psychological stress.  Indeed, decreased T cell 
proliferative response has been reported in humans (Lacey et al., 2000) and rats (Stefanski, 
2000; Stefanski & Engler, 1999) after chronic psychological stress.  However, this functional 
test is quite non-specific and the effects of chronic psychological stress on the CD4+:CD8+ T 
cell ratio and their activation status have not been established. 
 
The interpretation of the physiological response to prolonged stress also depends on the 
extent of short-term biological variation.  If the intra-individual day-to-day variation in a 
specific parameter is too high relative to inter-individual variation, it may be difficult to assess 
the physiological response to an acute intervention or to long-term accumulated effects 
(Terblanche et al., 2004).   Therefore, one aim of this study was to determine the extent of 
day-to-day variation in values obtained for selected immune and endocrine parameters in a 
population exposed to chronic stress. Other aims were to determine whether T cell reactivity 
(expression of CD69) was associated with any endocrine parameters in individuals exposed 
to occupation-related chronic psychological stress.  
 
 
 5.2 Methods 
 
Subject recruitment and criteria: Subjects exposed to chronic occupation-related stress were 
recruited via advertisements on bulletin boards in office buildings and via word of mouth.  11 
sedentary male subjects who were not on medication and who had no history of pathology 
(either physiological or psychological) and who had been in their current work positions for 
more than 2 years, were admitted to the study.  All subjects were subjected to a clinical 
assessment by a medical doctor before participation in the study. Athletes and well-trained 
individuals were excluded from this group, to prevent the confounding effects of chronic 
exercise stress.  Ethical approval for the study was gained from the University of 
Stellenbosch Research Sub-Committee B and all subjects gave informed, written consent 
prior to taking part in the study. 
 
Sample collection: Early morning resting, fasted blood samples were collected by 
venepuncture from a forearm vein on two occasions separated by 7 days.  At each time 
point, blood was collected in one EDTA-, one lithium heparin- and one SST Vacutainers (BD 
Systems, Plymouth, UK). Fresh EDTA blood were kept at room temperature and analysed 
for total and differential white cell count by automated analysis (STKS, Beckman/Coulter, 
Fullerton, CA, USA). Fresh heparinised blood samples were kept at room temperature and 
analysed within 4 hours for T lymphocyte subpopulation counts and in vitro spontaneous and 
mitogen-induced activation of helper- and suppressor T lymphocytes (CD69 expression) (for 
detailed description of assay procedure, refer to Appendix A).  SST blood samples were left 
to coagulate at room temperature for 10 minutes, after which they were centrifuged at 3000 
rpm for 10 minutes and frozen at –80 ºC until subsequent batch analysis of cortisol (Access 
B module 81600, Beckman/Coulter), dehydroepiandrosterone-sulphate (DHEAs) (Immulite I, 
Diagnostic Products Corporation, Los Angeles, CA, USA) and testosterone (Advia Centaur, 
Bayer Diagnostics, Leverkusen, Germany) concentrations.   
 
Psychological assessments (in the form of various questionnaires) were used to measure 
stress perception at each time point, as a measure of the actual stress status of each 
individual.  Subjects exhibited an “inverted iceberg” profile according to a profile of mood 
states (POMS) evaluation, i.e. the socre for vigour was decreased in relation to all other 
 parameters measured, which indicates a stressed condition (Morgan et al., 1987; Wughalter 
& Gondola, 1991). This aspect of the study formed part of the baseline measurements of an 
M.Sc. thesis investigating the efficacy of a stress-relief intervention (Saunders, 2002) and will 
not be discussed here.  
 
Statistical analysis: Data were analysed for differences between time points using repeated 
measures ANOVA and Bonferroni post hoc tests. Correlations between parameters, and 
correlations between time points, were assessed by determination of Pearson’s product 
moment correlation coefficients.  The relative influences of intra- and inter-individual 
variability on the repeatability of parameters were determined by calculation of repeatability 
(R) according to techniques described earlier (Krebs, 1999; Lessells & Boag, 1987), using 
the formulas: Rb = sb2/ (sb2 + sw2) and Rw = sw2/ (sb2 + sw2), where Rb and Rw are between-
(inter-) individual and within-(intra-) individual repeatability respectively, and s2 is the 
variance (mean square).   
 
5.3 Results 
 
Subject characteristics are summarised in Table 5.1.   
 
Table 5.1 Characteristics for 11 sedentary subjects. 
Age (yr) 33 ± 6 
Height (m) 1.79 ± 0.05 
Weight (kg) 82.7 ± 11.5 
BMI 25.8 ± 4.0 
 
Values are means ±  SD 
 
Means for all parameters assessed were within the normal range at both time points, with 
the exception of the average CD4+ and CD8+ cell counts, which were slightly lower than the 
reference ranges at time point 2, and the CD4:CD8 ratio which was slightly higher than the 
reference range at both time points (Table 5.2).  Both cortisol and DHEAs concentrations 
were within the respective reference ranges at both time points (Table 5.2). Ratios calculated 
in this study (Table 5.2) were similar to ratios reported (or calculated from cortisol and 
 DHEAs data) for 7-9 am blood samples in the literature (0.08 – 0.10) (Hechter et al., 1997; 
Straub et al., 2002; Villette et al., 1990).    Repeated measures ANOVA showed no main 
effect of time (P = 0.59), and Bonferroni post hoc analysis showed no significant difference 
between the time points in any of the parameters measured. Pearson intra-class correlations 
indicated good correlation coefficients for cortisol, testosterone and DHEAs concentrations 
and the CD4+:CD8+ ratio (R > 0.80; Table 5.2).  Variability for all parameters were high. For 
parameters pertaining to the endocrine system inter-individual variability was much higher 
than intra-individual variability, while for immune parameters inter- and intra-individual 
variability was quite similar, except when considering the CD4+:CD8+ ratio (Table 5.2).  
 
Table 5.2 Immune and endocrine parameters measured at two time points one week apart. 
 Reference ranges Time point 1 Time point 2 Pearson’s R-value 
Inter-
individual 
R 
Intra-
individual 
R 
Cortisol 140 – 650 nmol/L 523 ± 194 559 ± 142 0.84 0.83 0.17 
DHEAs 2.2 – 15.2 umol/L 6.0 ± 2.8 6.1± 2.4 0.94 0.94 0.06 
Cortisol:DHEAs † 0.09 ±  0.03 0.10 ± 0.04 0.76 0.80 0.20 
Testosterone 9.5 - 35 nmol/L 21.9 ± 7.4 19.5 ± 6.2 0.82 0.81 0.19 
Cortisol: 
Testosterone † 25.1 ± 9.6 30.2 ± 7.9 0.75 0.71 0.29 
Total WBC 4000 – 11000 cells/uL 5590 ± 1140 5680 ± 1020 0.62 0.74 0.26 
Total 
lymphocytes 1000 – 4000 cells/uL 2130 ± 460 1770 ± 420 -0.07 0.46 0.54 
CD3 1100 – 700 cells/uL 1473 ± 273 1238± 349 -0.05 0.48 0.52 
CD4 700 – 1100 cells/uL 832 ± 143 692 ± 169 0.25 0.57 0.43 
CD8 500 – 900 cells/uL 548 ± 154 476 ± 189 0.23 0.54 0.46 
CD4:CD8 ratio 1.0 – 1.5 1.6 ± 0.5 1.6 ± 0.6 0.85 0.87 0.13 
NK 200 – 400 cells/uL 371 ± 179 303 ± 143 0.62 0.72 0.28 
Spontaneous 
CD4CD69 † cells/uL 14 ± 7 8 ± 4 0.36 0.45 0.55 
Spontaneous 
CD8CD69 † cells/uL 40 ± 24 24 ± 25 -0.04 0.47 0.53 
Induced 
CD4CD69 † cells/uL 738 ± 229 621 ± 214 -0.20 0.47 0.53 
Induced 
CD8CD69 † cells/uL 386 ± 192 258 ± 136 -0.03 0.47 0.53 
 
Values are means ± SD. † No reference range available 
Statistical analysis: Repeated measures ANOVA, with Bonferroni post hoc tests. Not significant for all 
parameters.  
 Individual values for the two time points were averaged and used for further analysis.  The 
subjects were divided into either a low- or a high-responder group according to their average 
resting cortisol concentrations (low: below 500 nmol/L, n = 5; high: above 500 nmol/L, n = 6), 
so that the average cortisol concentrations were significantly different between the two 
groups (high-responders: 668 ± 55 vs. low-responders: 388 ± 86 nmol/L, P < 0.0001). 
Although the cut-off value of 500nmol/L was arbitrary, there was a clear natural division of 
subjects above and below this concentration. Although average resting DHEAs and 
testosterone concentrations were also significantly higher in high- vs. low-responders, 
cortisol:DHEAs and cortisol:testosterone ratios were not different between the two groups 
(Figure 5.1).   
 
Figure 5.1 Resting (a) DHEAs and (b) testosterone concentrations, as well as the ratios 
between cortisol concentration and (c) DHEAs and (d) testosterone concentrations for 
high- vs. low-responder groups.   
(a)     (b)     
 
 
 
 
 
 
 
 
 
 
(c)     (d) 
 
 
 
 
Values are means ± SD.Statistical analysis: One-way ANOVA with Bonferroni post hoc tests. 
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 A comparison of the immune parameters between time point-averaged values for the cortisol 
high-responder vs. low-responder groups is given in Table 5.3.  One-way ANOVA and 
Bonferroni post hoc analysis indicated a significantly lower spontaneous activation of CD8+ 
cells and a tendency for the same effect in CD4+ T cells in the low-responder group 
compared to the high-responder group. 
 
Table 5.3 Immune and endocrine parameters in the cortisol high-responder group 
compared to that of the cortisol low-responder group. 
 Reference ranges High-responders Low-responders 
Total WBC 4 000 – 11 000 cells/uL 5967 ± 611 5240 ± 1243 
Total lymphocyte count 1 000 – 4 000 cells/uL 2080 ± 270  1800 ± 280  
CD3 1 100 – 1 700 cells/uL 1198 ± 105  1038 ± 282  
CD4 700 – 1 100 cells/uL 700 ± 139  597 ± 243  
CD8 500 – 900 cells/uL 432 ± 71  386 ± 103  
CD4:CD8 ratio 1.0 – 1.5 1.7 ± 0.6  1.6 ± 0.5  
NK 200 – 400 cells/uL 182 ± 50  209 ± 178  
Spontaneous CD4CD69 † cells/uL 14 ± 9* 5 ± 3 
Spontaneous CD8CD69 † cells/uL 35 ± 13** 17 ± 10 
Induced CD4CD69 † cells/uL 583 ± 56 575 ± 267 
Induced CD8CD69 † cells/uL 290 ± 67  243 ± 62  
 
Values are means for two time points ± SD 
Statistical analysis: One-way ANOVA with Bonferroni post hoc tests.   
* P = 0.06; ** P < 0.05, values different between groups 
† no reference range available 
 
5.4 Discussion 
 
This study assessed various endocrine and immune parameters in sedentary individuals 
experiencing stress, at two time points separated by 7 days.  No significant change over time 
could indicate a chronic but stable stress situation.  However, high standard deviations were 
reported at both time points for most parameters assessed (Table 5.2), with magnitudes 
similar to those reported in previous studies by other groups (Green et al., 2003; Ronsen et 
al., 2001c; Vider et al., 2001). All these studies indicated great variation in these parameters, 
 which may have been a factor confounding conclusions.  However, even if intra-individual 
coefficient of variation are high, but inter-individual variability is much higher, it is possible to 
draw conclusions on the adaptability of a parameter (Terblanche et al., 2004). 
 
To assess the relative difference between inter-individual and intra-individual variability, 
repeatability (R) was calculated and revealed that for the endocrine parameters, relative 
inter-individual variability was sufficiently low. However, for immune parameters only the 
CD4+:CD8+ ratio seems to be a robust, repeatable indicator of immune status over time in a 
specific individual.  This result suggests that measurement of lymphocyte subsets and 
activation status may not be repeatable enough to draw firm conclusions, at least not in 
individuals who are subjected to stressors similar to that of the subjects in our study. 
 
Although average cortisol, DHEAs and testosterone concentrations were within the normal 
range at both time points, subjects in our group were clearly not all similar. Thus, considering 
only the average for the whole group may not reveal the full picture. Dividing subjects into 
cortisol high- and low-responders (Figure 5.1) confirms a dual response of cortisol to 
psychological stress similar to that reported previously in the literature in chronically stressed 
individuals at rest (Rosmond et al., 1998), and in response to exercise (Deuster et al., 1999; 
Petrides et al., 1997).   This dual response was previously suggested to be a result of stress 
exposure during a critical time of development, which led to altered responses of the 
nervous, immune and endocrine systems to stressors (Hurwitz & Morgenstern, 2001). This is 
in turn likely to be a result of changes on the level of glucogorticoid receptors, e.g. changes 
in the balance between GR type I and type II (Peters et al., 2004). However, since we did not 
assess GR concentration or binding affinity, we cannot draw conclusions in this regard.  Our 
results also indicate the same dual response for both DHEAs and testosterone, which is a 
novel finding in chronically stressed individuals, although it has been reported in athletes in 
response to exercise (Petrides et al., 1997). 
 
Previously, decreased cortisol:DHEAs  ratio (as low as 0.05) was reported in chronic fatigue 
syndrome patients (Scott et al., 2000), in athletes suffering from the overtraining syndrome 
(Lehmann et al., 1998), and in individuals with AIDS (Villette et al., 1990). The range of our 
results indicate that none of the subjects in the stress group (lowest cortisol:DHEAs  ratio 
 measured was 0.07) suffered from chronic stress to the same extent as the patients with 
pathological conditions.  Also, cortisol:DHEAs ratios in the two groups in our study were not 
different.  Therefore, measurement of the cortisol:DHEAs ratio may be a useful tool to 
monitor extreme stress, but possibly not mild stress.  In a study in elite athletes, average 
cortisol:testosterone ratio was ≈ 32 prior to increased training load, but decreased to ≈ 26 
after the 12-month protocol (Hakkinen et al., 1987). Although there was no significant inter-
group difference in the cortisol:testosterone ratios, the average cortisol:testosterone ratio for 
the high-responders in our study was similar to the ratios obtained before training, and that 
of the low-responders was similar to the average ratio reported after training in the study by 
Hakkinen et al. (1987).  This may suggest that monitoring the decline in cortisol:testosterone 
ratio over time may provide an indication of changes in stress status, which is valid for both 
physical and psychological stress. 
 
Not many studies have investigated the expression of CD69 on T cells, and most of these 
were performed on athletic populations (Green et al., 2003; Ronsen et al., 2001c; Ronsen et 
al., 2002; Vider et al., 2001), or individuals suffering a pathology (Schmid-Ott et al., 2001). 
However, some studies using mononuclear cell cultures of normal healthy people showed 
spontaneous CD69 expression in less than 10% of cells (Mardiney, III et al., 1996; Werfel et 
al., 1997), similar to our results in CD4+ and CD8+ cells of the low-responder group.  The 
significantly higher spontaneous activation status indicated in these immune cell 
subpopulations in the high-responder group, suggests that the divergent stress response 
influences immune function without necessarily influencing cell counts.  It is difficult to draw a 
conclusion about the clinical significance of this finding, since it did not appear to influence 
the ability of the immune cells to become activated in response to an exogenous challenge.  
Due to inter-laboratory differences in technique, e.g. the type of mitogen used to stimulate 
cells in vitro, it is not possible to compare the absolute values of our results to those reported 
in the literature.  Further studies are required to investigate the possibility of other adverse 
effects of a chronically increased spontaneous T cell activation status, e.g. whether this may 
result in a chronic low-grade inflammation.  Also, repeatability of this variable needs to be 
assessed in a healthy, unstressed population, as well as their response to an acute 
psychological stressor. 
 
 5.5 Conclusion 
 
We conclude that in a population whose lifestyle subjects them to psychological stress, 
cortisol concentration alone is not sufficient to indicate the stress status of an individual. 
Rather, DHEAs and testosterone concentrations should be measured in conjunction.  
However, the ratios between concentrations of these parameters and cortisol may be more 
relevant to assess in more extreme situations of stress.   
 
Furthermore, comparing our results to the literature on athletes elucidates various similarities 
in the endocrine and immune system adaptations to chronic psychological and chronic 
exercise stress. Therefore, results obtained and conclusions drawn from studies 
investigating the physiological response to psychological stress may also be applicable to 
exercise stress. 
 
Finally, it became apparent that the extent of intra-individual variability in immune 
parameters relative to the inter-individual variability places severe limitations on the 
conclusions that could be drawn from intervention studies. 
 Chapter 6 
 
The effect of acute immobilisation stress on the concentrations of 
corticosterone, testosterone and selected inflammatory cytokines in 
male Wistar rats 
 
6.1 Introduction 
 
Human studies have investigated the response to psychological stress in both free-living 
situations and in more controlled laboratory-settings. These studies, recently reviewed by 
Matalka (2003), which investigated the response of the endocrine stress-axis and the 
cytokine system to acute psychological stress, report variable responses even to a similar 
stressor (Matalka, 2003).  
 
Acute psychological stress in response to an academic examination was reported to 
increase circulating concentrations of cortisol, IL-6 and TNF-α (Maes et al., 1998).  However, 
under similar conditions in another study, IL-1β concentrations were not increased (Lacey et 
al., 2000), although cortisol concentrations were increased.  These results may seem 
contradictory, but IL-6 is known to down-regulate the concentration of IL-1β in the circulation, 
so that IL-1β is only present early in the inflammatory response to stress. Apart from 
differences in results due to timing of blood samples, multiple other factors may have an 
influence, such as the severity and duration of the stressor (Lacey et al., 2000) and inter-
individual differences in stress perception and adaptation to a stressor (Gerra et al., 2001), 
most of which cannot be eliminated in humans. For example in humans, repeated 
participation in a similar psychosocial stress test in a controlled environment, separated by 
one week, resulted in habituation to the stressor in 12 participants, so that they had a 
reduced ACTH and cortisol response to the second test, while 8 other participants displayed 
a similarly increased ACTH and cortisol response after both tests with no apparent 
adaptation (Gerra et al., 2001).  
 
 Since confounding factors cannot be accurately controlled for or standardised between 
individuals (although a questionnaire may give some indication of perceived stress), human 
studies are often difficult to interpret.  However, a more controlled, standardised stress 
protocol that would be ethically possible in animal studies, should enable clearer 
interpretations of the relationships between cortisol and cytokines in the response to 
psychological stress.  Also, experimental animal populations are relatively homogeneous 
and should therefore exhibit smaller inter-individual variability. 
 
Laboratory rat models of stress include immobilisation, prone restraint, forced swimming and 
inescapable tail shock (Arancibia et al., 2000; Armario et al., 1995; Deak et al., 1999; 
Fleshner et al., 1995b; Garcia et al., 2000; Marti et al., 2001).  Immobilisation stress is one of 
the less extreme and thus most applicable models to relatively healthy humans undergoing a 
stressor for a defined time period per day (e.g. the stress response to exercise training may 
be similar to that after short-duration immobilisation stress in rats). Although studies in rats 
subjected to immobilisation stress consistently report increased corticosterone concentration 
(Armario et al., 1995; Duclos et al., 2001; Garcia et al., 2000; Heiman et al., 1997; Marti et 
al., 2001), and some also report increased pro-inflammatory cytokine release after exposure 
to the stressor (Zhou et al., 1993), much inter-study variation exists, in part due to variations 
in the severity and duration of the stress episode (Garcia et al., 2000; Pitman et al., 1988), 
but also due to variations in sensitivity to stress in different strains of rat (Armario et al., 
1995), and an additive effect of previous chronic stress (Almeida et al., 2000).  Therefore, 
animal models of stress should be validated when first used by a new research group, to 
ensure that the protocol is effective, repeatable and sensitive enough for the purposes of the 
intended investigations, in their hands. 
 
Therefore, in order to establish a relevant animal model for stress in our laboratory, we 
investigated the effect of one 2-hour period of immobilisation stress on the corticosterone 
and pro-inflammatory cytokine response in male Wistar rats.  Particular aims were to 
investigate whether we could prevent a stress effect of the sacrifice protocol in the control 
group, and to determine if the stress was indeed mild and relatively transient, but still 
sufficient to produce a robust stress response in the experimental group. 
 
 6.2 Methods 
 
Experimental animals: 23 male Wistar rats were used in this study. All rats were housed in 
standard rat cages and fed rat chow and tap water ad libitum. Temperature in the housing 
facility was controlled at 21 ºC and lights set to a 12-hour light/dark cycle (lights on at 7 am). 
Rats were bought from a breeding facility and allowed 3 weeks to acclimatise to their new 
conditions before initiation of the study protocol.  Acclimatisation included purposeful 
handling by one researcher only, weighing of the animals once per day, as well as transport 
between experimental rooms in the animal house to accustom the rats to all actions 
necessary for the study protocol, bar the actual stress intervention. 
 
Stress intervention: Rats were divided into three weight-matched groups: a control group (C, 
n = 7), an acute stress group (S, n = 8) and a stress recovery group (R, n = 8).  C underwent 
no intervention, while both S and R were subjected to one 2-hr period of immobilisation in a 
Perspex cage (dimensions 7 cm x 8 cm x 15 cm) designed for this purpose. S rats were 
sacrificed immediately after the immobilisation period. R rats were allowed to recover for 24 
hours after immobilsation before sacrifice. All rats were sacrificed between 10h00 and 
11h00.  Ethical approval for the study was obtained from the Stellenbosch University Sub-
Committee C prior to the start of the protocol. 
 
Sample collection: Rats were decapitated and whole blood collected via a heparinised funnel 
into 5 ml SST Vacutainers (BD Vacutainer Systems, Plymouth, UK). Blood was kept on ice, 
and centrifuged within 20 minutes after collection at 3000 rpm for 10 minutes at 0 ºC.  Serum 
was aliquoted and frozen at –80 ºC for subsequent batch analysis of IL-1β, TNF-α, IL-6 and 
corticosterone concentrations.  
 
Analysis: Commercially available rat-specific ELISA kits were used for determination of IL-1β 
(Biotrak RPN 2743, AEC Amersham Biosciences, UK), TNF-α (865.000.096, Diaclone, 
France), IL-6 (Biotrak RPN 2742, AEC Amersham Biosciences, UK), corticosterone (AC-
14F1, Octeia, Immunodiagnostic Systems, USA) and testosterone (EIA-1559, DRG 
Instruments, Germany) concentrations. 
  
 Data analysis: Differences in corticosterone and cytokine concentrations between groups 
were assessed using one-way ANOVA and Bonferroni post hoc tests (Statistica 6, StatSoft 
Inc, OK, USA). Level of significance was set at P < 0.05.  
 
6.3 Results 
 
Rats in the different groups were matched for body mass at the start of the protocol, but 
immobilisation stress resulted in significant changes in body mass (Figure 6.1).   Mean 
corticosterone concentrations at the time of sacrifice were significantly increased in S vs. C 
and R, but C and R mean corticosterone concentrations did not differ (Figure 6.2a).  Mean 
testosterone concentration was similar in S vs. C, but significantly increased in R in 
comparison to C and S (Figure 6.2b).  The mean corticosterone:testosterone ratio followed a 
similar pattern to that of the corticosterone concentration (Figure 6.2c).  
 
Figure 6.1 Comparison of mean body mass in control rats and in rats subjected 
to acute, short-term immobilisation stress with or without subsequent recovery.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Error bars indicate SEM. 
Abbreviations: C = Control Non-stressed; S = Acutely Stressed; R = 24 hours 
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 Figure 6.2 Effect of acute short-term immobilisation stress and recovery from 
stress on mean a) serum corticosterone concentration, b) serum testosterone 
concentration and c) the corticosterone:testosterone ratio.   
(a) 
 
 
    
 
 
 
 
  
 
(b) 
 
(c)   
 
 
 
Error bars indicate SEM.  
Abbreviations: Cortico, Corticosterone; Testo, Testosterone 
 
IL-6 concentration was below detectable levels in all rats (i.e. less than 15 pg/mL). Also, in C 
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 pg/mL). For illustrative purposes, the samples with concentrations below detectable levels 
were assigned an arbitrary concentration value of 10 pg/mL (Figure 6.3b). Due to the high 
percentages of non-detectable TNF-α concentrations, statistical analysis was not performed 
for this parameter. One-way ANOVA indicated a group effect for IL-1β concentration (P < 
0.00001), and post hoc analysis indicated that IL-1β concentration was significantly higher in 
both S and R compared to C (Figure 6.3a). 
 
Figure 6.3 The effect acute immobilisation stress with or without 24 hr recovery 
on a) IL-1β and b) TNF-α concentrations.   
(a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Error bars indicate SEM. 
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Dotted line indicates detectable concentration limit (20 pg/mL). 
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 to normal, the complex downstream response to stress was not abolished after 24 hours of 
recovery. 
 
Although rats seemed to suffer significant weight loss as an acute result of immobilisation 
(Figure 6.1), the recovering group’s result indicates that the acute effect is quickly reversed, 
since they regained this weight within 24 hours. This weight loss was most probably the 
result of dehydration during exposure to stress from excessive panting, urination and 
diarrhoea.  Cumulative effects of a more chronic protocol of exposure to this relatively mild 
stressor may indeed result in long-term weight loss, since a previous study reported rapid 
increase in somatostatin release from the hypothalamus after only 15 minutes of prone 
(taped-down) restraint stress in Sprague-Dawley rats (Arancibia et al., 2000).  However, the 
latter is a more severe stressor than that used in this study. 
 
The finding of significantly increased corticosterone levels after acute immobilisation stress is 
in agreement with previous studies investigating effects of both chronic (Almeida et al., 1998; 
Almeida et al., 2000; Pitman et al., 1988) and acute stress (Pitman et al., 1988; Strausbaugh 
et al., 1999; Tinnikov, 1999) in rats.  Although the corticosterone concentrations in C rats and 
R rats were similar, acute stress was previously shown to result in greater numbers of 
corticosteroid receptors for more than 24 hours after cessation of the stress, as well as a 
decrease in CBG levels after acute stress (Deak et al., 1999; Fleshner et al., 1995b). 
Therefore, although corticosterone concentrations had themselves returned to baseline after 
24 hours, we cannot exclude the possibility of maintenance of enhanced bioactivity at 
cellular level for longer than 24 hours after stress exposure.   
 
Our result of similar testosterone concentrations in control rats and immediately after stress 
exposure, is in accordance with reports of unchanged testosterone concentrations during 
acute exercise stress exposure in human subjects, with decreased concentrations only 
occurring during the recovery period (Kuoppasalmi et al., 1980).  An earlier study in rats 
reported a decrease from baseline in testosterone concentration in response to 3 hours of 
acute immobilisation (tube restraint) stress (Akinbami et al., 1999), while another reported 
increased testosterone concentration after acute (5 minutes) immobilisation stress (Almeida 
et al., 2000). Since the stress protocol used in the first study was more severe than our 
 protocol, our result and that of Almeida et al. (2000) suggest that a moderate acute stressor 
is not severe enough to negatively influence the testosterone synthetic pathway and may 
even result in up-regulation of testosterone production, while a severe acute stressor may 
result in decreased testosterone production, possibly via a shift away from androgen 
production in favour of corticosteroid production.   Our finding of significantly higher 
testosterone concentration after 24 hours of recovery from 2 hours of immobilisation stress 
(group R) compared to C and S, supports this contention. Furthermore, a study using a rat 
model of chronic social stress (7 days), reported that testosterone concentrations were only 
decreased in bitten loser rats, but either unchanged or increased in winner rats (Stefanski, 
2000), providing further proof that the testosterone response to stress (both acute and 
chronic) is dependent on the intensity of the stressor. 
  
Despite the fact that mean testosterone concentration was higher in R compared to C and S, 
the corticosterone:testosterone ratio followed the same pattern as corticosterone 
concentration. This suggests that the increased testosterone concentration after recovery 
from acute mild psychological stress may not be sufficient to counter the effect of the highly 
increased corticosterone concentration seen immediately after stress exposure. This may 
suggest a cumulative negative effect in the long-term. A model of chronic mild stress could 
possibly elucidate this further.  
 
IL-1β, IL-6 and TNF-α are released in response to stress as a result of neural stress 
perception and cytokine interaction.  (These cytokines perform many similar and overlapping 
functions in response to stress, such as macrophage activation, increased NK cytotoxic 
activity, activation of T and B lymphocytes and release of acute phase reactants (Mackinnon, 
1992), and activation of the HPA-axis (Sapolsky et al., 2000; Watkins, 1994)).  One might 
therefore expect increased levels of all three cytokines after exposure to stress. Indeed, IL-
1β concentrations were increased after acute stress.  This was not unexpected, since IL-1β 
was previously shown to be responsible for enhancing the secretion of CRH, ACTH and 
corticosterone in stressed rats (Berkenbosch et al., 1987; Sapolsky et al., 2000; Watkins, 
1994).   IL-1β is also known to result in up-regulation of IL-6 secretion (Mackinnon, 1992), 
but in this study IL-6 concentrations were below the detectable range in all samples. Since 
our model is one of mild stress only, it is possible that either the intensity or the duration of 
 the stress episode, or both, was not sufficient to result in IL-6 secretion. However, the 
substantial increase in IL-1β argues against this. Rather, it would seem that the peak in IL-6 
concentration was not detected with the timing of sample collection used in this protocol, 
since previous rat studies reported increased IL-6 excretion in urine after only 30 minutes 
(Boucher et al., 2002), and increased plasma IL-6 already after one hour of immobilisation 
(Ishikawa et al., 2001) with the peak reported at 90 minutes during a 2-hour immobilsation 
protocol (Takaki et al., 1994), suggesting an early response and relatively quickly clearance 
compared to the other cytokines assessed in this study.    
 
Previous reports in humans indicate that TNF-α concentration may increase within one hour 
after exercise stress exposure (Espersen et al., 1990; Madrigal et al., 2002), but that the 
magnitude of change is often too small to be detected by ELISA (Ullum et al., 1994). The fact 
that most rats in C and S had TNF-α levels below the detectable range confirms this and 
suggests that circulating TNF-α is not a useful marker of acute psychological stress in rats.   
 
The high IL-1β levels 24 hours after cessation of stress may suggest incomplete recovery 
from the acute stressor. However, although chronic exercise stress in humans is associated 
with chronically elevated IL-1β concentration at rest (Evans et al., 1986), an acute bout of 
exercise resulted in either no significant change in IL-1β concentration (Evans et al., 1986), 
or return to baseline levels within 9 hours of recovery (Cannon et al., 1986).  However, the 
assays used in these relatively old studies, was much less specific compared to modern 
assay methods. Since our protocol involved one acute episode of stress only, it is unlikely to 
result in a chronically elevated IL-1β concentration. Also, most rats in R had comparatively 
higher TNF-α concentrations.  Therefore, it is more likely that the rats associated their 
weighing prior to sacrifice with the weighing prior to subjection to the stress protocol the 
previous day, despite the fact that they were handled and weighed prior to starting the 
protocol as well. This neural stress perception may have resulted in an acute stress 
response and therefore increased TNF-α concentrations just prior to decapitation in this 
group.  However, since rats were sacrificed within one minute of removal from their cages, 
only the cytokines released very early in response to stress would be elevated, explaining 
why downstream parameters such as IL-6 and corticosterone concentrations were not yet 
elevated.  This result however questions the usefulness of using rats in studies investigating 
 recovery from acute stress exposure, because unlike human subjects, they cannot be 
informed that no further stress challenge will take place.  Nevertheless, the slightly delayed 
nature of the corticosterone response would allow for this more robust marker of stress to be 
used in laboratories that have validated their expertise in using such a model. 
 
6.5 Conclusion 
 
The protocol used to induce psychological stress indeed resulted in increased secretion of 
upstream pro-inflammatory cytokines (IL-1β) as well as the major anti-inflammatory hormone 
(corticosterone) immediately following a two-hour stress exposure.  Also the control rats 
were truly habituated and unstressed by human handling.  The mild nature of the stressor is 
indicated by the return of corticosterone concentrations to baseline after 24 hours, and the 
fact that testosterone concentration was not depressed.  However, if the aim of a future 
study is to investigate the response of downstream cytokines, e.g. IL-6, blood samples 
should possibly be taken via an indwelling catheter, to allow multiple blood sampling time 
points.   
 
6.6 Limitations 
 
The use of an assay kit using a monoclonal antibody directed against IL-6 is a possible 
confounder in this study, since lower concentrations of IL-6 could not be detected. Use of a 
polyclonal antibody or a high-sensitivity assay kit would possibly allow for more accurate 
data pertaining to IL-6 concentration, especially when the concentration is very low. 
However, neither a polyclonal antibody, nor a high-sensitivity kit specific for rat IL-6 was 
available at the time of the study.  Although more sensitive kits are available (e.g. from 
Biosource), these kits are only suitable for use in a semi-automated analysis using 
specialised instrumentation (so-called “bead-systems” such as LuminexTM and MultiplexTM) 
which were not available to us.  
 Chapter 7 
 
The efficacy of Sutherlandia frutescens supplementation to reduce 
stress levels in rats subjected to chronic intermittent immobilisation 
stress 
 
7.1 Introduction 
 
Two of the most severe and common chronic diseases, cancer and HIV/AIDS, result in 
heightened activation of the hypothalamic-pituitary-adrenal (HPA) –axis and therefore 
chronically increased blood cortisol concentration (Christeff et al., 2000; Clerici et al., 1997; 
Costelli et al., 1993). The long-term effects of raised cortisol include decreased capacity of 
the cellular immune response (Hässig et al., 1996), chronic inflammation due to 
glucocorticoid insensitivity (Miller et al., 2002),  and increased muscle catabolism (Gore et 
al., 1993; Woolf, 1992).  All these effects result in chronically decreased standard of living.  
Considering the high cost of most commercial (synthetic) medicines prescribed for 
symptomatic treatment, it is of extreme importance to find a less expensive treatment for 
these debilitating symptoms. A natural remedy, Sutherlandia frutescens, has been used in 
traditional medicine in South Africa for many decades, for the treatment of stress-related 
illnesses (Van Wyk et al., 1997; Van Wyk & Gericke, 2000). 
 
Some of the components of the Sutherlandia frutescens plant, identified through chemical 
analyses (Brümmerhoff, 1969; Levy et al., 1999; Moshe, 1999; Viljoen, 1969), include L-
canavanine, gamma-aminobutyric acid (GABA) and pinitol.  The individual effects of these 
compounds have been illustrated in previous studies on rats: L-canavanine had anti-viral 
(Green, 1988) and anti-cancer action (Crooks & Rosenthal, 19940; Swaffar et al., 1995), and 
was proved to be a selective inhibitor of inducible nitric oxide synthase (Anfossi et al., 1999), 
which has been used effectively to treat endotoxic shock in rats (Levy et al., 1999). GABA is 
an inhibitory neurotransmitter and is known for having mood elevating properties. Pinitol has 
anti-inflammatory properties (Singh et al., 2001). Although the individual actions of these 
substances are known, the combined palliative effects of these substances in one compound 
have not been investigated before.  Nevertheless, a toxicology study in vervet monkeys 
 (Seier et al., 2002; Seier, 2002) has shown that Sutherlandia leaves, even at nine times the 
recommended dose, had no toxic or any other side effects with regard to haematological and 
biochemical parameters measured.   
 
The native words for this herb, “motlepelo” (Sotho for “bringing back the heart”), “insiswa” 
(ancient Zulu word meaning “the one which dispels darkness”) and “unwele” (Zulu for “hair” – 
alluding to the fact that the plant stops people from “pulling out their hair” with distress) are 
indicative of the main effect claimed – to relieve symptoms such as irritability, anxiety and 
depression.  Although much anecdotal evidence exists to validate this herb as having 
medicinal properties (Rood, 1994; Van Wyk et al., 1997; Van Wyk & Gericke, 2000), to our 
knowledge, no scientific proof exists of its action.   
 
Therefore the aim of this study was to determine the effects of daily supplementation with an 
extract of Sutherlandia frutescens subs. microphylla on selected serum hormone (both 
anabolic and catabolic) and cytokine levels, in a rat model of chronic immobilisation stress.   
 
7.2 Methods 
 
Experimental groups: Forty adult male Wistar rats (average body mass of 376 ± 40 g at start 
of intervention protocol) were used in this study. All rats were housed in groups of 4 in 
standard plastic-bottomed wire mesh cages with a 12-hour light-dark cycle. Rats were fed rat 
chow and tap water ad libitum. All rats were allowed 4 weeks to acclimatise after transport to 
the animal house, before commencing with the stress intervention and supplementation 
protocols. 
 
Rats were divided into four mass-matched groups (n = 10 for each group). Two groups 
represented the control groups. One of these received supplementation with Sutherlandia 
extract (CS), while the other received supplementation with placebo (isotonic saline) (CP) for 
the same period of time. The third and fourth groups were subjected to chronic 
immobilisation stress in addition to receiving either Sutherlandia extract (IS) or placebo (IP).  
 
 Interventions: All rats were weighed and handled once a day for 3 weeks before the start of 
the immobilisation protocol to accustom them to humans, preventing stress caused by 
(unaccustomed) handling from being a confounding factor in this study. Immobilisation was 
achieved by placing rats individually into small Perspex cages (dimensions 7 cm x 8 cm x 15 
cm) designed for this purpose, which do not allow free movement. Duration of immobilisation 
sessions was 2 hours, once daily, for 28 consecutive days.  
 
Commercially available Sutherlandia is sold as 700 mg tablets, each containing 300 mg 
Sutherlandia leaf powder. Manufacturers of these tablets (Phyto Nova (Pty) Ltd, Noordhoek, 
Cape Town) recommend a dose of one tablet twice daily. This recommended dose of 
commercially available Sutherlandia leaf powder equals 9 mg/kg body mass for humans. 
This corresponds to a daily dose of about 3.4 mg/rat/day, which was rounded up to 4 
mg/rat/day, to allow for weight gain during the study protocol. Specimens of Sutherlandia 
were harvested in the vicinity of Murraysburg, Western Cape Province, South Africa, and 
identified as Sutherlandia frutescens subspecies microphylla by Professor Ben-Erik van 
Wyk, of the Botany Department of Rand Afrikaans University (Voucher specimen from Mrs 
Grobler: C. Albrecht s.n sub B-E van Wyk 4126 (JRAU)).  Since the traditional way of 
administration is in the form of an herbal infusion, a warm water extract was prepared:  
boiling water was added to dried Sutherlandia leaves (8 mg/mL) and left to infuse overnight 
at room temperature. The infusion was not filtered, as this might have resulted in removal of 
an active component, but poured through a sieve to remove any bigger leaf particles. 
Hereafter, the extract was diluted 1:2 with 1.7 % saline to result in an extract of 4 mg/mL in 
isotonic saline. Placebo consisted of a solution of sterile 0.85 % saline. Since the 
Sutherlandia extract has a bitter taste, rats will not voluntarily ingest it, and forced oral 
administration would represent an uncontrolled additional stressor. Therefore, all rats were 
subjected to intraperitoneal injection twice per day, of either 0.5 ml of 0.85 % saline (CP and 
IP) or 0.5 ml of Sutherlandia extract (CS and IS).  The dosage of Sutherlandia used in this 
study was not adjusted to compensate for the higher metabolic rate of rats compared to 
humans. However, treatment was administered just prior to stress exposure, which was 
intermittent rather than constant as in humans, so that any preventative effect of 
Sutherlandia on the stress response would still occur despite the relatively faster metabolism 
of the compound. 
 Sample collection: At the end of the protocol, all rats were sacrificed between 11h00 and 
13h00 by decapitation. All rats were sacrificed in a rested state, i.e. 24 hours after the last 
stress or treatment intervention. Rats were taken from the housing cage one at a time, 
placed into a weighing basket and carried to another room, where it was weighed and then 
decapitated. (The sacrifice process, from removal from the cage to decapitation took less 
than 1 minute per rat.) Whole blood collected by exsanguination from the aorta, into SST 
blood collection tubes (BD Vacutainer Systems, Preanalytical Solutions, Plymouth, UK). 
Blood was allowed to clot at room temperature for 10 minutes, after which it was centrifuged 
at 3000 rpm for 10 minutes at 4 °C, and the serum aliquoted and frozen at –80 °C until 
subsequent analysis.   Between subsequent sacrifices, all traces of blood and animal waste 
was removed from the room, and the working area disinfected with the disinfectant routinely 
used to clean housing cages, to prevent acute stress in rats just prior to sacrifice. 
 
Analysis: Serum samples were analysed for corticosterone concentration by radio-
immunoassay (Biotrak RPA 548, Amersham), testosterone concentration by immunoassay 
(Advia Centaur, Bayer Diagnostics) and IL-6 and TNF-α concentrations by ELISA (Biotrak 
RPN 2742 and RPN 2734, Amersham). Data were analysed using 2-way ANOVA with Fisher 
post hoc tests to assess differences between subgroups. Relationships between variables 
were assessed using Pearson correlations. 
 
7.3 Results 
 
Effects of Sutherlandia treatment, stress and interaction of supplementation and stress on 
blood parameters are illustrated in Table 7.1 and Figure 7.1. 2-way ANOVA indicated no 
significant main effect of Sutherlandia treatment alone. There was however a significant 
main effect of stress on both corticosterone (P < 0.05) and testosterone (P < 0.05) 
concentrations, associated with a significant change in corticosterone:testosterone ratio (P < 
0.01), as well as a significant effect of interaction of stress and Sutherlandia treatment on 
serum corticosterone concentration (P < 0.005) (Table 7.1).  
 
 Table 7.1 Effects of stress, Sutherlandia treatment and interaction on concentrations of 
parameters measured.  
 
 Corticosterone (ng/mL) 
Testosterone 
(nmol/mL) C:T ratio 
IL-6 
(pg/mL) 
Treatment NS NS NS NS 
Stress P < 0.05 P < 0.05 P < 0.01 NS 
Stress x Treatment P < 0.005 NS NS NS 
         
Statistical analysis: Values are P- values obtained by 2-way ANOVA analysis. 
Abbreviations: C:T = Corticosterone:Testosterone  
 
Fisher’s post hoc analysis indicated significantly higher corticosterone concentration in IP vs. 
CP (P < 0.001), and significantly lower corticosterone concentration in IS vs. IP (P < 0.05; 
Figure 7.1a). Despite the (conservative) ANOVA result of no effect of Sutherlandia treatment 
alone on corticosterone concentration, which were most probably as result of large inter-
individual variations in all four groups, post hoc analysis indicated that corticosterone 
concentration was significantly higher in CS vs. CP (P < 0.05; Figure 7.1a).  Both CP and CS 
had significantly higher testosterone concentrations compared to IS (P < 0.01 and P < 0.05; 
Figure 7.1b), while the corticosterone:testosterone ratio were significantly higher in IP vs. CP 
(P < 0.05; Figure 7.1c).  
 
Figure 7.1 Serum concentrations of (a) corticosterone, (b) testosterone and (c) the 
corticosterone:testosterone ratio.  
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Error bars indicate SD.  
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Statistical analysis: P-values indicate significant 
differences obtained by Fisher post hoc analysis that 
followed 2-way ANOVA. 
 
IL-6 concentration showed a high level of inter-individual variation and was not significantly 
different from the others in any group (Figure 7.2). TNF-α concentration was below 
detectable levels (< 10 pg/mL) in all samples.   
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 Figure 7.2 Box-plot analysis of serum IL-6 concentrations.  
    
 
 
 
 
 
 
 
 
 
 
 
           
 
 
 
 
 
Boxes indicate mean ± SEM, error bars indicate SD, circles indicate 
outliers and triangles indicate extreme outliers. 
 
7.4 Discussion 
 
We reported increased cortiscosterone concentrations after a single exposure to 
immobilisation stress in rats in Chapter 6.  Also, intermittent immobilisation of rats is 
frequently used as a model for inducing mild but physiologically significant stress (Almeida et 
al., 1998; Hu et al., 2000; Pellegrini et al., 1998; Pitman et al., 1988). Therefore, the finding 
in the current study that stress significantly increased basal serum corticosterone 
concentration (P < 0.05; Table 7.1) was expected.  Although a single exposure to mild 
psychological stress only transiently decreased testosterone concentrations in a previous 
study by our group (Chapter 6), the finding that chronic stress resulted in a decreased basal 
serum testosterone concentration (P < 0.05; Table 7.1), is in accordance with results from 
previous studies (Akinbami et al., 1999; Kostic et al., 2000; Pellegrini et al., 1998). 
 
In addition, we present two main novel findings: Firstly, that Sutherlandia treatment 
decreased the corticosterone response to chronic intermittent immobilisation stress, and 
secondly, that Sutherlandia treatment in control rats increased basal corticosterone 
concentrations in these rats when compared to control placebo-supplemented rats. The first 
main finding, of an attenuated corticosterone response to stress, supports the indigenous 
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 knowledge that Sutherlandia has stress-relieving properties. However, further investigation is 
necessary to establish the exact mechanism by which this is achieved. Possible target 
tissues for an anti-stress function of the herb include the hypocampus (down-regulated 
stress perception), the hypothalamus or pituitary gland (down-regulation of HPA-axis 
activation) and the adrenal gland (down-regulation of corticosterone production). Since the 
herb has not been fully characterised and all the active ingredients are not yet known, it is 
too early to speculate further on possible mechanisms. 
 
The second main finding has more than one possible explanation. Firstly, the herb was 
prepared in the traditional way, after which it was filtered through a coarse sieve (pore size 
0.5mm), but not sterilised, since sterilisation at high temperature held the possibility that an 
as yet unknown active substance may have been inactivated. Similarly, filtration could 
possibly remove a larger molecule from the extract. The Sutherlandia infusion was then 
administered by intraperitoneal injection, and not via the upper digestive tract, as it would 
traditionally be ingested (reasons discussed in methods section). The possibility therefore 
exists that the herb may have elicited an inflammatory response, resulting in increased basal 
corticosterone concentrations, compared to placebo-controls, which received sterile saline. 
However, TNF-α concentrations was below detectable levels in all samples, and IL-6 
concentrations in the treated control rats were not significantly different from the other 
groups, arguing against a chronic inflammatory state at the time of sacrifice. A second, more 
likely explanation, is that the Sutherlandia herb acts as an adaptogen (a substance 
increasing the body’s ability to adapt and increase its resistance to stress and disease, 
changing the course of an illness into a favourable outcome by normalising body functions), 
bringing about a more functional basal corticosterone concentration through allostasis.  
Allostasis is the term used to describe the process of maintaining homeostasis by means of 
multiple interacting adaptive processes (Goldstein & McEwen, 2002), which may be 
achieved by combinations of mediators, produced by the immune system, autonomic 
nervous system and the HPA-axis (McEwen, 2002; McEwen & Seeman, 1999).The fact that 
the average basal corticosterone and IL-6 concentrations in the two Sutherlandia groups are 
similar, despite the fact that one group was also subjected to immobilisation stress, supports 
this idea.   However, the mechanism(s) by which this result is achieved is not yet known, and 
is unlikely to be elucidated while using the “intact” extract administered as treatment in this 
 study: Sutherlandia is a compound with several active substances which may be role-players 
in the corticosterone response, as discussed in the introduction.  Furthermore, some as yet 
unidentified role players may also come into play. Therefore, future studies should focus on 
investigating these substances individually after extraction and isolation (if possible), to more 
clearly determine the possible interactive pathways that resulted in the results reported here. 
 
While acute stress is known to increase both IL-6 (Maes et al., 1998; Nukina et al., 1998) 
and corticosterone levels (Armario et al., 1995; Nukina et al., 1998), these increases in IL-6 
levels are inversely related to the increases in glucocorticoid levels (Kunz-Ebrecht et al., 
2003) and short-lived, due to the anti-inflammatory action of the increased circulating 
corticosterone produced during stress (Li et al., 2000).  However, chronic stress is known to 
result in glucocorticoid insensitivity of monocytes, resulting in chronically increased IL-6 
concentration (Miller et al., 2002). Our result of no significant difference in IL-6 concentration 
between experimental groups seems to differ from the available literature.  However, taking 
into account the high inter-individual variation reported for IL-6 in this study (Figure 7.2) and 
in the literature (Lenczowski et al., 1997; Tsirpanlis et al., 2004), the relative small sample 
number used in the current study may have masked effects of Sutherlandia treatment and 
chronic intermittent stress on secretion of IL-6.  Further studies on the acute cytokine 
responses to Sutherlandia treatment, possibly using larger sample numbers, are required to 
investigate this possibility.  A more sensitive assay method should also be used (a high-
sensitivity kit for rat blood is currently not available).  Furthermore, the phasic release of 
TNF-α secretion, as well as its down-regulation by both IL-6 (Nukina et al., 1998; Xing et al., 
1998) and glucocorticoids (Fantuzzi et al., 1995), may account for the non-detectable levels 
of TNF-α reported here.    
 
The suppressive effect of stress alone on testosterone levels (P < 0.05; Table 7.1) and the 
resultant effect of increasing the corticosterone:testosterone ratio (P < 0.01; Table 7.1) may 
be due to inhibition of the nocturnal rise in testosterone levels by glucocorticoid action (Doerr 
& Pirke, 1976). Although Sutherlandia treatment did not appear to have any direct effect on 
testosterone levels when compared to control rats (Table 7.1 & Figure 7.1b), small sample 
size and large inter-individual variation may mask such an effect in the current study. This 
issue warrants further investigation, since it is of particular importance in chronic illness to be 
 able to maintain testosterone levels, since it is vital for tissue growth and recovery (Bhasin et 
al., 1996; Bhasin et al., 2001).   
 
7.5 Conclusion 
 
Our data for the first time confirms scientifically the indigenous knowledge that the 
Sutherlandia frutescens herb has stress-relieving properties. In addition, our results indicate 
the necessity for further investigations of the effects of this herb, since it appears to have a 
complex mechanism of action and may therefore prove to be appropriate for other illnesses 
as well. 
 
7.6 Acknowledgements 
 
We would like to thank Dr. Carl Albrecht for donation of the dried Sutherlandia leaf specimen 
used in preparation of the experimental extract.  
 Chapter 8 
 
Effect of in vivo administration of an anti-IL-6 antibody on the response 
of selected endocrine and immune parameters to short-term 
intermittent immobilisation stress in rats 
 
8.1 Introduction 
 
The effect of psychological stress on the immune system is complex and incompletely 
understood. Acute social stress in rats was previously shown to depress T cell count after 2 
hours, and to a lesser extent after 48 hours of constant stress exposure. The in vitro 
mitogen-induced T cell proliferative response followed the same pattern and was depressed 
after 2 hours, but not after 48 hours of stress (Stefanski & Engler, 1998). However, impaired 
T cell-dependent antibody production was recently reported after 6 weeks of chronic 
psychological stress of greater severity, in a murine model of chronic mild depression 
(Silberman et al., 2004). This change was not related to the circulating total glucocorticoid 
concentration, which remained unchanged.  This suggests either an increase in T cell 
sensitivity to stress hormones, or an alternative indirect mechanism for the effect of 
glucocorticoids, possibly via cytokine action, on T cell function after chronic stress.   
 
Acute psychological stress is known to result in increased release of inflammatory cytokines 
in humans (Maes et al., 1998) and in rats (Mastronardi et al., 2001).  Apart from triggering 
the release of cortisol (Vander et al., 1998a), IL-6 has also been shown to inhibit the 
synthesis of cortisol binding globulin (CBG) in culture (Bartalena et al., 1993), which 
suggests an additional role for IL-6 in enhancing bioavailability of cortisol. These results 
suggest a role for cytokines, and in particular IL-6, in regulating both the secretion and 
downstream effects of cortisol in response to stress.  However, these relationships are 
complex and may be complicated by additional regulatory factors, e.g. IL-1β, which has a 
role in the stimulation of cortisol production and is in turn down-regulated by cortisol.  
Contrary to the role of IL-6 as a stimulator of cortisol release, increases in IL-6 concentration 
was shown to be inversely associated with that of cortisol concentration in response to 
 chronic mild psychological stress in humans (Kunz-Ebrecht et al., 2003).  We suggest that 
this may have been due to negative feedback.  
 
Considering the known negative effects of cortisol on inflammation and immune cell function 
(Genuth, 1983a; Vander et al., 1998a), it is important to establish more clearly the 
mechanism of this hormone’s effects on the immune system, including both cytokines and 
immune cells. However, very few in vivo studies have investigated the effect of stress on 
cytokines in conjunction with both endocrine and immune parameters.  Recently, the 
possibility of blocking the effects of one or another cytokine in the cascade of the 
inflammatory response has become possible by either using knockout models, e.g. an IL-6 
knockout mouse model (Xing et al., 1998), or administration of antiserum or antibody, e.g. 
antibodies directed against IL-6 (Arruda et al., 2000; Marby et al., 2001). Such studies, 
although not close to in vivo physiological models of imposed stress, can illuminate our 
understanding of the complex responses to stress or illness.  
 
In a rat model of meningitis, treatment with anti-IL-6 antibodies resulted in a decreased 
immune response to the disease (fewer WBC in cerebrospinal fluid) (Marby et al., 2001), 
indicating a direct role for IL-6 in up-regulation of WBC proliferation. In IL-6 knockout-mice, 
TNF-α concentrations were higher after experimental endotoxemia (LPS injections) 
compared to those in IL-6 intact mice (Xing et al., 1998).  Since IL-1 is the primary stimulus 
for TNF- α production and is also known to be upstream of IL-6 secretion (Roitt, 1994), this 
led to the conclusion that IL-6 normally limits the up-regulation of TNF-α and possibly other 
pro-inflammatory cytokines.  However, in the absence of other circulating immune and 
stress-endocrine measurements, the significance of this result is difficult to interpret.  
Although it is clear from the above literature that cytokines are an important link in the 
disease-induced immune response, the exact mechanisms and role-players, and also their 
roles in response to milder psychological stressors, are still very unclear.   
 
Therefore, the aim of this study was to induce a stress response in rats, while blocking the 
function of IL-6, to determine a) the role of this cytokine in the inflammatory stress response, 
b) its effect on immune cell function, and c) the responses of other cytokines, e.g. IL-1, and 
their downstream functions in the absence of IL-6. 
 8.2 Methods 
 
Experimental animals: 40 male Wistar rats were used in this study.  Rats were housed in 
standard rat cages (6x7x18cm) and fed rat chow and tap water ad libitum. Temperature in 
the housing facility was controlled at 21 ºC and lights set to a 12-hour light/dark cycle (lights 
on at 7am). Rats were bought in from a breeding facility and allowed 3 weeks to acclimate 
before initiation of the study protocol, during which time they were handled and weighed 
once per day (7 times per week) to accustom them to this procedure.   
 
Preparation of anti-IL-6 antibody treatments: An antibody raised in goats immunised with 
purified E.coli-derived recombinant rat IL-6 (AF506, R&D Systems, Germany) was used as 
intervention treatment in this study. 100 ug lyophilised antibody was reconstituted with 1 mL 
sterile PBS, according to manufacturer’s instructions, to yield an antibody concentration of 
0.1 mg/mL. This stock solution was further diluted in sterile PBS to yield a final concentration 
of 2 ug/mL, so that an injection of 0.5 mL per day would result in a dose of 1 ug/rat/day of 
anti-IL-6 antibody, in accordance with the manufacturer’s indicated neutralisation dosage, as 
well as with previous studies (Arruda et al., 2000; Hogan et al., 2003).  This solution was 
kept at 4 ºC for the duration of the protocol (stable for one month at this temperature, 
according to manufacturer). 
 
Intervention: Rats were divided into four experimental groups of 10 rats each: control 
placebo (CP), control antibody (CA), immobilisation placebo (IP) and immobilisation antibody 
(IA).  Placebo rats (CP and IP) were injected intraperitoneally with 0.5 mL of sterile isotonic 
saline once per day, and antibody rats (CA and IA) were injected intraperitoneally with 0.5 
mL of anti-IL-6 antibody, prepared as described above.  In addition, immobilisation rat 
groups were subjected to immobilisation stress once per day, using the protocol described in 
Chapter 6.  Both the injection treatment and immobilisation stress protocols lasted 4 days, 
after which rats were sacrificed by decapitation. 
 
Sample collection: Whole blood was collected by exsanguination, via a heparinised funnel, 
into one lithium heparin and one SST Vacutainer tube (BD Systems, Plymouth, UK).  The 
heparinised blood was analysed for total and differential white blood cell counts and 
 mitogen-induced PBMC IL-6 secretion in vitro.  SST blood was centrifuged at 3000 rpm for 
10 minutes at 0 ºC, before being aliquoted and frozen at –80 ºC for subsequent batch 
analysis of IL-1β, TNF-α, IL-6 and corticosterone concentrations. 
 
Sample analysis: All analyses on fresh blood were performed within 3 hours of collection. 
500 uL of heparinsed blood was decanted immediately into a 1.5 mL reaction vial 
(Eppendorff, Sigma) for determination of a total and differential white blood cell count, 
performed by automated analysis in a professional veterinary pathology laboratory (Pathcare 
Vetcare, Parow).  The rest of the blood was used to determine the ability of PBMCs in 
culture to secrete IL-6 both spontaneously (no added stimulation) and in response to 
mitogen (E. coli LPS) stimulation, using an adaptation of an earlier method used for 
investigations in human blood (Pool et al., 1998; Pool, 1999) (refer to appendix C for details 
of the assay procedure).  Values obtained for spontaneous stimulation are termed 
“spontaneous IL-6 release”, while those termed “mitogen-induced IL-6 release” reflects the 
concentration of IL-6 released when stimulated with LPS, after subtraction of the 
spontaneously released concentration, so that it represents only the extra amount of IL-6 
secreted as result of the mitogen stimulus. 
 
Commercially available ELISA kits were used for determination of serum IL-1β (Biotrak RPN 
2743, AEC Amersham Biosciences, UK), TNF-α (865.000.096, Diaclone, France), IL-6 
(Biotrak RPN 2742, AEC Amersham Biosciences, UK) and corticosterone (AC-14F1, Octeia, 
Immunodiagnostic Systems, USA) concentrations. 
 
Statistical analysis: Effects of interventions were assessed by ANOVA and differences 
between experimental groups determined with Bonferroni and Tukey-Kramer post hoc tests. 
Correlations between parameters measured were determined by Pearson’s correlations. 
 
8.3 Results 
 
Average change in body mass was calculated for days 1-4 before the start of the intervention 
protocol, as well as for the 4 days of the intervention protocol. Average change in body mass 
was similar in all groups during the 4 days before entry into the study, and groups had similar 
 average body masses on day 1 of the intervention protocol (means ± SD: CP: 519 ± 57, CA: 
509 ± 33, IP: 517 ± 47 and IA: 498 ± 67 g).  Both groups subjected to immobilisation stress 
lost a significantly greater percentage body mass during the intervention protocol compared 
to the non-stressed groups (Figure 8.1).  The non-significant decrease in body mass in 
control rats may be ascribed to a very mild stress effect of the placebo injections 
administered (also refer to discussion). 
 
Figure 8.1 Percentage change in body mass for 4 days before the start of the intervention 
protocol vs. during the 4 days of the intervention protocol.  
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Values are means ± SEM.  
Statistical analysis: P-values were obtained with Bonferroni post hoc analysis.  
Abbreviations: CP = Control, Placebo treated; CA = Control, Anti-IL-6 antibody treated; 
IP  = Immobilised, Placebo treated; IA = Immobilised, Anti-IL-6 treated 
 
Mean corticosterone concentration was significantly higher in IP vs. both CP and CA (Figure 
8.2). Although this increase tended to be ameliorated in IA, mean corticosterone 
concentration of IA was not different from any other group.  
 Figure 8.2 Differences in corticosterone concentration between experimental groups. 
 
 
 
 
 
 
 
 
Values are means ± SEM. Statistical analysis and abbreviations as for Figure 8.1. 
 
IL-6 concentration was below the detectable level in all but four samples, and TNF-α was 
detectable in only two (different) samples. However, IL-1β concentration was significantly 
lower in IA when compared to all other groups (Figure 8.3). 
 
Figure 8.3 Differences in serum IL-1β concentrations between experimental groups. 
 
 
 
 
 
 
 
 
Values are means ± SEM. Statistical analysis and abbreviations as for Figure 8.1. 
 
Total and differential WBC counts were similar for all experimental groups (Table 8.1).  
 
Table 8.1 Total and differential WBC counts at sacrifice.  
 CP CA IP IA 
WBC (x109/L) 8.4 ± 0.8 9.8 ± 0.4 8.4 ± 0.6 7.8 ± 0.4 
Neutrophils (x109/L) 0.8 ± 0.2 0.9 ± 0.2 0.7 ± 0.1 1.0 ± 0.3 
Lymphocytes (x109/L) 7.2 ± 0.7 8.6 ± 0.5 7.3 ± 0.6 6.6 ± 0.5 
Monocytes (x109/L) 0.15 ± 0.07 0.15 ± 0.05 0.15 ± 0.06 0.10 ± 0.05 
 
Values are means ± SEM.  Statistical analysis and abbreviations as for Figure 8.1. 
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 Although spontaneous in vitro IL-6 release by PBMCs was not influenced by the study 
protocol (Figure 8.4a), treatment with anti-IL-6 antibody was associated with significantly 
increased IL-6 release from PBMCs after 24 hours of incubation (P < 0.05).  Although the 
treatment effect was significant, post hoc analysis indicated a more robust difference from 
non-treated groups in CA than IA, for both absolute IL-6 release (Figure 8.4b), as well as IL-
6 release expressed relative to PMBC count (CP: 31.0 ± 8.1, CA: 72.4 ± 16.1, IP: 31.8 ± 
16.9, IA: 47.6 ± 15.8 pg/cell x 106 ).    
 
Figure 8.4 Effect of in vivo anti-IL-6 treatment on (a) spontaneous and (b) mitogen-
induced secretion of IL-6 by PBMCs in plasma-replaced blood culture, after 24 hours of 
incubation.  
(a)  
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
Values are means ± SEM 
 Statistical analysis and abbreviations as for Figure 8.1. 
 
 
LPS-induced IL-6 secretion in vitro was positively correlated with serum IL-1β concentration 
in both antibody-treated groups (Table 8.2).  While serum corticosterone concentration was 
positively correlated with LPS-induced secretion of IL-6 in CP, this relationship was lost after 
intervention with either antibody, or immobilisation, or both (Table 8.2). 
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 Table 8.2 Correlations between LPS-induced IL-6 secretion by PBMCs in culture and 
serum IL-1β and corticosterone concentration.  
 
 
 
Values are R-values. 
* P < 0.05 
 
8.4 Discussion 
 
The main findings we report here are a) significant loss of body mass in response to short-
term intermittent mild psychological stress, b) immobilisation-induced increases in 
corticosterone secretion that were at least partially dependent on the presence of IL-6, c) 
decreased basal serum IL-1β concentration after stress exposure combined with blocking of 
IL-6, that was not apparent at all without stress, and d) a positive correlation between basal 
serum IL-1β concentration and LPS-induced PBMC function in vitro after blocking of IL-6, a 
finding that was independent of stress. 
 
Similar to earlier results by our group (refer to Chapters 6 & 7) as well as other research 
groups (Dronjak et al., 2004; Pitman et al., 1988), immobilisation stress resulted in 
significantly increased serum corticosterone concentrations when compared to control 
groups.  However, a novel finding is that in the IL-6-antibody-treated stressed group, this 
increase was attenuated (Figure 8.2). These results are not in agreement with a previous 
study investigating the acute stress response in anti-IL-6-treated mice, that showed no 
difference in the corticosterone response to immobilisation between experimental groups 
treated with antibody and those treated with placebo (Nukina et al., 1998).  However, there 
may have been a few confounding factors in the latter study. Firstly, the mean corticosterone 
concentration reported for the control (non-stressed) group was very high (108 ± 35 ng/mL 
compared to our result of 20 ± 6 ng/mL in CP and even only 50 ± 5 ng/mL in IP), which 
 CP CA IP IA 
Serum IL-1β concentration (pg/uL) 
vs. LPS-induced IL-6 (pg/mL) -0.18 0.70* -0.07 0.78* 
Serum corticosterone concentration 
(ng/mL) vs. LPS-induced IL-6 (pg/mL) 0.66* -0.49 -0.12 0.14 
 suggests moderate stress in the controls. This is supported by another study in mice, where 
reported corticosterone concentrations in control mice were < 20 ng/mL, and 30 minutes of 
restraint stress resulted in values of ≈ 50 ng/mL (Lund et al., 2004).  Excess corticosterone 
may therefore have been present before the start of the stress-inducing intervention protocol 
in all groups.  The fact that IL-1β, which is down-regulated by corticosterone, was below 
detectable levels in all groups in the study by Nukina et al. (1998), supports this possibility. 
Secondly, highly variable results within the stressed groups (279 ± 110 and 262 ± 80 pg/mL), 
combined with small sample size (n=5 in some groups), may account for not finding any 
differences between groups. Our result therefore does not support the conclusion made by 
this group, that restraint stress activates the HPA-axis independently of IL-6.  Rather, our 
results suggest that the full-blown corticosterone response is dependent, in part, on IL-6.  
 
Increased serum IL-6 concentration has been reported to result in a decreased TNF-α 
production in a rodent model of pathogen-induced weight loss (Matthys et al., 1995).  In a 
different study, treatment with anti-IL-6 resulted in an increase in TNF-α concentration 
immediately after and 60 minutes after restraint stress (Nukina et al., 1998).  However, IL-6 
levels have also been reported to return to baseline levels within 12 - 24 hours after 
exposure to acute moderate stress, albeit in other models (Northoff et al., 1994; Xing et al., 
1998).  Therefore, our results of non-detectable levels of both IL-6 and TNF-α at rest 24 
hours after short-term intermittent exposure to a mild stressor are not inexplicable. 
Furthermore, since the duration of chronic stress exposure that resulted in up-regulation of 
basal IL-6 concentration in the circulation of human subjects was in excess of 6 years 
(Kiecolt-Glaser et al., 2003), our results suggest that four days of intermittent exposure to a 
mild stressor in rodents, is not analogous to a model of chronically elevated circulating IL-6, 
but is clearly a model of early phase adaptation to mild stress.  Nonetheless, the phenotype 
of weight loss in response to stress was apparent.   Changes in the concentration of IL-6 
mRNA levels in immune cells may possibly elucidate the early adaptive response to mild 
stress further. However, since we did not assess this parameter, we cannot make any 
conclusions in this regard. 
 
Chronic stress is commonly associated with weight loss in both human (Anker et al., 1997; 
Kotler, 1994; Zinna & Yarasheski, 2003) and animal models (Stefanski, 1998).  Although the 
 mechanisms are not fully elucidated, TNF-α and cortisol may be possible mediators of this 
process. It is possible that the immobilisation stress protocol used in our study, although 
relatively mild, was severe enough to result in a shift in the protein balance in favour of 
catabolism, particularly of skeletal muscle.  Other studies have found evidence of severe 
muscle atrophy in rats subjected to more severe immobilisation protocols of longer duration 
(Pattison et al., 2003; Sakakima et al., 2004). While 10 days of hind limb immobilisation 
resulted in a 27 – 37 % decrease in soleus muscle mass (Pattison et al., 2003), 14 days of 
ankle immobilisation resulted in a decrease in muscle fibre cross-sectional area of 62 – 66% 
in the soleus muscle and a reduction of 68 – 78 % in the gastrocnemius muscle (Sakakima 
et al., 2004).  Although the results of these studies are of greater magnitude than our result, 
these models of disuse immobilisation are far more severe than ours and invoke several 
mechanisms for atrophy.  We suggest that our model, although yielding only a mild 
phenotype, is a more physiological model for psychological stress than the latter two studies, 
which models were specifically intended for investigating muscle unloading in the absence of 
mechanical stresses, which induces local atrophy-inducing factors.  Further studies on 
muscle tissue are currently underway, as part of a M.Sc. thesis, to describe further the 
characteristics of stress-induced muscle atrophy present in our model, in which 
immobilisation is kept to a minimum and circulating atrophy-inducing factors are likely to 
predominate. 
 
Normally, IL-1β production results in an up-regulation of IL-6 secretion (Ishikawa et al., 2001; 
Roitt, 1994), with a resultant increase in circulating corticosterone, which provides negative 
feedback to attenuate IL-1β secretion. This negative feedback appeared to be sufficient in IP 
rats for their IL-1β concentrations to be similar to their controls (CP) despite stress.  A novel 
finding in our study was that blocking of IL-6 is associated with a decrease in IL-1β only in 
the presence of stress (Figure 8.3).  However, IL-1β also activates the release of CRH and 
ACTH directly, again with negative feedback provided by cortisol (Sapolsky et al., 2000; 
Watkins, 1994). In our study it appeared as if the effect of down-regulation of IL-1β secretion 
by cortisol was obscured in the stressed groups, with significantly lower IL-1β levels in IA 
than in IP.  This suggests a positive feedback by IL-6 on IL-1β secretion that can partially 
negate the effect of cortisol on IL-1β in mild stress. However, since the same effect was not 
observed in CA, it is unlikely to be a direct effect, but rather associated with some aspect of 
 the complex stress response. This finding and our interpretation is novel.  That it has not 
been seen before could be related to the fact that many stress protocols are more extreme 
than ours, resulting in a greater corticosterone response which would down-regulate IL-1β 
more clearly. Also, anti-IL-6 antibodies have not previously been used in a model of mild 
stress.   
 
The interventions used in this study did not significantly affect total or differential white blood 
cell counts (Table 8.1).  Absolute total WBC and lymphocyte counts were slightly higher, and 
the neutrophil count lower, than those reported earlier in Long-Evans rats subjected to either 
no stress, or 2 or 48 hours of social stress (Stefanski & Engler, 1998).  However, since these 
immune cell counts did not respond to stress in either study, the difference in cell counts 
between the two studies are most likely due to inter-strain differences.  However, considering 
the reported decrease in peripheral node lymphocyte function after acute inescapable tail 
shock (Fleshner et al., 1995a), an unchanged total WBC or lymphocyte cell count does not 
necessarily imply unchanged cell function.  Therefore, functional test results should also be 
considered in a comprehensive evaluation of the immune response to stress. 
 
PBMCs in culture exhibited a similar ability to spontaneously secrete IL-6 during incubation 
in all groups. This suggests that neither 4 days of immobilisation stress, nor short-term 
blocking of IL-6, is sufficiently severe to result in a change in excitation of mononuclear cells 
in the absence of a specific stimulant.  However, a main effect of anti-IL-6 antibody treatment 
was a significant increase in mitogen-induced IL-6 secretion by the combined antibody-
treated group compared to the combined placebo group (P < 0.05), with no independent or 
interactive effect of immobilisation. The result of no effect of immobilisation is in accordance 
with previous reports of unchanged mitogen-induced lymphocyte proliferation rate in rats 
subjected to social stress (Stefanski & Engler, 1998).  If the replacement of blood plasma by 
culture medium in the assay procedure did not successfully remove all the antibody from the 
cell culture, it is possible that the antibody present initially bound to the IL-6 secreted in 
response to LPS. This would result in an increased cytokine secretion due to lack of early 
negative feedback by IL-6 on cell function.  Alternatively, if anti-IL-6 antibody became 
membrane-bound and was not washed out by plasma replacement, it may have prevented 
 negative feedback throughout the assay time period.  However, given the magnitude of 
increase in IL-6 secretion in the antibody-treated rats, the concentration of residual antibody 
is unlikely to have such a substantial effect.  More likely, blocking of IL-6 may have caused 
adaptation of PBMCs to render them more sensitive to mitogen stimulation, so that 
stimulation resulted in excess cytokine secretion by these cells.  The fact that mitogen-
induced IL-6 release was positively correlated with serum IL-1β concentrations in the 
antibody-treated groups only, suggests that the proposed effect on PBMCs may be mediated 
by IL-1β.   It also argues against the finding being an artefact of residual antibody in the 
assay procedure, since the correlation was with serum IL-1β, and not with in vitro mitogen-
induced PBMC-secreted IL-1β. 
 
8.5 Conclusion 
 
Our results illustrate three important points regarding IL-6: a) that psychological stress 
activates the HPA-axis in a manner augmented by IL-6, b) that IL-6 plays a role in 
maintenance of the IL-1β concentration under conditions of mild stress, thus allowing a 
continued elevation of corticosterone release, and c) that IL-1β plays a role in priming 
PBMCs for enhanced function, a function normally obscured by IL-6. 
 
 
 Chapter 9 
 
Synthesis 
 
9.1 Introduction 
 
Acute exercise stress results in physiological changes in the immune system and endocrine 
stress-axis that are usually only transient.  Repeated exercise bouts in quick succession may 
however prevent the body from fully recovering between bouts. In training regimens followed 
by elite athletes, insufficient recovery time from exercise is frequent, rather than the 
exception.  These athletes are also under constant psychological stress (both sport and 
every-day life stresses), which further contributes to their overall stress status.  Unless an 
athlete is able to adapt and cope with the increased stress, the body may become unable to 
react effectively to additional stressors, resulting in increased risk of acute illness, inability to 
train and decreased performance in competitive events.  Alternatively, the body may be 
rendered unable to down-regulate the stress response, which may lead to chronic disease. 
Both these possible outcomes are equally detrimental to a career in sports.   
 
From the reviewed literature it is clear that chronic exercise-related stress affects both the 
immune system and endocrine stress-axis, but there are still many uncertainties (2.7).  The 
contributions of this thesis to filling some of the gaps will be highlighted. 
 
9.2 Impact of results 
 
Even though the in vitro PBMC assay has been used before by exercise physiologists, the 
spontaneous secretion of IL-6 after incubation was not reported as a finding.  This may be 
because it was assumed to be a response to the assay conditions, and thus merely used in 
calculation of the mitogen-induced response.  However, one of the most important results in 
Chapter 3 was that there was an inverse relationship between the spontaneous and 
mitogen-induced IL-6 release by PBMCs at rest.  Higher spontaneous release was 
associated with lower mitogen-induced release of IL-6.  In a previous study of which I was a 
 co-author (Pool et al., 2002), we showed that spontaneous IL-6 release in sedentary 
subjects was very low (≈ 25-fold lower) compared to that in endurance athletes at rest.  
Together, these results indicate that chronic exercise stress results in a chronic low-grade 
activation of pro-inflammatory activity, which renders PBMCs less capable of mounting a 
response to an additional stressor.  This first study posed some questions: 
a) Which other immune cells are chronically activated? 
b) Is this up-regulation the result of an increased upstream activation, or a lack of negative 
feedback? For example, a lower level of CD8+ suppressor T cell activation could lead to an 
overactivation of CD4+ cells. Similarly, chronic exposure to cortisol may decrease the 
sensitivity of its inhibitory action on T lymphocyte cytokine release.  
c) Is reduced mitogen-induced IL-6 release at rest after chronic stress the result of a direct 
feedback of circulatory IL-6? 
 
In the next study (Chapter 4) we purposefully subjected recreationally competitive cyclists to 
a training regimen more similar to that of elite athletes.  A main finding in the training study 
was the decreased absolute CD8+ cell count at rest after training, which could lead to a lack 
of suppressor cell capacity to inhibit CD4+ cell activation.  However, the average CD4+:CD8+ 
ratio for the group was not affected by the intervention with unaccustomed training.  Rather, 
the CD4+:CD8+ ratio at rest was associated with individual habitual training volume, with 
lower ratios associated with higher training volumes. 
 
Another important finding was that spontaneous activation of CD4+ lymphocytes was 
increased at rest after unaccustomed high-intensity interval training.  However, this was not 
true for the CD8+ cells, indicating that CD4+ cell activation may be more sensitive to exercise 
stress. Similar to the finding in the in vitro assay in Chapter 3, the mitogen-induced response 
in the CD4+ cells was lower, suggesting that a negative effect of chronic spontaneous cell 
activation on the immune response to a subsequent mitogenic challenge is generally 
applicable.    
 
Cortisol high-responders to chronic psychological stress (Chapter 5) also showed 
significantly higher spontaneous CD4+ (as in Chapter 4) as well as CD8+  (not shown in 
Chapter 4) cell activation when compared to cortisol low-responders in the same study, 
 indicating that chronic exposure to cortisol may reduce the effectiveness of its normal 
inhibitory role in spontaneous T cell reactivity.   This led us to develop an animal model in 
which stress exposure could be controlled, to further investigate this possibility. 
 
In the first animal study (Chapter 6) we confirmed that the model of mild physiological stress 
worked in our hands.  This was confirmed when a known anxiety-reducing supplement 
abolished the stress response (Chapter 7).  Another interesting finding in the first study 
(Chapter 6) was that IL-1β concentration was elevated immediately after acute stress 
exposure, as well as 24 hours later, whereas IL-6 was not elevated at either time point.  This 
result, as well as no detectable IL-6 at rest at any time point during the training study 
(Chapter 4, result not reported), led us to question the significance of IL-6 as essential to a) 
the chronic stress response and b) immune cell reactivity. 
 
Our final study was designed to investigate the influence of stress on the immune and 
endocrine systems in the absence of IL-6 (Chapter 8).  We successfully demonstrated that 
IL-6 is required to induce a proper corticosterone response to immobilisation stress (Figure 
8.2). Since a marker for CD69 expression in rat T cells is not available, we reverted to the 
less specific PBMC assay.  Unfortunately, spontaneous IL-6 release was not affected by the 
4 days of exposure to mild stress.  Neither did the stress protocol affect mitogen-induced IL-
6 secretion.  These results imply that the 4-day animal stress model is not similar to chronic 
exercise stress and that if IL-6 does play a role in immune cell reactivity, it will either be more 
acute, i.e. not evident in a sample taken at rest, or only develop with longer-term exposure.  
 
Nevertheless, influences of both corticosterone and IL-6 on the mitogen-induced IL-6 
response were evident.  Blocking of IL-6 in control rats resulted in an increased mitogen-
induced IL-6 response, suggesting moderate self-regulation of IL-6 release under normal 
conditions. This is not dissimilar to the conclusion that can be drawn from the relationship 
reported between spontaneous and mitogen-induced IL-6 release in the first study (Figure 
3.3).  However, as in the first study, this relationship was not evident in the presence of 
stress.  This implies that another factor associated with stress can inhibit IL-6 secretion.  The 
complex interactions between the pro-inflammatory and anti-inflammatory markers we 
measured are very clearly indicated in Table 8.2.   Under normal conditions (no stress), 
 within the low normal range of corticosterone, its concentration correlated positively with 
mitogen-induced IL-6 release, but when one or more conditions were manipulated (either 
stress exposure, or blocking of IL-6, or both), this relationship was not evident. In the 
presence of normal low corticosterone and anti-IL-6 antibody, corticosterone concentration 
no longer affected mitogen-induced IL-6 release directly. Instead, IL-1β correlated with the 
enhanced response. In the presence of stress, despite the presence of sufficient IL-1β, 
corticosterone down-regulated IL-6 secretion. This also occurred in the presence of the 
antibody, although IL-1β was able to partially rescue the mitogen-induced secretion of IL-6.   
 
Given the complexities in the interpretation of resting immune cell counts and functions 
(which may be related in part also to their intra-individual variability) reverting back to the 
endocrine system markers of stress status (which have more acceptable intra-individual 
variability; Table 5.2) should be considered.  In the well-controlled animal model of chronic, 
intermittent immobilisation stress lasting 28 days, corticosterone concentration, as well as 
the corticosterone:testosterone ratio, was increased (Figure 7.1).  However, in the training 
study (Chapter 4), no training effect was evident on either the mean absolute concentrations 
of endocrine parameters, or the relationships between them (Table 4.2).  Nonetheless, after 
re-analysing results from Chapter 4, dividing these subjects into two groups according to 
their cortisol concentration at baseline, there was a clear difference in the cortisol responses 
to training between the two groups (Figure 9.1a).  While the group with higher initial cortisol 
concentrations (n = 3) showed a decrease in resting cortisol concentration during training, 
the opposite effect was evident for the group who started with a moderate cortisol 
concentration (n = 4) at baseline. (No subject exhibited resting cortisol concentrations as low 
as those in the low-responder group in Chapter 5, and this group was therefore termed 
“moderate” responders.) Although the testosterone responses appeared similar for the two 
groups (Figure 9.1b), the cortisol:testosterone ratio in the group with moderate baseline 
cortisol concentration was more responsive (albeit with high variability) to the exercise 
training intervention when compared to the group with high baseline cortisol concentration 
(Figure 9.1c). 
 
 Figure 9.1 Differences in the effect of training on the responses of a) cortisol, b) 
testosterone and c) the cortisol:testosterone ratio at rest in subjects with either high or 
moderate serum cortisol concentration at baseline (data from Chapter 4, re-analysed). 
 
(a) 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
 
c) 
 
 
 
 
 
 
 
Values are means ± SD. 
 
 
These results indicate that consideration of both cortisol and the cortisol:testosterone ratio 
may be useful for the assessment of changes in stress status. However, careful classification 
of the subject group at baseline is necessary for comprehensive interpretation of results, 
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 since a lack of this precaution may mask such changes.  This approach requires higher 
subject numbers so that division into groups is more feasible than in the current study. 
 
9.3 Conclusions and recommendations for future studies 
 
Although the interactions between role-players in the systemic stress response cannot be 
accurately simulated in in vitro studies, the latter techniques allow for the controlled 
manipulation of potential stress-response mechanisms.  I conclude that the effects of stress 
on specific role-players, or interactions between them, may never be elucidated unless the in 
vitro systems are artificially manipulated.  For example, our results suggest a positive 
feedback loop between IL-1β and IL-6 in the presence of a stressor, rather than a one-way 
up-regulation of secretion of IL-6 by IL-1β only.  Follow-up studies in appropriate subject 
populations are needed to illuminate the mechanism by which this may be achieved. 
Possible mechanisms include a) cytokine-mediated alterations to the setpoint (balance) 
between different types of glucocorticoid receptors present on immune cells, as recently 
suggested (Peters et al., 2004; Strickland et al., 2001), or b) increases in cytokine gene 
transcription rates, which may be a result of decreased glucocorticoid-mediated 
transrepression (transcriptional interference) of key regulatory factors in gene expression, 
such as nuclear factor-kappaB and activator protein I, or  an increase in cytokine response 
element-mediated transactivation (gene transcription). 
 
Our results of the chronic up-regulation of spontaneous activation status of both PBMCs and 
T lymphocytes in athletes in response to exercise stress are novel.  However, the PBMC 
assay that we used, does not distinguish between monocytes and lymphocytes, while the 
assessment of CD69 expression by T cells cannot distinguish between the activation of TH1 
and TH2 lymphocytes. Given the different roles or these cells in the immune response, 
namely activation of the cell-mediated vs. the antibody-mediated immune responses, it is of 
importance to determine the nature of this up-regulated spontaneous activation in response 
to stress, in a cell type specific manner.  This could be done by culturing isolated cell 
populations,  instead of whole blood.  Furthermore, given the divergent cortisol response to 
chronic stress (illustrated in both sedentary and athlete populations), and its implication for 
 immune reactivity (illustrated in sedentary subjects after psychological stress), we 
recommend that future studies should investigate possible differences in the regulation of 
spontaneous TH1 and TH2 cell activation in response to chronic exercise stress in cortisol 
high- vs. low-responder athletes. 
 
Finally, we report that our result of unchanged cortisol concentration at rest in response to 
chronic stress, is the net result of a divergent response to stress, rather than a reflection of 
no change. Serum cortisol concentration at rest, and potentially the cortisol:testosterone 
ratio, may in fact be useful indicators of stress status, with the precondition of subject 
classification at baseline.  Further studies, using larger subject numbers and a more varied 
population, are required to further substantiate our finding in studies with relatively low 
subject numbers.  
  Appendix A 
 
Determination of T lymphocyte subpopulation distribution and 
responsiveness using flow cytometry 
 
Assay principle 
 
Flow cytometry uses either structural features of cells, or components on the cell, such as 
fluorescent antibodies directed against the cells, to quantify these cells by optical means. 
The cells may be alive or fixed at the time of measurement, but must be in monodisperse 
(single cell) suspension. They are passed single-file through a laser beam by continuous 
flow of a fine stream of the suspension.  Each cell scatters some of the laser light, and also 
emits fluorescent light excited by the laser. The flow cytometer measures several parameters 
simultaneously for each cell: 
1) forward scatter intensity, which is approximately proportional to cell diameter  
2) 90º side scatter intensity, which is approximately proportional to the quantity of 
granular structures within the cell, and 
3) fluorescence intensities at several wavelengths, so that if  particles have been 
stained with one or more fluorescent dyes, the light source excites these dyes to 
provide additional biological information about each particle, such as presence of 
specific surface and intracellular markers (Lewis & Rickman, 1992; Shapiro, 1995; 
Steen, 1990). 
These fluorescent pulses and scattered light are converted into digital pulses and sent to a 
computer for analysis.  Light scatter alone is sufficient to distinguish lymphocytes from 
monocytes from granulocytes in blood leukocyte samples. Fluorescent antibodies are often 
used to report the densities of specific surface receptors, and thus to distinguish 
subpopulations of differentiated cell types (Hannet et al., 1992; Lewis & Rickman, 1992; 
Maino et al., 1995; Shapiro, 1995; Steen, 1990).  
 
 Interpretation of results 
 
There are two ways to identify lymphocytes in a whole blood sample.  One way is to label the 
lymphocytes with a fluorescence-labeled antibody directed against CD45, a general 
lymphocyte surface marker. A scatter plot is then generated according to CD45 fluorescence 
(X-axis) and side scatter (Y-axis). The other way is to generate a scatter plot without using a 
cellular marker antibody, according to forward scatter (X-axis) and side scatter (Y-axis). (The 
latter is typically used for analysing non-human samples.) Forward scatter increases with 
increased cell size, while increased side scatter indicates higher cell granularity. Typical 
scatter plots obtained in these ways are illustrated below: 
 
a) Using scatter characteristics only   b) Using fluorescence labeled CD45 antibody 
 
 
Lymphocytes may be distinguished on the two graphs by the characteristics (a) “FSChigh 
SSClow”, which means that lymphocytes exhibit high forward and low side scatter, or (b) 
“CD45bright SSClow”, which means that they are positive for CD45, and exhibits low side 
scatter on a flow cytometry scatter plot,  (Lewis & Rickman, 1992).  These lymphocytes are 
then selected, or “gated” manually (indicated on the plots above).  These cells only are then 
plotted again on a similar scatter plot, but according to fluorescence of CD3 (for T cells) on 
the X-axis vs. fluorescence of CD4 or CD8 on the Y-axis. Representative scatter plots 
achieved this way are illustrated below: 
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 a) CD3 vs. CD4 fluorescence   b) CD3 vs. CD8 fluorescence 
 
 
From this it is clear that the CD4+ and CD8+ T cells are in the right hand upper quadrant of 
each graph respectively.  These groups of cells can then each be gated again and another 
scatter plot generated according to CD4 or CD8 vs. CD69 fluorescence. Typical plots are 
illustrated below: 
 
a) CD4 vs. CD69    b) CD8 vs. CD69 
  
Again, cells expressing both CD69 and CD4, or both CD69 and CD8, will appear in the right 
hand upper quadrant of the scatter plot.  For all graphs, all gated cells are automatically 
expressed as a percentage of total lymphocytes counted.  Using the differential white cell 
count, these percentages can be converted into absolute cell counts. 
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 Expected normal values for human lymphocyte subpopulations* 
     (Lewis & Rickman, 1992; Maino et al., 1995) 
 
Subpopulation Range (18 – 70 years) 
CD3+ 1 100 – 1 700 cells/uL 
CD4+ 700 – 1 100 cells/uL 
CD8+ 500 – 900 cells/uL 
CD4+:CD8+ ratio 1.0 – 1.5 : 1 
CD19+ (B cells) 200 – 400 cells/uL 
CD16/56+ (NK cells) 200 – 400 cells/uL 
CD4+CD69+ No reference range established yet 
CD8+CD69+ No reference range established yet 
 
* No normal values has been established for rat blood samples 
 Analytical procedure  
 
1. Lymphocyte phenotyping 
Reagents and equipment 
Multitest CD3FITC/CD4APC/CD8PE/CD45PerCP antibody 
Multitest CD3FITC/CD16+56PE/CD19APC/CD45PerCP antibody 
Fluorescent Activated Cell Sorter (FACS) Lysing Solution 
FACS tubes 
3-colour flow cytometer (FACS Calibur) 
 
All reagents and equipment are available from Becton Dickinson, New Jersey, USA  
Method 
1. Label two tubes per sample. 
2. Prepare a 1:3 dilution of each Multitest antibody reagent in phosphate buffered 
saline (PBS). 
3. Add 20ul of antibody dilutions to two separate tubes. 
4. Add 50ul of heparin/EDTA whole blood to each tube. 
5. Mix gently and incubate at room temperature for 15 minutes in the dark. 
6. Mix again and add 450ul FACS Lysing Solution (diluted 1:10 in distilled water). 
7. Mix and incubate for 10 minutes at room temperature in the dark. 
8. Analyse on flow cytometer. 
 
 2. Determination of CD69 expression 
Reagents and equipment 
12-O-tetradecanoylphorbol-13-acetate (TPA) 
Ionomycin 
Multitest CD3PerCP/CD4FITC/CD69PE antibody 
Multitest CD3PerCP/CD8FITC/CD69PE antibody 
Fluorescent Activated Cell Sorter (FACS) Lysing Solution 
FACS Cell Fixative 
FACS tubes 
3-colour flow cytometer (FACS Calibur) 
 
All reagents and equipment are available from Becton Dickinson, New Jersey, USA. 
Method 
1. Preparation of TPA: 
a) Prepare a 1mg/ml stock solution in DMSO medium (aliquots of 20ul stored 
at –20 °C). 
b) Dilute 20ul in 980ul culture medium (1:100). 
2. Preparation of Ionomycin: 
a) Make up a stock solution of 1mg/ml in ethanol (store in aliquots of 50ul at –
20 °C). 
b) Dilute 50ul in 450ml culture medium (1:10) 
3. Label 4 tubes per sample: two for unstimulated cells and two for stimulated cells. 
4. To unstimulated-labelled tubes, add 100ul whole blood (heparin/EDTA). 
5. To stimulated-labelled tubes, add 100ul whole blood, 4ul ionomycin and 5ul TPA. 
6. Incubate for 4 hours at 37 °C at 5 % CO2 and 98 % humidity. 
7. Add 10ul of CD4/CD69 and 10ul CD8/CD69 to one ‘unstim.’ and one ‘stim.’ tube 
each. 
8. Incubate for 20 minutes at room temperature in the dark. 
9. Add 500ul FACS Lysing Solution to all tubes. 
10. Incubate for 10 minutes at room temperature in the dark. 
 11. Analyse on flow cytometer within 60 minutes. 
12. If not possible, centrifuge samples at 1800 rpm for 5 minutes. Decant supernatant. 
Add 2ml PBS and centrifuge again. Decant. Add 500ul fixative to the cells and store 
at 2 – 8 °C until analysis.  
 Appendix B 
 
ELISA for IL-6 secretion in whole blood culture supernatant (human) 
 
Reagents 
 
Rabbit anti-IL-6 (Sigma) 
Rabbit serum (Highveld Biologicals) 
Trition X100 wash solution (Merck Chemicals)  
Recombinant human IL-6 (Sigma) 
Biotinylated rabbit anti-IL-6 (Sigma IL-6 antibody biotinylated using Boehringer Mannheim 
protein biotinylation kit) 
Avidin-peroxidase complex (Amdex, Denmark) 
TBM substrate (Boehringer  Mannheim, Germany) 
0.2 M H2SO4 
96-well plates 
 
Method 
 
A) Plate preparation: 
1. Dilute rabbit anti-IL-6 antibody 1:1000 with saline. 
2. Coat plates with rabbit anti-IL-6 by adding 100uL/well and incubating overnight at 
room temperature. 
3. Aspirate and block wells by adding 200uL/well of 1% rabbit serum in saline, 
incubating 30 minutes at room temperature. 
4. Wash plates once with saline containing 0.1 % Triton X100 (wash solution). 
 
B) IL-6 assay: 
1. Prepare standard solutions for IL-6 using human recombinant IL-6.  
2. Add 100uL/well of samples or standards were added (100 uL/well) and incubated at 
37 °C for 90 minutes. 
 3. Wash plate three times in wash solution. 
4. Dilute biotinylated rabbit anti-IL-6 1:200 in 1 % rabbit serum, add 100 uL/well and 
incubate at 37 °C for 90 minutes.  
5. Wash plate three times in wash solution. 
6. Dilute avidin-peroxidase complex 1:1000 in 1 % rabbit serum, add 100 uL/well and 
incubate at room temperature for 20 minutes. 
7. Wash plate four times in wash solution. 
8. Add 100 uL/well of TBM substrate and incubate at room temperature in the dark for 
20 minutes.  Stop the chromogenic reaction by addition of 100 uL/well of 0.2 M 
H2SO4. 
9. Read optical density on a plate reader at 450 nm. 
 
C) Standard curve: 
1. Use standard solutions to generate a linear standard curve, from which IL-6 
concentrations in samples can be extrapolated. 
2. A representative typical standard curve is illustrated below: 
 
Standard curve for IL-6
y = 1205.1x - 171.12
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3. NOTE: The linear detection range was previously established at 10 – 1240 pg/mL.  
Coefficients of variation between samples analysed in duplicate, and between 
assays, are typically less than 7 %.  
 Appendix C 
 
Determination of in vitro mitogen-induced IL-6 secretion after in vivo 
administration of anti-IL-6 antibody (rat) 
 
Assay principle 
 
This assay is similar to the one described earlier, used in humans participating in an ultra-
marathon (refer to Chapter 3). However, since this was the first time the assay was used to 
analyse rat blood, it had to be optimised first by doing a dose-time response determination.  
Also, since the whole blood would contain the administered anti-IL-6 antibody, the plasma of 
all samples was removed (taking care not to remove white cells as well) and replaced by an 
equal volume of RPMI medium to prevent interference of the antibody with the assay 
procedure. 
 
Reagents 
 
E.coli LPS (Sigma) 
RPMI 1640 medium, containing 5% glutamine (Highveld Biologicals) 
Rat IL-6 kit (Biotrak 2742, AEC Amersham) 
Sterile test tubes 
Sterile pipette tips 
 
 A) Dose-time response assay (performed on pooled rat whole blood) 
 
Method 
 
1. Make up LPS concentrations of 0.0 ug/mL, 0.5 ug/mL, 1.0 ug/mL and 1.5ug/mL 
(dosage most frequently used in literature, is 1ug/mL (Li et al., 2002; Sautebin et al., 
1999)) in RPMI 1640 medium. 
2. Label 4 tubes each for 4, 8, 12, 16, 18, 20 and 24 hours (incubation times reported 
for rat and murine cell cultures are 12 – 24 hours (Li et al., 2002; Sautebin et al., 
1999), and for human whole blood 4 – 18 hours (Pool, 1999; Pool et al., 2002; 
Tantak et al., 1991). 
3. Into all tubes, pipette 500 uL whole blood. 
4. For each time point, pipette into 4 test tubes 2000 uL of 0.0, 0.5, 1.0 or 1.5 ug/L 
LPS-RPMI solution. 
5. Incubate at 37 °C, in the presence of 98 % humidity and 5 % CO2. 
6. Centrifuge a set of 4 tubes at incubation time points 4, 8, 12, 18 and 24 hours and 
collect supernatant. 
7. Freeze at –80 °C until batch analysis of IL-6. 
8. Determine IL-6 concentration using assay kit. 
9. Draw curve of time and IL-6 concentration for each LPS concentration. 
 
 
 Results 
 
Figure 1  Standard curve obtained for IL-6 
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Figure 2 IL-6 secretion measured for each incubation time and LPS dosage 
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 Discussion 
 
Cells showed the best reaction to 1.5 ug/L LPS after 12 hours of incubation. However, the 
values obtained after 16, 18, 20 and 24 hours suggested that cells responded in absence of 
LPS, indicating stress, while addition of LPS as well resulted in a decreased response. This 
may indicate that the cells were experiencing oxidative stress in the closed reaction tubes, 
so that cells died off after 16 hours, resulting in a less that optimal response.  In addition, the 
large volume of blood necessitated the use of pooled rat blood, so that this pilot assay does 
not give an indication of the inter-individual variation that can be expected in the actual study 
assay. Therefore, we decided to incubate cells with 1.5ug/L LPS for both 12 and 24 hours for 
our study protocol.  In addition, the reaction tubes were not closed airtight, to prevent oxygen 
starvation.   
 
 B) Culture assay for determination of LPS-induced IL-6 secretion in rat whole 
blood 
 
Method  
 
1. Prepare of LPS-RPMI medium with a final concentration of 1.5 ug/mL LPS. 
2. Prepare whole blood: To reduce the concentration of anti-IL-6 antibody in the whole 
blood, centrifuge blood for 10 minutes at 3000 rpm at room temperature. Then 
remove plasma and replace with an equal volume of RPMI medium. Mix gently and 
use for blood culture. 
3. Prepare cell culture: 
a. Prepare 4 tubes for each rat: 1x stim. 12 hours, 1x stim. 24 hours, 1x unstim. 
12 hours, 1x unstim. 24 hours 
b. To stim tubes add 1ml RPMI-LPS medium and to unstim tubes 1ml RPMI 
medium. 
c. To all tubes add 250ul blood, prepared in (2). 
d. Incubate for 12 and 24 hours at 37 °C, in the presence of 98 % humidity and 
5 % CO2. 
e. Centrifuge at 3000 rpm for 10 minutes and draw off supernatant into 2 
eppies. 
f. Freeze at –80 °C until batch analysis using IL-6 kits, as used in the dose-
time response assays. 
4. Determine IL-6 concentrations in all supernatants. 
5. To calculate the amount of IL-6 secreted in response to mitogen stimulation, subtract 
the IL-6 concentration measured in the “stim” tube from that of the “unstim” tube. 
 
Results 
 
Results obtained indicated that the cells in the time-dose response assay may indeed have 
been oxygen starved, since values for spontaneous release of IL-6 was much lower in the 
control group (CP) in the latter assay (Figure 3).   
  
Figure 3 Comparison between spontaneous IL-6 release by PBMCs in culture (i.e. in 
absence of LPS) in dose-time response assay (pooled control) vs. the actual study 
protocol (control placebo) to illustrate the effect of oxygen starvation on cell activation. 
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Furthermore, due to high inter-individual variation (Figure 4), incubation for 24 hours proved 
more optimal than 12 hours for our purposes.  Therefore, only the results of the 24-hour 
culture are reported in Chapter 9. 
 
Figure 4 Comparison of the mitogen-induced release of IL-6 in vitro after 12 and 24 
hours of incubation. 
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 Figure 1.1 Lymphocyte subpopulations 
Helper T-cells 
CD45+/CD3+/CD4+ 
These cells activate B-cells to 
differentiate into antibody-secreting 
plasma cells and also activate cytotoxic 
T-cells.  They may also play a role in 
generation of suppressor T-cells. 
Suppressor T-cells 
CD45+/CD3+/CD8+ 
The function of these cells is still somewhat debated. 
The basic concept is that suppressor T-cells inhibit 
the establishment of an immune response, by 
suppressing the immune action of B- and other T-
cells. The mechanism is unclear, and research made 
difficult by the absence of a surface marker specific 
to this cell-type.
Cytotoxic T-cells 
CD45+/CD3+/CD8+ 
These effector lymphocytes have Fc 
receptors to allow it to bind to and kill 
antibody-coated (sensitized) target 
cells by antibody-dependent cell-
mediated cytotoxicity (ADCC). 
Natural killer T-cells 
CD45+/CD16+ or CD45+/CD56+ 
These large granular cells kill various tumor cells and virus-
infected cells by phagocytosis, in a non-specific manner.  
Immunisation does not increase the number of natural killer 
cells in circulation. These cells may also play a role in ADCC. 
T-lymphocytes 
CD45+/CD3+ 
T-cells are the main components in cellular immunity.  T-
cells in general attack virus-infected cells, and abnormal 
tissue, such as foreign tissue and tumor tissue. They also 
produce a number of substances to regulate the immune 
response.
B-lymphocytes 
CD45+/CD19+ 
B-cells are responsible for the antibody-mediated immune 
response. The main function of B-cells is to differentiate 
upon stimulation to form plasma cells, which produce 
specific immunoglobulins (antibodies) to destroy identified 
foreign substances.
Lymphocytes 
CD45+ 
Lymphocytes identify foreign substances or bodies and produce 
antibodies and cells that specifically target them. Depending on the 
cell type responding, it may take from a few days to several weeks 
for the immune system to react to and destroy a new foreign 
substance.
TH2-cells 
The activity of this cell type is thought to inhibit cell-
mediated immune responses and to enhance the 
humoral immune response. TH 2-cells secrete IL-4, 
IL-5, IL-6, IL-10 and IL-13, which assists B-cells to 
produce IgE and IgG1, as well as supporting 
eosinophils and mast cells. 
TH1-cells 
These cells enhance cell-mediated immune response by secreting 
IL-1 and γ-interferon.  This cell type inhibits TH2 subset activity and 
the humoral immune response. In addition, they secrete IL-2 and β-
TNF, are pro-inflammatory, assist B-cells in production of IgG2a, 
activate cytotoxic T-cells and macrophages, and stimulate delayed 
hypersensitivity reactions. 
Null cell 
CD45+ 
This is an early population of 
lymphocytes, which expresses 
neither T-, nor B-cell surface 
markers. 
TH3-cells 
Produces the inhibitory cytokines IL-10 
and transforming growth factor (TGF)-β. 
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Figure 1.2 Interaction between cytokines and 
immune cells in the immune response  
 
 
Abbreviations: 
 
M = Monocyte NK = Natural killer cell 
N = Neutrophil CT = Cytotoxic T cell 
T = T lymphocyte ST = Suppressor T cell 
B = B lymphocyte PC = Plasma cell 
Cell-mediated immune response                                                               Antibody-mediated immune response 
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IL-4 
IL-6 
